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ABSTRACT 
Caudal Circulation in the Short-finned Eel AnguiZZa austraZis sc~idtii 
(Phillips). P.S. Davie. Department of Zoology, University of 
Canterbury, Christchurch, New Zealand. 
The anatomy, neuroanatomy and neural control of the caudal lymph 
heart of the short-finned eel are described. 
accessory caudal vascular pumps is discussed. 
The evolution of 
An isolated saline perfused eel tail preparation is described which 
is suitable for investigation of vascular and interstitial fluid 
circulation. Dose versus vascular resistance response curves for 
adrenaline, noradrenaline and isoprenaline are presented. The eel tail 
vascular bed has alpha constrictory and beta two dilatory adrenergic 
receptors. Beta two receptors may be stimulated in vivo by sympathetic 
nervous activity. Vascular volume changes in the eel tail during 
constriction and dilation were small; less than three per cent of the 
tail vascular volume. Significant amounts of perfusate were extra-
vasa ted when resistance increased more than - 100% of baseline 
resistance. 
Frequency and amplitude of the lymph heart of the perfused tail 
increased when resistance increased by more than - 100% of baseline 
resistance. Frequency increases were probably caused by interstitial 
fluid build up rather than direct actions of vasoconstrictory drugs. 
One important function of the lymph heart is recovery of interstitial 
fluid from the tail. 
Cardiac output, and ventral aortic, dorsal aortic and caudal 
venous blood pressures were recorded from unrestrained eels at rest, 
while swimming at 15 cm.s- l and 22-25 cm.s- l , and after exercise. 
During swimming cardiac output fell slightly and transbranchial 
pressure differential increased. Elevated ventral aortic pressure 
was the principal cause of the increase in transbranchial pressure 
differential. Plasma catecholamine concentrations probably do not 
increase during swimming in the short-finned eel. Spontaneous cessation 
of swimming often occurred at very high branchial resistances. It is 
suggested that this response has a protective function for the gill 
tissues. 
GENERAL INTRODUCTION 
The series of reviews on topics in fish physiology edited by,W.S. 
Hoar and D.J. Randall (1970) and the monograph 'Circulation in Fishes' 
by G.H. Satchell (1971) have stimulated research into many areas of 
fish physiology. Fish species which are important food sources have 
provided most of the information on which our understanding of fish 
cardiovascular physiology is based. Although our knowledge of the 
cardiovascular system in species of salmonid, eel and cod is relatively 
comprehensive, there remain several important problems to be resolved 
such as .whether blood flow to vascular beds is controlled by circulating 
catecholamine concentrations or by sympathetic nervous activity. 
Questions such as the role of the lymphatic circulation in fishes have 
still to be asked. 
This thesis is mainly concerned with two aspects of circulation of 
body fluids within the tail of the short-finned eel (Anguilla australis 
schmidtii) . These are the control of vascular resistance of the eel 
tail and the function and functioning of the caudal lymphatic heart. 
The text is divided into three sections each of which begins with a full 
introduction and ends with a summary of the principal findings and 
conclusions. The first section is an account of the caudal lymphatic 
heart as an organ and describes the anatomy and neural control system 
of the lymph heart. The second deals with the vascular bed of the eel 
tail in isolation from the rest of the body, particularly its responses 
to sympathetornimetic drugs. The third section is a study of the intact 
eel circulatory system during swi:m:ming in an attempt to relate isolated 
tissue results to the animal as a whole. 
1 
PART I THE CAUDAL LYMPHATIC HEART OF 
ANGUILLA AUSTRALIS SCHMIDTII 
I.l Introductions 
I.l.l The lymphatic system of fishes 
Lymphatic vessels are an integral part of the circulatory system of 
vertebrates. Embryologically lymph vessels are derived from mesenchyme 
and are phylogenetically almost as old as the veins and arteries of 
chordates. Cephalochordates have sacs or spaces equivalent to the 
lymphatics of higher vertebrates, but the first appearance of true 
lymphatics occurs within the fishes (Kampmeier, 1969). 
Lymphatics are divisible into capillaries, precollecting ducts and 
collecting ducts on the basis of size and the structure of the vessel 
wall. Lymphatic capillaries are the smallest, with a diameter of 
- 10-50 ~m. The walls are composed of very permeable endothelium only 
(Casley-Smith and Florey, 1961). Lymph capillaries are not continuous 
with the arterio-venous system, but end in blind sacs within tissues. 
Pre collecting lymph ducts have diameters that vary between ~ 20 and 
200 ~m. These ducts have a layer of elastic connective tissue 
surrounding the endothelium and carry lymphatic fluid from the lymphatic 
capillaries through the tissue bulk to large collecting ducts. The 
larger collecting ducts have diameters greater than ~ 200 ~m. Their 
walls have layers of smooth muscle surrounding the endothelium and 
elastic connective sheaths. In mammals large collecting ducts have 
valves which prevent backflow of lymph. The largest of lymph vessels 
in mammals, the thoracic duct, empties into the innominate vein through 
a valved orifice thereby returning lymph to the blood vascular system 
(Battezzati and Donini, 1972). 
The primary function of lymphatics is to recover interstitial 
fluids and solutes, particularly proteins from tissues. In higher 
vertebrates the lymphatic system has assumed a number of other functions 
including haemopoesis, anti-infection action by lymphocytes and anti-
bodies, glandular secretions and fat transport within the chylous 
vessels. 
The formation of lymph has received a great deal of attention. 
The question of how lymph is formed can only be satisfactorily answered 
once an understanding of the dynamic equilibrium that exists between 
blood tissue and lymph has been gained. Starling (1894, 1896) proposed 
a theory which later became known as the Starling hypothesis. This 
hypothesis describes the transcapillary exchange processes; it 
2 
basically states that the efflux of fluid into tissue from the arterial 
end of capillaries containing oxygen, ions and nutrients is proportional 
to the fluid hydrostatic pressure within the capillaries. This is the 
process of ultrafiltration or convection. Hydrostatic pressure decreases 
over the length of the capillaries as a result of fluid loss and friction 
against vessel walls. At the venous end of capillaries, low hydrostatic 
pressure and a high colloid osmotic pressure, because of restricted 
movement of very large molecules through the capillary walls, causes 
resorbtion of fluid lost to the tissues at the arterial end. Thus by 
constant efflux of fluid at the arterial end and resorbtion at the venous 
end tissues adjacent to capillaries are continuously bathed with fluid 
derived from the blood. The hypothesis still stands as the basis for 
our current concepts of capillary exchange processes with additions and 
modifications from subsequent research (see Pappenheimer and Soto-Revera, 
1948; Mellander and Johansson, 1968; Barcroft, 1976; Mellander, 1978). 
Lymph is derived from interstitial fluid. Thus lymph formation 
can be described by three separate but.related mechanisms. First the 
production of tissue fluid by ultrafiltration, diffusion and vesicular 
exchange across the 'arterial' capillary walls. Second, interstitial 
fluid moves through the interstitium transporting and exchanging solutes. 
Third, tissue fluid either leaves the interstitium via the 'venous' 
capillaries or is sequestered into the blind endings of the lymphatic 
capillaries which penetrate into almost all tissues. 
Tissue fluid does not exist as a free solution but is bound onto 
hydrophyllic connective tissue fibres that form the matrix between the 
cells. Movements of water and molecules through this space is by 
restricted diffusion. Large molecules (> 60 nm in diameter) behave as 
if travelling through a 'gel column' rather than through a fluid space 
(Watson and Grodinis, 1978). 
Sequestration of fluid from the matrix into the very porous 
lymphatic endings remains largely unexplained. It was considered that 
the positive pressure differential between tissue and lymphatic fluid of 
- 0.05 kPa was the driving force (see Barcroft, 1976). Whether or not 
the tissue fluid exerts a positive or negative hydrostatic pressure is 
uncertain (see McMaster, 1946; Guyton, Granger and Taylor, 1971). 
Other mechanisms suggested include active transport, phagocytosis and 
changes in the bonds between water and connective fibres which could 
allow free solutions to form near the lymphatic endings. This last 
hypothesis was advanced by Mottura (1960) when he stated that, 
" the lymphatic channel system originates where the 
characteristic linear macromolecular structures of the ground 
substance cease. At this point the absorbtion capabilities 
of the ground substance change and free fluid is able to form. 
The ground substance changes its cellular conformation from 
matrix to endothelial sheets which gradually take on the 
characteristic features of the lymphatic capillaries." 
Although the details of lymph formation remain obscure, a wealth 
of evidence from isolated prefused preparations (see Starling, 1894; 
McMaster, 1946; Arturson, Groth and Grotte 1972; Brace and Guyton, 
1977) clearly shows that when capillary blood pressure is raised, 
interstitial fluid production increases. With greater tissue fluid 
volume, and possibly pressure, lymph production increases until a new 
equilibrium is established at the blood capillaries. If elevated 
o n 
bljod capillary pressures are maintained, resor$tion at the 'venous' 
I 
capillaries and ultrafiltration at the 'arterial' capillaries reach a 
new equilibrium and lymph production declines toward pre-perturbation 
rates. 
The lymphatic anatomies of more species of fish have been 
described than any other animal class (Kampmeier, 1969). Within the 
fishes there is a transition from anatomically poorly defined lymph 
systems to anatomically discrete, functionally competent lymphatics 
(Casley-Smith, 1971). 
Of the Agnatha, the petromyzonts have been best described. They 
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have extensive well defined lymphatic vessels and sinuses in addition to 
the arterio-venous system. .Many of the early descriptions relied upon 
injection methods to visualise the vasculature. The valves that guard 
lymphatico-venous connections in petromyzonts are weak, consequently 
blood or injected solutions were often forced back from the veins into 
the lymphatic vessels (see Johansen, Fange and Johanneson., 1962). Thus 
many lymphatic vessels were originally designated as veins. Most of 
these problems have been resolved and Kampmeier's descriptions appear to 
have taken account of inaccuracies in early descriptions. 
The elasmobranchs (Chondrichthyes) are believed to have evolved in 
parallel with the bony fish (Osteichthyes). However the elasmobranch 
lymphatic system appears degenerate and the species described show the 
lymphatic system to be poorly defined and greatly reduced compared to 
other fishes. Again the problems of differentiation between veins and 
lymphatic vessels arose. In many elasmobranchs veins are present in the 
4 
positions where lymphatic vessels are found in other fishes. For 
example the lateral cutaneous vein in the dogfish occupies the same 
position as the lateral cutaneous lymphatic vessels of teleosts. 
Furthermore, in this vein the blood flows caudally toward the tail venous 
pump (Birch, Carre and Satchell, 1969). Elasmobranchs have only two 
distinct lymphatic vessels, the cardial lymphatics, which are very small. 
Within the Osteichthyes, the Chondrostei have a lymphatic system 
which is similar in position and extent to that of the elasmobranchs 
(Favaro, 1906; Allen, 1910). Alternatively the Holostei, or bony 
ganoids, and the Teleostei have extensive and well defined lymphatics. 
A generalized composite diagram of the teleost lymphatic system is 
presented in figure 1.1. Three lymphatico-venous connections commonly 
occur within the head of teleosts, (vents I, II, III) while a single 
connection is observed at the tip of the tail. There is considerable 
variation between species and indeed between individuals within the same 
species. 
1.1.2 Accessory vascular pumps 
At the lymphatico-venous junctions, the lymphatic sinuses often 
possess the ability to propel their contents into the blood stream. 
Where the propulsion is provided by adjacent muscles whose prime function 
is other than lymph propulsion, these are designated lymph propulsors, 
after Allen (1910). Where the lymph sinus is associated with muscles 
whose principal function is to pump lymph, they are called lymph hearts. 
Rostral and caudal lymph propulsors are found in most teleost orders. 
Agnatha have a unique caudal blood propulsor which was described by 
Greene (1899) and Allen (1917) in the hagfish PoZistotrema stouti and 
by Johansen (1963) in Myxine gZutinosa. MUsteZus antarcticus has no 
lymph propulsors but possesses a caudal venous blood pump which in some 
ways resembles the caudal lymph hearts of teleosts (Satchell, 1971) • 
Leeuwenhoek (1695, cited in Polimanti, 1912) first .described the 
lymph heart of the eel as a "Hohlen-und Klappenapparat", or hollow 
beating organ. Since this initial observation four reviews of fish 
lymph hearts have been published (Favaro, 1906; Polimanti, 1912; 
Przemyska-Smosarska, 1951; Kampmeier, 1969). Both Polimanti and 
Przemyska-Smosarska failed to cite all the available information. 
Favaro provided an exhaustive review of the topic which has been brought 
up to date and reduced in size by Kampmeier (1969). These publications 
concentrated upon anatomy and the occurrence or absence of the lymph 
heart in various taxa. Caudal lymph hearts are common in most teleost 
FIGURE 1.1 Generalised lymphatic vascular anatomy ofteleosts. a.c.l., 
accessory caudal lymphatic; a.l.s., abdominal lymphatic 
sinus; c.a., caudal artery; c-a.l.p., circum-anal 
lymphatic plexus; c.cl., collateral cardial lymphatics; 
card.l., cardinal lymphatic; caud.l., caudal lymphatic; 
c.f.l., caudal fin lymphatic; c.l.h., caudal lymph heart; 
c.l.p., cervical lymph propulsori c.v., caudal vein; d.l., 
dorsal lymphatic; f.l., facial lymphatic; h., heart; 
i.l., intestinal lymphatic; 1. and s.l., lateral and 
segmental lymphatics; p.c.v., posterior cardial vein; 
p.l., pectoral lymphatic; VI, VII, VIII, vents I, II, III. 
(After Kampmeier, 1969). 
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orders, except the Acanthopterygii, the most advanced order. Within the 
teleosts there is evidence for the evolutionary development of both lymph 
vessels and lymph hearts. The most complex lymph heart is found' in the 
Anguillidae. 
Lymph hearts are present in other vertebrate classes. Anurans 
have two coccygeal and two cervical lymph hearts (see Schipp and Flindt, 
1968). Tailed amphibians have a series of smaller lymph hearts 
arranged segmentally along the length of the tail. Kampmeier (1969) 
stated that all reptiles so far examined have lymph hearts, often 
segmentally arranged along the length of the body_ Bird embryos 
occasionally exhibit a caudal lymph heart which is lost after reaching 
maturity (Sala, 1900). Although no data are available for Monotremes, 
lymph hearts are absent in Eutheria and Metatheria. Large mammalian 
lymph collecting ducts have regularly contracting valved vessels which 
assist lymph flow (Mislin and Rathenow, 1962; Hargens and Zwefach, 
1977) _ Mammalian jejunal lacteals appear to be microscopic lymph 
pumps (Lee, 1974). 
The mechanism by which lymph is propelled from lymph hearts varies 
between vertebrate classes. As mentioned before lymph propulsors 
derive propulsive force from the surrounding muscle. True lymph hearts 
have specific muscles assigned to this role. Favaro (1905) described 
the pattern of flow through the lymphatics in the area of the lymph heart 
of the european eel which is presented in figure 1.2. Lymph is received 
by the right chamber from the caudal, caudal fin and lateral lymphatics. 
Lymph is then pumped from the right side through the hypural foramen to 
the left side from where it is expelled into the caudal vein through a 
short extension of the left side of the lymph heart. Control of the 
muscular contractions of the lymph heart was studied by Mislin (1960). 
He concluded from experiments exposing different parts of the body to 
different temperatures that frequency was controlled by, or at least 
influenced by higher central nervous centres, despite many early records 
of maintained contraction after spinal cord destruction (see Polimanti, 
1912) • Chan (1971) suggested on the basis of pharmacological evidence 
that the lymph heart was myogenic. However no clear account of how 
lymph heart beat is maintained or modified has been published. 
Anuran lymph heart muscle receives excitatory nicotinic and 
inhibitory muscarinic cholinergic innervation from the X1th spinal 
nerve (BrUke and Umrath, 1930, 1933; Obara, 1962; Day, Rech and Robb, 
1963; Such, 1968). Mammalian lymph vessels are constricted by smooth 
muscle which from their pharmacology appear to be controlled in a similar 
FIGURE I.2 Circulation pattern through the caudal l~phatic vessels 
of the european eeL c. f.1., caudal fin l~phatic; c. f.1. s . , 
caudal fin lymphatic sinus; c.f.v., caudal fin vein; 
c.v.s., caudal venous sinus; l.h., lymph heart; 1.1./ 
lateral lymphatic. (After Favaro, 1905}. 
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manner to blood vessels (Ohhashi, Kawai and Azuma, 1978). 
The eel lymph heart was chosen for this study of the lymph heart 
because it is well described and is the most advanced example of teleost 
lymph hearts. Despite the long history of research on eel lymph hearts, 
information is lacking in several areas. The gross anatomy is well 
established but fine detail of the lymph heart muscle has not been 
described. Apart from the preliminary study by Davie (1975) there are 
no reports on teleost lymph heart neuroanatomy. Thus questions as to the 
number of nerves and axons that innervate the lymph heart, the types of 
myoneural junctions and the presence and type of sensory structures need 
to be answered. The aims of this section are to confirm previous 
anatomical studies and to provide the answers to the above questions at 
the light and electron microscope levels. After the neuroanatomy is 
established a study of the control system of the eel lymph heart is made. 
I.2 Experimental Animals 
Short-finned eels (AnguiZZa austraZis sahmidtii Phillips) used in 
this study were trapped with fyke nets in the Selwyn River near the 
'Selwyn Huts' (450 43 I S, 1720 26 I E). The long-finned eel (AnguiZZa 
dieffenbaahi Gray) was also trapped but was less common. The ecology 
of the short-finned eel has recently been described by Ryan (1978). 
Eels were maintained for at least two weeks after capture in an indoor 
9 
tank (volume 1600 Z), under conditions of low illumination. Experiments 
were performed within six weeks of capture during which time fish were 
not fed. In none of the eels was there signs of silvering, the 
preparation for migration. The Selwyn River flows into Lake Ellesmere 
where New Zealand's most important eel fishery is sited. 
fishing in the Selwyn River however is not permitted. 
Commerical 
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1.3 Anatomical Methods 
1.3.1 Gross anatomy 
The vascular anatomy of the region of the lymph heart is described 
with the vascular anatomy of the whole tail, in section 11.2. 
Skeletal elements of the tail were exposed by boiling the caudal-
most part of the tail in 10% KOH, or by digesting away the tissue in a 
solution of 0.22% pancreatin and 1.75% KOH at 37oC. The bones left were 
stained in 1% alizarin red until they appeared red. The preparations 
were dehydrated in ethanol and mounted under glass in balsam. 
1.3.2 Microscopic techniques 
1.3.2.1 Fixation 
Blocks of tissue no thicker than three rom were fixed in either 
aged alcoholic Bouins fluid (Gregory, 1970) for 24-48 hours, 10% 
neutral buffered formaldehyde (Lillee, 1965) for three weeks, or 
occasionally in 8% formic acid-butanol-propanol solution (Blest and 
Davie, 1978) for 60 minutes. These blocks were decalcified in 5% 
trichloroacetic acid for 8-12 hours before dehydration. After 
dehydration the blocks were cleared in either terpineol or benzene 
before embedding in three changes of fresh paraffin wax (56oC). 
1.3.2.2 Sectioning 
Sections were cut on a Beckman microtome at 8 ~m unless otherwise 
stated and affixed onto glass slides with 1 : 1 glycerine-albumin 
mixture. This adhesive was vacuum filtered through a sintered glass 
and diluted 20 times with distilled water and used as a floatation 
medium. 
1.3.2.3 Frozen sections 
Material to be used for motor end plate cholinesterase staining 
methods was fixed for 12 hours in neutral buffered paraformaldehyde 
(McIsaac and Kiernan, 1974). Frozen sections were cut at between 
20 ~m and 40 ~m on a Brights freezing microtome, (Huntingdon, England) 
and collected onto distilled water. 
1.3.3 Staining 
1.3.3.1 Methylene Blue 
The last three to five vertebral segments were removed from 
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decapitated animals. The skin and overlying muscles were cleared from 
the lymph heart area and the tissue left overnight in 0.03% methylene 
blue in fresh water eel ringer at 4oC. These preparations were examined 
fresh or fixed in saturated ammonium molybdate solution for two hours. 
Fixed preparations were dehydrated in ethanol series and stored in 
cedarwood oil. 
1.3,3.2 
1961) 
Modified Holmes-Blest reduced silver stain (after Blest, 
1. Fix in aged Dubosq-Brasil (Gregory, 1970) 
2. Clear in terpineol 
3. Wax embed 
4. Impregnate with 20% AgN03 - 2~ hours 
5. Rinse in distilled water - 5 minutes 
6. Incubate in the following solution - 18 hours at 370 C 
1/5 M boric acid 27.5 ml 
1/20 M borax 
1% AgN03 
Pyridine 
2,6-lutidine 
22.5 ml 
3.0 ml 
2.0 m1 
2.0 ml 
distilled water 250 ml 
.0. pH 1S 8.4 at 20 C, measured w1th B.D.H. narrow range 
indicator strips 
7. Reduce in the following solution for 3 minutes at 55-60oC 
Hydroquinone 1 g 
Anhydrous Na2S 20 3 10 g 
Distilled water 300 ml 
8. Wash in tap water - 3-5 minutes 
9. Rinse in distilled water 
10. Tone in 0.2% NaAuC14 .2H20 - 1-3 minutes 
11. Rinse in distilled water - 1 minute 
12. Reduce in 2% oxalic acid - 5 minutes 
13. Wash in distilled water - 3 minutes 
14. Fix in 5% NaS03 - l~ minutes 
15. Wash in distilled water thoroughly - 5-10 minutes 
16. Dehydrate and mount 
Times for each of the stages 4, 6 and 10 were varied to obtain the 
best results. Stages 11 to 13 were repeated until observation of the 
sections revealed that sufficient toning had occurred. The length 
of time needed to adequately tone these preparations was between 75 
and 180 seconds. 
I.3.3.3 Masson's trichrome stain (after Pantin, 1948) 
1. Fix in aged Dubosq-Basil (Gregory, 1970) 
2. Wax embed 
3. Stain in Weigerts - 3 minutes 
4. Wash in tap water - 15 minutes 
;y( 
5. Stain in Bi~tiech Scarlet till darker than finally required 
I 
- 30 seconds 
6. Rinse in distilled water 
7. Differentiate in phosphomolybdic acid - 4 minutes 
8. Stain collagen in Fast green - 30 seconds 
9. Dehydrate rapidly, i.e. into 90% ethanol then to 100% and 
mount. 
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1.3.3.4 
1974) 
Bromoindigo end plate stain (after McIsaac and Kiernan, 
1. Free floating sections are incubated in the following 
solution for 45 minutes at 37oC. 
5-Bromoindoxyl acetate (Sigma) 
Ethanol to dissolve 
0.05 M Potassium 
0.05 M Potassium 
Tris - HCl buffer 
0.1 M CaC12 
Distilled water 
ferro cyanide 
ferricyanide 
pH 7.2 (Pearse, 
1.3 mg 
0.1 ml 
1.0 ml 
1.0 ml 
1968) 2.0 ml 
1.0 ml 
to 10.0 ml 
Sections were handled with glass instruments at all times 
before incubation. 
2. Rinse in distilled water 
3. Mount on glass slides with glycerine-albumin adhesive and 
dried for 60 minutes 
At this stage the sections were either dehydrated and covered or taken 
through the Modified Holmes-Blest reduced silver stain. Cholinesterase 
staining with the thiolacetic acid method (Nakata and Nishijima, 1971) 
proved unsuccessful on this tissue. 
I.3.3.5 Electron microscope grid preparation 
1. Fix in glutaraldehyde fixative - 1 hour 
25% Glutaraldehyde 5.0 ml 
0.2 M Cacodylate buffer 12.5 ml 
1.0 M sucrose 5.0 ml 
Make up to 50 ml with distilled water 
2. Wash in washing solution - ~ hour 
Quantities as above but omit glutaraldehyde and increase 
1.0 ml sucrose to 15 ml 
3. Post fix in 1% Osmium tetroxide - l~ hours 
0.1 g OS04 in 10 ml of washing solution 
store at 40 C 
4. Gently agitate in two changes of propylene oxide for ~ hour 
each 
5. Transfer tissue to 1:1 mixture of resin and propylene oxide 
and gently mix for longer than 2 hours 
6. Then transfer to 9:1 resin: propylene oxide for longer than 
12 hours - 24 hours 
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7. Place tissue in casting vials with fresh resin and leave for 2 
days at room temperature 
8. Polymerise at 600 C for 24 hours 
Spurr's Resin (after Spurr, 1969) 
( i) E.R.L. 4206 3.33 g 
(ii) D.E.R. 736 2.00 g 
(iii) N.S .A. 8.66 g 
(iv) 8-1 (hardener) 0.12 g 
The first three ingredients (i-iii) are mixed gently together before the 
addition of the hardener (iv). 
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I.4 Anatomical Results 
1.4.1 Introduction 
Favaro (1905, 1906) described in detail the anatomy of the lymph 
heart of many species of fish including the european eel. Kampmeier 
(1969) summarised these findings, adding more recent findings of Hoyer 
(see Hoyer, 1934, cited in Kampmeier, 1969). The gross anatomy of the 
lymph heart of this species closely resembles that of the short-finned 
eel. A preliminary report of these results was presented in an un-
published undergraduate project (Davie, 1975). 
1.4.2 Caudal skeleton 
Figure 1.3 is a diagram of the skeletal elements in the caudal 
most centimetre of the short-finned eel tail. The last vertebra is 
modified caudally to form two flattened plates, the hypural plates (h). 
The gap between the hypural plates is the hypural foramen (h. f). Just 
caudaiR of the hypural plates is the hypural canal (h.c). The haemal 
zygaphophysis (h.z) of the left side is laterally and rostrally extended. 
The urostyle (u) combines with the specialized neural processes (s.n.p) 
from the most posterior part of the neural arch (n.a) in which is found 
the urophysis, or caudal neurosecretory organ. The penultimate vertebra 
is unmodified from the typical teleost caudal vertebra (Parker and 
Haswell, 1962). The neural spine (n.s) forms the neural arch (n.a) 
dorsally and provides support for the neural arch processes (n.p) onto 
which the dorsal fin rays are attached. Ventrally the haemal spine 
and its processes form the haemal arch and support. the ventral fin 
rays. 
1. 4. 3 Lymph heart muscle 
The lymph heart appears as two flattened oval pink bodies about 
two to three mm in length, lying either side of thehypural plates. 
It is readily observed when the skin and overlying tissue of the caudal-
most part of the tail are dissected away_ In fresh specimens the pink 
colour indicates the high blood vessel density in the muscles. 
Transverse sections (see figure I.4a) show that the lymph heart 
lumen is lined with endothelium. A layer of connective tissue is 
interposed petween endothelium and muscle tissue. Valves are observed 
in the hypural foramen although because of tissue hardness in the area 
valvular tissue was often fragmented and lost whilst sectioning. There 
FIGURE I.3 Diagram of the skeletal components in·tne area of the last 
three vertebral s.egments of the tail. The lymph heart 
covers the shaded area. h., hypural plates; h.a., 
haemal arch; h.c., hypuralcanal; h.f., hypural foramen; 
h.s., haemal spine; h.p., haemalprocess; h.z., haemal 
zygapophysis; n.a., neural arch;· n.p., neural process; 
n.s., neural spine; s.n.p., specialised neural process; 
u., urostyle; v.f.r., ventral fin rays. 
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FIGURE I.4a 
FIGURE I.4b 
FIGURE I.4c 
FIGURE I.4d 
Light micrograph ot a transverse section through the short-
finned eel caudal lymph heart. h., hypural plate; h.f., 
hypural foramen; d.d.m., dorsal deep muscle block; v.d.m., 
ventral deep muscle block; s.m., superficial muscle block. 
(Masson's trichrome). 
Light micrograph of lymph heart superficial muscle fibres. 
(Holmes-Blest reduced silver) • 
Electron micrograph of lymph heart superficial muscle 
showing the extent of the sarcoreticular system. The 
system fuses near the Z line and in the centre of the A 
band to torm a tenestrated network over the surface of the 
sarcomere. c., collar; 1., longitudinal system; t., 
transverse system; tr., traids at the junction of the 
transverse and longitudinal systems. 
Light micrograph of transverse section of spinal cord from 
the penultimate vertebral segment. (Holmes-Blest reduced 
silver) • 
16 
b 
lO ~m 
d 
O. lmrr 
17 
are three muscle blocks on each side of the lymph heart. The outermost 
muscle block (superficial muscle, S.F.) has fibres which run dorso-
ventrally. The two inner muscle blocks both have fibres in a rostro-
caudal orientation. These muscles have been designated the dorsal and 
ventral deep muscle (D.D.M, V.D.M) respectively. This description is 
essentially the same as that of Favaro (1906) for the european eel. 
At higher magnifications the muscle fibres in each of the three 
muscle blocks are seen to be striated with similar sarcomere lengths of 
around 2.0 ~m (see figure I.4b). Nucleii are located peripherally and 
numerous small blood vessels extend between muscle fibres. At electron 
microscopic level (see figure I.4c) typical striated muscle structure is 
seen. Numerous glycogen granules are visible around the muscle cells and 
an extensive sarcoplasmic reticulum (S.R.) extends over the muscle 
surface. The junctions of the S.R. and the transverse tubule or T 
system occurs between adjacent cells at the Z line and forms distinctive 
structures called triads. 
I.4.4 Nerves in the area of the lymph heart 
A reduced silver staining technique was chosen specifically to 
stain the nerves in the area of the lymph heart. Methylene blue 
preparations revealed little because the connective fibres, blood 
vessels and muscle fibres also took up the dye. 
Transverse sections of the area and of the spinal cord alone showed 
that dorsal to, and toward the rostral end of the penultimate vertebra, 
dorsal and ventral nerve roots emerged (see figures I.4d and I.7). 
within this area of the cord the anterior end of the urophysis is also 
evident, occupying the ventral part of the cord and extending caudally 
where it occupies the whole of the spinal cord. The ventral and 
dorsal roots converge within the neural arch and emerge from the vertebra 
through a single foramen. Some fibres from this tract enter a 
ganglion of cell bodies, possibly a sympathetic ganglion~ located in a 
cavity half way up the outside of the vertebra. Most of the fibres pass 
through this point and traverse the vertebra ventrally. At a point 
lateral and adjacent to the haemal arch of the penultimate vertebra the 
nerve trunk turns caudally and merges with the nerve from the adjacent 
rostral vertebra (see figures I.Sa, I.Sb) .. This combined nerve trunk 
passes caudally for about 1 rom to the rostral tip of the lymph heart 
muscle where it divides. The nerve from the third to last vertebra 
runs dorso-caudally across the surface of the lymph heart superficial 
muscle and passes through the hypural canal to the posterior fin rays. 
FIGURE I.5a 
FIGURE I.5b 
Light micrograph of transverse section through lymph 
heart nerve (Nl). The two bundles ofaxons both contain 
myelinated and nonmyelinated axonswhich can be visualised 
by using different histological techniques. (Holmes-Blest 
reduced silver) . 
Light micrograph of longitudinal section through the 
lymph heart nerve (Nl). The fibres traverse ventro-
caudally from the spinal foramen for approximately 1 rom, 
then extend caudally toward the cephalic end of the 
lymph heart muscles. NI, lymph heart nerve. (Holmes-
Blest reduced silver) • 
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The nerve from the penultimate vertebra spreads over the surface of the 
lymph heart and subdivides. The same description applies to both sides 
of the lymph heart. Most nerve fibres extend up to the dorsal edge of 
the superficial muscle and small fibres extend ventrally from the dorsal 
edge. 
The small fibres were traced to their endings in the muscle and 
were visualized with the aid of the bromoindigo cholinesterase stain 
(see figure 1.6a). The end plates are small (5-12 ~m) 'en plaque' 
type (Bone, 1964). Electron microscope preparations of the end plates 
show uncharacteristic absence of extensive interdigitations at the 
myoneural junctions. The spherical vesicles within the terminal are 
50-60 nm in diameter and agranular, suggesting cholinergic vesicles 
(Uehara, Campbell and Burnstock, 1976) (see figure 1.6b). 
Figure 1.7 is a composite diagram giving the neuroanatomy of 
the lymph heart of the short-finned eel. Spinal nerve fibres (sensory 
and or motor) connect the lymph heart muscle fibres to the spinal cord 
above the penultimate vertebra. The number of fibres in the nerve 
labelled Nl is around 40. The sizes of the axons estimated from silver 
or osmium tetroxide stained cross sections of the nerve range from 0.3 ~m 
to 4.0 ~m in diameter. The diameter of the whole nerve Nl is 
approximately 200 ~m. About one third of the fibres are contained within 
the smaller bundle of fibres within the nerve trunk. The other two 
thirds are contained in the larger bundle. 
run parallel to form the single nerve Nl. 
Both of these subdivisions 
FIGURE I.6a 
FIGURE I.6b 
Light micrograph of end plates on lymph heart superficial 
muscle fibre. e., end plate. (Bromoindigo end plate 
stain, counterstainedwith Holmes-Blest reduced silver). 
Electron micrograph bf neuromuscular junction between 
lymph heart superficial muscles and lymph heart nerve. 
Note the absence of extensive inter~igitation at the 
myoneural junction and the abundant vessicles·in the 
nerve. v. I vessicles. (Prepared by and. reproduced with 
the permission of Mr N.S. Greenhill). 
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FIGURE 1.7 Neuroanatomy of the short-finned ee.l calldal lymph heart. 
l.h.m., lymph heart muscle; tn, lymph heart nerve; s.c., 
spinal cord. 
21 
N1 Ihm 
22 
I.5 Control of the Lymph Heart Beat 
I.5.1 Introduction 
As no previous attempt to study the control of the lymph heart beat 
had been successful (see section I.l.2) the problem was approached by 
three methods: ablation of the spinal cord and nerves near the lymph 
heart; application of selected pharmacological agents; and electro-
physiological recording. 
A simple isolated preparation was used for each of these studies. 
The preparation consisted of the last five to seven vertebral segments 
of the tail which were quickly removed from a freshly anaesthetised 
(0.04% benzocaine, H.F. Stevens & Co., Christchurch) or decapitated 
animal. This of tissue was placed into a dish of heparinized 
fresh water eel saline (see section II.4.2) where the skin was dissected 
free. The overlying muscle and connective tissue was removed and the 
tissue placed into a shallow constant temperature bath (lOoC) containing 
around 30 ml of fresh saline. Further dissection of tissues from the 
area to be examined was accomplished under a dissecting microscope. 
Benzocaine abolished lymph heart beat as did MS 222 (Chan, 1971). 
Contractions returned however after five to ten minutes in saline. 
Frequency of the lymph heart beat increases with temperature. Measure-
ments of frequency of the isolated lymph heart and the lymph heart of 
o 
resting intact live animals at a range of temperatures between 10 C and 
240 C gave the following regression lines. 
Isolated preparation LHf =8.96.ToC -69.3 
Intact animal LHf = 8.20.ToC -57.2 
where LHf is lymph heart frequency and 
T is temperature in degrees celsius, data from Davie (1975). 
Neither the slopes of the lines nor the intercepts of the two lines were 
significantly different. This indicates the suitability of the isolated 
preparation for the proposed experiments. 
I.5.2 Ablation experiments 
Once an isolated preparation was beating regularly, (~ 30 beats per 
minute at 100 C) nerves labelled N3, N2, N 1 on one side (see figure 1. 8) 
were successively severed and the activity of the lymph heart observed. 
No change in activity could be observed until N1 was cut. When N1 was 
cut the lymph heart stopped, however a faint beat returned five to ten 
seconds after the ablation. This weak activity was passive movement of 
the muscles on the side being observed caused by contractions of the 
FIGURE L8 Diagram of the nerves of the last three vertebral segments 
of the eel tail. NI, lymph heart nerve, N2, nerve to 
caudal fin rays, N3, nerve to ventral fin rays, VO, the 
vertebra comprised of the hypural plates and the urostyle, 
VI, the penultimate vertebra from which NI emerges; V2, 
the next cephalad vertebra from' which 'N2 eme,rges; V3, 
the vertebra in the fourth from last segment from whence 
N3 emanates. 
23 
V3 V2 V1 VO 
N3 N2 N1 
muscle on the opposite side of the lymph heart. When only Nl was cut 
unilaterally, the same result ensued. Cutting Nl on both sides caused 
permanent inactivity. 
heart activity. 
Clearly Nl is important in maintaining lymph 
Exposure of the cord was accomplished by carefully removing the 
connective tissue between the neural arches. Once removed the cord 
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was transected between vertebrae V4 and V3, V3 and V2, V2 and VI, VI and 
vo, (see figure I.14). No effect was observed when the cord was cut 
between V4 and V3, and V3 and V2. Cutting the cord between V2 and VI 
always stopped the lymph heart beat. In two of the 14 preparations 
tested the beat returned after 10 to 15 minutes. Transection of the 
cord between VI and VO abolished the beat in all but two preparations, 
but contractions returned within 15 minutes in 12 out of the 17 
preparations tested in this manner. The piece of cord from which Nl 
originates (dorsal and rostral to VI) is necessary for maintenance of 
lymph heart beat. Temporary abolition of activity which occasionally 
occurred when the cord was cut near VI, could be the result of trau-
matization of the cord in the area. A severe physical stimulus in the 
vicinity of the essential cells could easily disrupt normal functions. 
I,5.3 Pharmacology of the lymph heart 
Davie (1975) presented results from experiments involving topical 
application of certain pharmacologically active agents onto the isolated 
lymph heart preparation. A summary of these results is presented here. 
Acetyl choline at 6 x 10-6 M induced small increases in frequency and 
amplitude. At higher concentrations, (6 x 10-5 M, 6 x 10-4 M) both 
amplitude and frequency were depressed. 
PhysostigmiI1e at a concentration of 3 x 100 produced a brief increase in 
the force of contraction. 
Serotonin, (5 - HT) had little or no action at 5 x 100 M or 5 x 10-5 M 
concentrations. 
d-Tubocurarine at concentrations of 1 x 10-6 M and 1 x 10- 5 M abolished 
contractions of the superficial muscle. 
Decamethonium at 4 x 10- 6 produced a transient contraction followed by 
quiescence. 
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Noradrenaline at 3 x 10- 6 M, 3 x 10- 5 M, and 3 x 10-4 M increased lymph 
heart amplitude but not frequency after a latency of - 40s. 
These results, although from a preliminary investigation, suggest that 
the lymph heart receives excitatory cholinergic innervation, probably 
nicotinic, rather than muscarinic. 
1.5.4 Electrophysiological recordings 
The small size of the nerve Nl, (- 200 ~m in diameter), its 
inaccessibility and sensitivity to manipulations thwarted all but one 
of the 49 attempts to make 'en passant' recordings of neural activity. 
Unfortunately the muscle spikes were not recorded simultaneously. The 
successful recording apparatus was a tungsten hook electrode which could 
be insulated with mineral oil driven down a moveable sleeve by a remote 
syringe (Wilkins and Wolfe, 1974). Muscle records were taken with a 
suction electrode (see Delcomyn, 1974). Representative records of the 
muscle and nerve activity are presented in figures I.9a and I.9b 
respectively. Muscle activity was easily recorded with suction 
electrodes. In stable preparations two muscle spikes were regularly 
recorded, although occasionally three or four depolarizations were 
observed. The first spike or pair of spikes was larger than the second 
and coincided with superficial muscle contraction. The second muscle 
spike coincided with the contraction of the deep muscles. Both sides 
of the lymph heart contracted simultaneously. The time interval 
between the pair of spikes was 123.1 ± 17.9 ms (mean ± 1 SEM, n 140. 
10 cycles from 14 preparations which were beating at 33 to 37 beats 
per minute) . 
From the one set of satisfactory records from the nerve N1 it is 
clear that there are two sets of impulses per lymph heart beat. The 
group of 4 to 6, (4.58 ± 0.219, mean ± 1 SEM, n = 20) larger spikes 
occurred immediately before the onset of muscular contraotion. The 
group of 6 to 10 (7.83 ± 0.405, mean ± 1 SEM, n = 20) smaller spikes 
which appeared in a less discrete group coincided with distension of the 
lymph heart between contractions. Two experiments were performed on 
this preparation. The nerve N1 was cut central to the point of 
recording and the larger (motor) spikes were no longer present in the 
record. However the rhythmic contractions of the muscle on the side 
opposite to that being recorded from caused regular distension of the 
passive muscles on the recording side. During each distension a 
regular, if somewhat different group of impulses were recorded from the 
FIGURE I.9a 
FIGURE I.9b 
Electrophysiolpgical record O:f lymph heart muscle activity. 
Two muscle spikes were r,egularly observed, the larger first 
spike or spikes corresponded with contraction of the super-
ficial muscle. The smaller second spike or spikes 
corresponded with contraction of the deep muscles. 
Vertical scale = 50 mV. Horizontal scale = 1 s. 
(Suction electrode) . 
Electrophysiological recording of lymph heart nerve 
activity during lymph heart contraction. Two groups of 
action potentials occurred during a single cycle of lymph 
heart contraction. The Smaller group labelled 'm' are 
designated motor spikes as they corresponded with contraction 
of the superficial and deep mQscles. The larger group of 
smaller and less distinct spikes labelled 's' oceurred 
during distension of the lymph heart between contractions. 
Although the records of muscle and nerveactivlty were 
taken from different preparations, at approximately the 
same temperature the frequencies are similar. The time 
scale of the two records are the same •• Thus we can see 
that the motor spikes occur when muscle spikes appear on 
the muscle record but that the group of nerve spikes have 
no corresponding muscular contraction. Vertical scale ::= 
10 mV. Horizontal scale = 1 s. (Oil insulated tungsten 
hook electrode) • 
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nerve stump. Furthermore physical distension or stretching of the 
muscle blocks with forceps induced bursts of activity. 
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A detailed analysis of the results from a single preparation is 
not warranted, but these results show that the nerve NI carries motor 
impulses to the lymph heart muscles from the spinal cord above the 
vertebra VI. The same nerve also appears to carry sensory information 
from the lymph heart to the spinal cord during distension. 
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I.6 Discussion 
I.6.1 Discussion of results 
The gross anatomy of the eel lymph heart has been accurately 
described and reviewed (Robin, 1880; Favaro, 1906; Kampmeier, 1969). 
The tissue layers and the positions of the muscle blocks are the same in 
the short-finned eel as in the european eel. However no reports of the 
fine structure of teleost lymph hearts or of their innervation are 
available. 
Eel lymph heart muscle is striated and resembles fast acting 
skeletal muscle of many other vertebrates (Uehara, et al., 1976). The 
extensive transverse tubule system and the sarcoplasmic reticulum 
indicate rapid conduction of muscle depolarization throughout the muscle 
block. The sarcoplasmic reticulum is similar to that of the fr.og twitch 
fibres (Page, 1968) and it extends over the surface of the sarcomere 
length of the sarcomere and forms a fenestrated envelope. When compared 
to frog lymph heart muscle (Kawaguti, 1967; Schipp and Flindt, 1968) 
eel lymph heart muscle is more regularly arranged into muscle blocks. 
Frog lymph heart muscle is striated and is arranged in a three dimensional 
array within a connective tissue matrix. On contraction fibres must 
exert forces in a variety of directions. 
The spinal cord above vertebrae V4 to V2 has typical teleost spinal 
cord organisation (Kappers, Huber, and Crosby, 1936). These authors 
stated that caudal dorsal root ganglia are located outside the neural 
canal in teleosts. No dorsal root ganglia were seen within the canal 
in sections from the eel but the group of cell bodies located outside 
the neural canal could be a sensory ganglion. Their general form 
however suggests that they are autonomic rather than sensory. The 
dorsal horn at the point of insertion of the dorsal root contains cell 
bodies that may be sensory. This point is still to be resolved. 
The urophysis lies in the ventral cord above V2 and VI and enlarges 
caudally to fill the whole cord above va. The urophysis receives 
nervous input from higher central nervous centres which can initiate 
secretion of active principles (Fridberg and Bern, 1967). Chan (1975) 
found that urotensins I and II have hypertensive effects upon the 
japanese eel, and that urotensin II was the most potent. Urotensin II 
also caused increased frequency and amplitude of the caudal lymph heart. 
Hypervolemia caused release of urotensin II and or a lymph heart 
stimUlating substance (Chan, 1971, 1975). Hypervolemia would of course 
cause excess lymph production, thus it is logical that lymph heart 
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frequency and amplitude should increase to alleviate the load. Chan (1971) 
suggested that the urophysis is involved in the control of fluid 
balance in the tails of teleosts. Where caudal circulation is reduced 
as in seahorses (Syngnathidae), and ocean sunfishes (Molidae), there is 
little or no urotensin II activity, and lymph hearts are also absent. 
Recently Ichikawa (1978) tested teleost urophyses for acetylcholine and 
found very high concentrations. The reason for such an abundance of 
acetylcholine is not known. It is clear that the urophysis and the 
caudal lymph heart are involved in the return of fluid to the circulatory 
system from the tail. 
Early experiments with teleost lymph hearts involved spinal cord 
destruction and suggested that they were my.ogenic (see Kampmeier, 1969). 
Mislin (1960) inferred indirectly that the eel lymph heart was under 
spinal control. The results from the present study show that spinal 
motor and sensory fibres traverse from the segment of spinal cord above 
the penultimate vertebra to the surface of the lymph heart muscle fibres. 
Some of these fibres, presumably motor, end on the muscle fibres in 
small 'en plaque' feet (see Couteaux, 1973; Uehara et al., 1976). 
These end plates can be visualized with a cholinesterase specific stain. 
The vessicles contained within the end plates are clear, spherical and 
of the same size as cholinergic vessicles. No vessicles of the 
smaller irregular granular type typical of aminergic terminals were seen 
in electron micrographs. The lack of interd~gitation between the muscle 
and nerve membranes is atypical of fast skeletal myoneural junctions. 
Preliminary pharmacological evidence adds weight to the hypothesis that 
the excitatory neuromuscular transmitter is acetylcholine. 
Electrophysiological recordings from the nerve NI show two trains 
of impUlses. One immediately preceeds the contraction of the muscles 
while the other is less discrete and composed of smaller spikes and 
occurs with distension of the muscle or filling. The latter persists 
after ablation of the nerve between the recording point and the spinal 
cord and probably emanates from some type of mechano-receptors perhaps 
in the tendons of the lymph heart muscles (Bone and Chubb, 1975). No stretch 
receptors were seen in any of the histological preparations. 
I propose an hypothesis of lymph heart beat control as follows 
(see figure I.IO). A pacemaker cell or neuropile located in the spinal 
cord above vertebra VI initiates a train of impulses which are 
transmitted to the lymph heart via the nerve Nl. The output from the 
pacemaker can be modified from feedback from stretch or other types of 
receptors in the lymph heart tendons. The nature of the receptors is 
FIGURE I.lO Proposed 'wiring diagram' of the lymph heart of the short-
finned eel. Motor action potentials are generated by a 
neural pacemaker (p.m.) located in the spinal cord in 
vertebra VI. These spikes are conducted via the lymph 
heart nerve Nl to the lymph heart muscles. Sensory 
information from receptors located somewhere in the region 
of the lymph heart (r) send information about distension 
to the spinal cord. Possible influence of higher central 
nervous system (h.c.n.s.) may act on the pacemaker or on 
the urophysis (u.). Liberated active principles from the 
urophysis (Urotensin II or lymph heart stimulating 
substance, (Chan, 1971» may be delivered to the lymph 
heart via the blood or lymphatic systems. 
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yet to be determined. Lymph heart frequency and amplitude can be 
modified by neural input from higher central nervous centres (see 
Berkowitz, 1956) either by acting directly on the pacemaker (Mislin, 
1960) or by the release of urotensin II and/or lymph heart stimulating 
substance (Chan, 1971, 1975). Higher central nervous input is not 
essential to maintain lymph heart activity. The possibility of 
inhibitory innervation from the spinal cord as in the frog lymph heart 
also exists, (see Day, Rech and Robb, 1963). 
I.6.2 Evolution of caudal vascular pumps 
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Fish locomotion by transmission of sinusoidal waves from the rostral 
to the caudal end of the body, increasing in amplitude toward the tail 
(Lighthill, 1971) appears to have presented problems to the circulation of 
body fluids within the tail. The effect of forces produced by these 
waves upon collapsable superficial vessels will be to force fluid to 
accumulate at the tip of the tail. Caudal lymph propulsors in fishes 
utilize swimming movements of the tail to propel lymph from the lymph 
propulsor into the caudal vein. This is accomplished by the water 
pressure that is created with each side stroke of the tail compressing 
the sinus, thus forcing the fluid through the valves. Anguilliform 
fishes derive considerable thrust from the dorsal and ventral caudal 
fins (Gray, 1933), which results in comparatively low hydrostatic 
pressure against the tip of the tail when swimming. This point was 
made by Allen (1910) and Kampmeier has taken the analysis one step 
further to sU9gest that the locomotory mechanism may have been the 
evolutionary cause of lymph heart development in anguilliform fishes. 
Various species have evolved different mechanisms to overcome the 
problem. 
Within the elasmobranchs the Port Jackson shark (Heterodontus 
portjacksoni), has a series of valved veins which receive venous blood 
from the superficial vessels and direct it first deeper into the body, 
and then rostrally toward the caudal vein. Contractions of swimming 
muscles of the tail provide the propulsive force (Birch et al., 1969). 
Mustelus antarcticus has a similar vascular arrangement except that the 
row of muscles that deflect the tail continue to contract in response 
to spinal motoneuron discharge during quiescence (Satchell, 
1971) • 
In the Agnatha the caudal blood heart of the hagfish (Polistotrema 
stouti) has a pair of venous sinuses located either side of a median 
cartilaginous plate. Alternate contractions of the single muscle 
(musculari cordis cordalis, m.c.c.) on either side causes flexion of the 
plate and subsequent expulsion of blood into the cauda~ vein. 
(1899) stated that, 
Greene 
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"There is an automatic caudal heart centre located in the spinal 
cord which discharges rhythmic motor impulses to the caudal heart 
muscles." 
The rhythmic motor impulses are transmitted to them.c.c. by the third, 
fourth and fifth to last spinal nerves (Allen, 1917). Allen adds that 
up to eight muscle spindles are to be found in the m.c.c. which extend 
fibres along one of the nerve trunks to the spinal cord. 
The situation is surprisingly similar for teleost lymphatics, 
rather than blood vessels. Many species have lymphatic sinuses which 
are emptied by the contraction of adjacent skeletal muscles. Fishes which 
have elongated body shapes commonly have active pumps to assist 
propulsion of lymphatic fluid into the blood stream. The short-finned 
eel has two lymphatic cavities located on either side of the tip of the 
tail which are encompassed on each side by three muscle blocks. These 
three muscle blocks form the lymph heart mUScles which in every respect 
are similar to skeletal muscle and are probably derived from caudal 
tail muscles during devolution of the caudal fin. It is interesting 
to note that three spinal nerves from more vertebral segments innervate 
the caudal blood heart of the hagfish, but that only one muscle is found 
on each side. The m.c.c. is however differentiated into lateral and 
ventral portions (Greene, 18991. The lymph heart of the eel exhibits 
regular contractions and is not as sensitive to external stimuli, for 
example touch, as the hagfish caudal heart. No structures resembling 
sensory nerve endi?gs were observed in any of the sections of the 
short-finned eel lymph heart. Sensory information does however emanate 
from the lymph heart. The source of these impulses is clearly not 
the teleost equivalent of the hagfish mUScle spindles (Allen, 1917). 
The fact that teleost caudal lymph hearts pump lymPh s~ggests 
that with the development of higher blood pressures" blood recovery 
from the tail became less of a problem. The very low pressure 
lymphatic vessels, especially those that lie directly beneath the skin 
however would be vulnerable to the forces resulting from swimming. 
Thus the parallel evolution of strikingly similar structures in different 
fish taxa acting on different fluids under the same evolutionary 
pressures has resulted in the array of accessory caudal vascular pumps 
seen today. 
1.7 Summary 
1. The skeletal anatomy of the last three vertebral segments of the 
tail of the short-finned eel is described (section 1.4.2). 
2. Light and electron microscope studies of the three muscle blocks 
that comprise each side of the lymph heart show that the muscle is 
typical of vertebrate fast skeletal muscles (section 1.4.3). 
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3. Muscles on each side of the lymph heart are innervated by a spinal 
nerve from the penultimate vertebral segment. This nerve contains 
approximately 40 axons which have diameters between 0.3 ~m and 4.0 ~m. 
Some of the axonsmerge with the spinal cord at the dorsal root and 
others at the ventral root indicating the presence of both sensory and 
motor fibres respectively (section 1.4.4) • 
4. Neuromuscular junctions between the nerve from the penultimate 
vertebral segment and lymph heart muscle were visualized with a 
cholinesterase specific stain and are of the 'en plaque' type. At the 
electron microscope level the terminal nerve swellings contained spherical 
agranular vessicles of 40-60 nm diameter, suggesting that acetylcholine 
is the .transmitter. Cholinesterase staining and preliminary 
pharmacology support the hypothesis that acetylcholine is the 
transmitter. 
5. No stretch receptors were observed in any of the sections of the 
lymph heart muscle. 
6. Electrophysiological recordings from the lymph heart muscle usually 
produced records of two muscle spikes. The first larger spike 
coincided with the contraction of the outermost layer of muscle while 
the second smaller spike coincided with contraction of the inner muscles 
(section 1.5.4) • 
7. Only one set of electrophysiological records from the spinal nerve 
which innervates the lymph heart was obtained. This set of records 
revealed two trains of impulses in the ne~ve (section 1.5.4) • The 
group of four to six larger spikes corresponded with lymph heart 
contraction, whereas the group of six to ten smaller spikes corresponded 
with lymph heart distension. 
8. Lymph heart contractions are under the direct control of spinal 
nerves emanating from the spinal cord located above the penultimate 
vertebra. 
9. It is proposed that fish swimming movements restrict fluid return 
from the tail to the heart. The problem of vascular return from the 
tail of fishes is accentuated by elongated body form and low vascular 
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pressures. This problem appears to have been overcome by the 
development of a variety of accessory caudal vascular pumps in different 
groups of fishes. The caudal lymphatic heart of the eel is a 
specialised and well developed example of an accessory vascular pump. 
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PART II THE ISOLATED SALINE PERFUSED EEL TAIL 
11.1 Introduction 
Our understanding of the physiology of animals owes a lot to the 
study of isolated tissues. Much of our knowledge about cardiovascular 
functions and control has come from the study of isolated preparations. 
Two principal methods are applied to isolated tissue preparations; 
bathing or superfusion and perfusion. The first method is probably more 
fundamental. It involves suspension of thin strips or sheets of tissue 
from say heart or blood vessel in a bath of physiological salt solution. 
Responses to applied conditions (drugs, ions, osmolarity, temperature, 
etc.) are measured by the force or shortening produced during contraction 
or relaxation of the muscles. Such studies have provided the basis of 
pharrnac~ynamics in cardiovascular and other tissues where drugs have 
been applied. Some features of the cardiovascular system that are 
produced by smooth muscle activity are related to, but not directly 
calculable from this approach. Perfusion of tissues through their 
vascular network with a saline or blood allows the examination of many of 
the responses otherwise not accessible. Also larger pieces of tissue 
such as whole organs can be studied. 
Responses to drugs are important in our understanding of control 
mechanisms within the cardiovascular system. When vascular tissue 
suspended in a bath is exposed to vasoactive agents, the rate of 
development of the response is often limited by the rate of diffusion of 
the agent through the tissue layers to its site of action. During 
perfusion we assume that transcapillary exchange is rapid (Landis and 
Pappenheimer, 1963), consequently the development of a response is 
limited by the delivery of the agent to the site of action; that is 
perfusion limited (see Waud, 1968). Despite the complexity of a 
perfused tissue compared to a bathed preparation it is intuitively a 
preferred method if the experimenter wishes to examine the effects of 
perfusate borne agents upon vascular parameters. 
Resistance to flow is principally determined by the radius of 
the pre-capillary vessels (Mellander and Johansson, 1968). Radius 
changes are accomplished by changes in tension of the smooth muscle 
which surrounds these vessels. Although a bathed helical strip of 
artery will give values for tension changes in response to applied 
stimuli, direct measurements of resistance are not possible. Likewise 
vascular volume changes and capillary exchange processes can only be 
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studied if a perfused preparation is used. Resistance is defined as 
flow rate divided by the pressure differential across the vascular bed. 
From the Hagen-Poiselle equation for laminar flow of a newtonian fluid 
through a rigid tube of circular cross section, 
/J,P 'IT RIt Q = --=----:::..:..-
811L 
Resistance is proportional to viscosity, 11, and path length, L, and is 
inversely proportional to the radius to the fourth power, R4. Usually 
resistance is measured during steady state conditions where flow, Q, and 
pressure differential, /J,p, are recorded while other variables are held 
constant. 
Two methods of perfusion are commonly used: Constant pressure 
with variable flow, and constant flow with variable pressure. A 
further method is to allow both pressure and flow to vary (Nichol, 
Girling, Jerrard, Claxton and Burton, 1951). Mellander and Johansson 
(1968) state that perfusion at constant pressure while flow varies, more 
closely approaches the 'in vivo' state since in-most animals blood 
pressure varies much less than does flow. These authors presented 
calculations showing that maximum resistance changes in skeletal muscle 
preparations during constant pressure perfusion were five times greater 
than maximum changes during constant flow. More recently Wood and 
Shelton (1975) compared maximum resistance changes with variable flow 
and variable pressure perfusion against maximum resistance changes with 
constant flow perfusion in the trunk of the rainbow trout (SaZmo gairdneri) • 
They found that maximum resistance changes were around four times, greater 
for variable pressure and flow perfusion. Al though maximum changes 
were greater for variable flow, variable pressure perfusion, Wood and 
Shelton (1975) found that pump perfusion (constant flow) resulted in 
higher resistance values at equivalent flows. 
The behaviour of the cardiovascular system as observed in whole 
animals is the summation of all the circulatory events that occur in 
every tissue at that time. To study anyone particular control system 
or response it is essential that as many as possible of the factors that 
could influence the measured parameter are held steady or measured 
accurately. For example, to measure the resistance change in an 
isolated perfused preparation following the application of a 
vasoactive drug it is essential that path length, viscosity and say 
flow are held constant while the pressure varies in response to the 
drug. Isolation of a vascular bed often results in the abolition of 
sympathetic nervous activity which can play an important role in 
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vascular tone maintenance (Su, 1975, 1978), thereby reducing one source 
of variability. Replacement of the blood with a Newtonian perfusate 
removes the effects of unknown concentrations of endogenous vasohumours 
and the anomalous viscosity properties of blood (Burton, 1965). In the 
absence of endogenous vasoactive agents, known amounts of substances such 
as catecholamines can be administered and their effects recorded. In the 
absence of motor nerve input, muscle activity in a skeletal muscle 
preparation will be reduced to a level approaching that of the basal 
metabolism thereby reducing the magnitude of the effects that metabolites 
will have on the local vasculature. 
To extract useful information from a perfused vascular preparation 
all vascular parameters should be measured simultaneously. Where 
equipment or other limitations prevent monitoring of a wide array of 
events, as many as possible should be held constant. One feature of 
perfusion studies that emerges from the literature is that the objectives 
of the research should be clearly defined beforehand and the choice of 
tissue should be selective. Reasons for perfusing tissues in the past 
have included the study of transcapillary exchange processes, temperature 
regulation, gas and ion exchange and transport or simply to maintain the 
tissue to allow say neurophysiological recordings to be made. 
Perfusion studies of teleost tissues have concentrated on the gills. 
Most gill preparations have utilized constant pressure perfusion (Keys, 
1931: Rankin and Maetz, 1971; Payan and Matty, 1975; Haywood, Isaia 
and Maetz, 1977). Some branchial preparations have used constant flow 
perfusion (Keys and Bateman, 1932; Kirshner, 1969; Shuttleworth, 1972; 
Bergman, Olson and Fromm, 1974; Wood, 1975; Payan and Girard, 1977; 
Smith, 1977). By no means were all of these perfused gill preparations 
designed to investigate the vascular system of the gills since ionic and 
gaseous exchange processes are also located within the gills. The 
, systemic vascular system of teleosts has been studied by isolated perfused 
techniques. Keys and Bateman (1932) perfused the whole body of the eel 
at constant flow as did Forster (1976a). The trout trunk preparation 
developed by Wood and Shelton (1975) excluded the branchial vascular bed 
and was perfused principally at constant flow. This particular 
preparation has yielded a great deal of very useful information (see 
Wood, 1976, 1977). Perfusion studies of the isolated swimbladder 
preparations have included those of Fange (1953) and Stray-Pedersen (1970). 
Both authors used constant pressure perfusion. An eel rete preparation 
perfused at constant flow was described by Stray-Pedersen and Steen (1975). 
Holmgren (1977) utilized a constant flow perfusion system in her 
isolated head-kidney heart preparation from the cod (Gadus morhua) • 
Isolated artery strips from fish have been studied by Kirby and 
Burnstock {1969} , Burnstock (1969), Klaverkamp and D.yer (1974) and 
Holmgren and Nilsson (1974). Experiments with swimbladder strips have 
been performed by Fange, Holmgren and Nilsson (1976). 
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Constant pressure perfusion has seldom been used for fish systemic 
circulation studies. Although constant pressure perfusion may seem 
preferable on the grounds that it more closely approaches the natural 
situation, constant flow experiments have produced results that indicate 
that the perfusion conditions were most satisfactory and that the changes 
in resistance at constant flow were reliably measured (Wood and Shelton, 
1975) . Bergman et ala (1974) stated that perfusion of rainbow trout gills 
at constant flow by a peristaltic pump was qualitatively superior to 
perfusion at constant pressure (see Wood, 1975). 
Vascular tone in teleosts has been considered to be controlled 
principally by circulating catecholamines (Stevens and Randall, 1967a; 
Randall and Stevens, 1967; Burnstock, 1969; Randall, 1970; Wood, 1974a; 
Wahlqvist and Nilsson, 1977), although this concept has been questioned 
more recently by Holmgren (1977, 1978) and Smith (1978). The presence of 
beta (dilatory) adrenergic receptors in the gills and alpha (constrictory) 
adrenergic receptors in the systemic vasculature of teleosts is well 
established (see Wood, 1974ai Wood and Shelton, 1975). Alpha receptors 
have been reported in the gills of some species, (Belaud, Payraud-
Waitzenegger and Payraud, 1971; Bergman et al., 1974; Wood, 1974a). 
Whether or not beta receptors are generally present in teleost systemic 
vasculature is not clear. (Section II.6.1 summarises reports on the 
presence or absence of alpha and beta receptors in teleost systemic 
vasculature) . 
Responses pf teleost systemic vessels to catecholamines have been 
intensively studied in one species, the rainbow trout, by Wood (1976). 
Holmgren and Nilsson (1974) however give a good account of the adrenergic 
system of the cod. The importance placed upon circulating catecholamines 
in the control of vascular functions in teleosts and the unresolved 
question of sympathetic nervous versus circulating catecholamine control 
indicates that more species should be studied. Despite the fact that 
teleost adrenergic receptors were first described from the european eel 
(Anguilla anguilla) by Keys and Bateman (1932) work comparable to that 
of Wood and Shelton (1975) and Wood (1976) on the systemic vasculature 
of the eel is lacking. There is however a large body of knowledge 
available about many aspects of the physiology of this commercially 
important family. When combined with the ready availability of eels 
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and their hardy nature they are attractive experimental subjects. Of 
the two species of eel available in New Zealand waters, the short-finned 
eel was arbitrarily chosen. The other species, the long-finned eel may 
well have been equally suitable (Shuttleworth, 1972). 
The eel tail was chosen for perfusion for many reasons. The tail 
consists mainly of muscle as does the trunk of the trout. However a 
larger proportion of muscle is found in the tail and the visceral organs 
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are excluded. In mammals the vascular reactions of visceral organs 
such as the liver, kidney and gastrointestinal tract to catecholamines 
are substantially different to the responses reported for skeletal 
muscle (see Mellander and Johansson, 1968). Thus a preparation including 
these organs may well be complicated by problems such as redistribution 
of blood and the production and catabolism of catecholamines by visceral 
tissues. In fish catecholamines are released into the venous system 
particularly the cardinal veins from interrenal tissue (Holmgren, 1977) 
and are thus ideally placed to affect the heart and gills. Fish veins 
are reported to be unresponsive to catecholamines (Burnstock, 1969). 
Endogenous catecholamines released into the veins of the perfused trout 
trunk preparation of Wood and Shelton (1975) are likely to have had little 
or no effect on the results. 
Skeletal muscle appears to be an homogeneous tissue most suitable 
for perfusion as an organ. The presence of red and white or mosaic 
muscles (Hulbert and Moon, 1978) and their substantially different 
vasculatures (Gorkewicz, 1948) opens such a generalization to criticism. 
The post-anal tail of the short-finned eel represents approximately 45% 
of the animals total body weight and is almost entirely muscle. 
Because the tail represents such a large portion of the body, vascular 
adjustments within it are likely to have significant effects upon the 
whole circulatory system. In mammals the skeletal muscle beta 
vasodilatory response is a most important circulatory adjustment to 
exercise (Viveros, Garlick and Renkin, 1968; Rengo, Trimarco, Perez 
and Chiariello, 1976). During swimming teleost muscles build up lactate 
which is indicative of oxygen debt (Black, 1957; Driedzic and Kiceniuk, 
1976) and suggests poor muscle blood supply. Webb (1971) maintained 
that in trout swimming power was provided by aerobic metabolism, 
consequently the need for adequate muscle blood supply indicates that 
the skeletal muscle vascular beds appear to be good subjects in which 
to examine systemic adrenergic receptors in teleosts. 
The principal objectives of this section were to develop an 
isolated perfused eel tail preparation suitable for vascular research. 
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By the study of resistance responses to sympathetomimetic drugs the 
adrenergic receptors of the eel tail were to be classified. The 
adrenergic pharmacology of the preparation was to be compared to results 
from similar studies, especially those of Wood and Shelton (1975), Wood 
(1976) and Holmgren and Nilsson (1974). Pharmacological experiments 
were designed to yield information about vascular and non-vascular volume 
adjustments during resistance changes. To elucidate the function of 
the lymph heart, correlation of lymph heart activity with changes in non-
vascular volume was planned to complement the results from the first 
section. 
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II.2 Caudal Circulatory Anatomy 
II. 2.1 Introduction 
There are few published descriptions of eel tail vascular anatomy. 
Mott (1950a) described the gross anatomy of the arterial and venous 
vessels of the european eel. She described the course of the caudal vein 
to the kidney where it divides to form the renal portal vein 5-15 rom from 
the caudal limit of the kidney tissue. Variable numbers of anastomoses 
connect the renal portal and hapatic portal veins. Pollak (1957a,b) 
described in detail the arterial, venous and lymphatic vessels in the tail 
of the european eel. This study confirmed Dunajewski's (1930) description 
of the tail lymphatics of the same species but. gave greater detail. 
Kampmeier (1969) reviewed the lymphatic system of vertebrates and provides 
a good account of the lymphatics of fish including the tail vessels of 
teleosts. Chan (1971) described the blood vessels in the area of the 
last three vertebrae of the asiatic eel (AnguiUa japonica). 
II. 2.2 Methods 
The caudal blood vessels of the short-finned eel were examined by 
dissection and by injection of a silicone rubber injection compound 
"Microfil', (Canton Bio-Medical Products, Boulder Colorado, MVI12). 
Whole anaesthetised fish were perfused at 0.5 ml min- 1 100 g-l through 
the ventral aorta with saline by a peristaltic pump, (Cole Palmer, 
Masterflex) until the effluent from the bulbus was blood free. The 
silicone rubber 'Microfil' was then prepared and pumped through the whole 
body. Alternatively the tail only was perfused via the caudal artery and 
filled with 'Microfil' in a similar manner. When the 'Microfil' emerged 
from the bulbus or the caudal vein the vessels or cannulae were clamped 
off and the tissue held at 40 C for 15 minutes. The spinal cord of 
whole animals was then cut just caudal of the opercula. Twelve to 
sixteen hours at 40 C was allowed for complete polymerisation of the 
'Microfil'. The tissue was then cleared in a series of glycerine 
solutions of 20%, 50%, 90% for one to two days and then stored in 100% 
glycerine. Alternatively the tissue was etched in a 0.22% solution of 
pancreatin in 1.75% KOH for 48 hours at 37oC. The latter procedure 
was of little value since the skeletal components also disintegrated 
under the treatment and the cast collapsed. 
The lymphatics were visualised by injection of 5% Patent Blue dye 
(a-Zurine, Sigma Chemical Co.) solution in saline subcutan-
eously (Gooneratne, 1974). Lymphatics selectively take up this dye 
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and appear bright blue. 
One perfused tail preparation was perfused with a radiopaque 
material and X-ray photographs were taken during perfusion, (see section 
11.5.3) • These plates gave information about the course of the larger 
arteries and veins in the tail. 
11.2.3 Results 
The positions and courses of the major vessels in the area just 
anterior of the haemal arch of the short-finned eel are essentially the 
same as desc+ibed by Mott (1950a)in the european eel. The short-finned 
eel has a length of caudal artery and caudal vein just cephalad of the 
first haemal arch between four and ten rom long that is free of kidney 
tissue. This space is essential when preparing the tail for perfusion 
since at this point both vessels are ligatured once the cannulae are in 
place. In approximately one third of the tails prepared for perfusion 
there was a short venous anastomosis between the renal portal vein and 
the cardinal vein about five rom cephalad of the posterior limit of the 
kidney tissue. During preparation this vessel was cut between two fine 
ligatures tightened around it. 
The five cleared 'Microfil' preparations and the X-ray photographs 
show that the segmental arteries and veins of the short-finned eel are 
arranged in a very similar manner to. those of the european eel (see 
Pollak, 1957a). As with most fish vascular anatomy, individual 
variation in the size and number of vessels was present but to a lesser 
degree than experienced in·the visceral region. 
The blood vascular anatomY'of the last three vertebral segments 
in this species is similar to the description of the area in the asiatic 
eel (AnguiZZa japoniaa), by Chan (1971) and european eel by Pollak 
(1957b) • A diagram of arterial and venous systems of the short-finned 
eel tail is presented in figure 11.1. Detail of blood and lymphatic 
vasculatures in the lymph heart area are presented in figure 11.2. The 
muscle of the lymph heart is seen to have a very extensive blood supply 
compared to surrounding tissues. 
The lymphatic vessels of the tail are extensive. The caudal 
lymphatic vessel lies ventral to the caudal artery and vein within the 
haemal arches. Glaser (1933, c:i:ted in Kampm~ier, 1969) has shown that 
the caudal lymphatic is not a continuation of the cardinal lymphatic but 
is a separate vessel which connects cephalically with the circum-anal 
lymph plexus, and caudally with centrally directed branches from the two 
lateral lymphatics. Kampmeier (1969) stated that the caudal lymphatic 
FIGURE II.I Blood vascular anatomy of the short-finned eel tail. card.v., cardinal vein; caud.a., caudal artery; 
caud.v., caudal vein; l.h., lymph heart~ r.p.v., renal portal vein; s.a., segmental arteries; s.v., 
segmental veins; v., vertebrae; v~a., venous anastomosis. Composite drawing from fresh specimens, 
'microfil
' 
injected specimens and X-ray photographs of radiopaque medium in the vasculature. 
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FIGURE II.2 V~scular an~tomy in the area of the lymph heart. 
Arteries h~tched, veins black ~nd lymphatics unshaded. 
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drains into the circum-anal plexus. Observations in the short-finned 
eel indicate that this vessel empties at least part of its contents into 
the right hand side of the lymph heart as described by Favaro (1905). 
At the junction of the caudal lymphatic with the lymph heart, the vessel 
is about 1.5 times the diameter of the caudal vein, (see figure 11.2). 
The caudal fin lymphatic connects the caudal fin lymph sinus and the 
lymph heart. This vessel passes through the narrow gap between the 
thickened posterior extensions of the hypural plates. The caudal 
fin lymph sinus collects lymph from the fin ray lymph vessels and from 
the lateral lymphatics. The caudal lymphatic vessel and the lateral 
lymphatics both have more than one lymphatico-venous connection. 
Injection of indian ink into the left side of the lymph heart fills 
the caudal vein but not the right side of the lymph heart. Likewise, 
injection into the right side of the lymph heart fails to fill the lymph 
vessels that empty into it. Valves between the two chambers of the lymph 
heart and at the points of entry of the caudal and caudal fin lymphatics 
have been observed in histological preparations of the area. A further 
valve at the lymphatico-venous confluence of the lymph heart and caudal 
vein was found to be larger and thicker than the other three valves. 
All the valves appeared to be bicuspid. 
46 
II.3 Perfusion of the Eel Tail. Methodology 
II. 3.1 Preparation of the eel tail for perfusion 
Short-finned eels between 270 and 719 g (461.8 ± 5.7 gi mean ± 1 
S.E.M.; n = 86) were anaesthetised in 0.04% aqueous benzocaine, 
(Wedemeyer, 1970). Anaesthesia took 9.9 ± 0.4 minutes (mean ± 1 S.E.M.; 
n = 86) . The fish were laid ventral side up on a dissection bench at 
room temperature and the bulbus arteriosus exposed. Heparin (ammonium 
salt, Sigma Chemical Co.) was administered at 500 iu per 100 g body 
weight in 1.0 ml of saline and allowed to circulate for five minutes. 
Blood was then withdrawn from the bulbus and stored in the syringe at 
40C if required later. A ventral incision about 30 rom long was made 
in the body wall to the left of the midline; ~ 20 rom caudal of the vent. 
The kidney tissue was carefully dissected from the connective attaching 
it to the body wall and the caudal artery and veins exposed to their 
point of entry into the haemal arch. The front of the eel was then 
cut from the tail just caudal of the vent. Two cotton ligatures and 
one silk thread were placed around the caudal artery before cannulation. 
One cotton thread was placed around the caudal vein before cannulation. 
Portex pp160 cannula (120 rom long) was used to cannulate both vessels. 
Cannulae were prefilled with heparinized saline, (100 iu per ml) • The 
cannulae were inserted until they were ~ 20 rom caudal of the first haemal 
arch, the arterial cannula a millimetre or so more caudal than the venous 
cannula. The cannulae were tied in and a further silk ligature was tied 
about the caudal vein and the kidney to which it is attached. 
A tourniquet of size 2 silk was placed about the body just caudal 
of the first haemal arch and was tied tight. The preparation was 
connected to a peristaltic pump (Cole Palmer Masterflex, Cole Palmer 
6408 - 41 tubing) and exsanguinated (5-10 minutes), with heparinised 
saline. The tail was then weighed and placed in the 7 Z constant 
temperature saline bath, (10 ± 10C). Once in the bath the tail was 
sutured to a yoke which supported the cephalad end (see figure II. 3) . 
The tip of the tail was pinned over a wax block which had the centre 
cut out. The hole in the posterior support allowed a light to be shone 
through the tissue so that skeletal elements in the tail could be 
recognised. The lymph heart recorder could then be accurately 
micromanipulated into place. 
Preparation time from the end of anaesthesia until the preparation 
was exsanguinated was 31.3 ± 0.4 minutes (mean ± I S.E.M.; n = 86). No 
experiment was continued for more than six hours. After the end of 
FIGURE II.3 Diagram of experimental apparatus used for perfusion of 
the eel tail. CA, caudal artery cannula; CV, caudal 
vein cannula; D, depulsator; MTd, mechanotransducer; 
PTd, pressure transducer; P, peristaltic pump; R, to 
recorder; T, tourniquet. 
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each experiment the tail was reweighed and all equipment was soaked for 
12 hours in 'Pyroneg' (Diversery Wallace Ltd., Papatoetoe, Auckland) 
before washing, rinsing in distilled water and drying at 80oC. 
II. 3.2 Perfusion methods 
Two perfusion methods were used. The first consisted of a vertical 
tube of known volume per unit neignt (1.11 ml per 10 mm) which was fiUed 
with saline. When connected to the preparation via the arterial cannula 
the fluid was allowed to pass through the vascular bed and out the venous 
cannula. As the level of saline in the tube fell, the input pressure 
fell. Change in pressure is directly related to flow. Hence from the 
record of pressure with time, flow was calculated. 
The second perfusion method was by means of the aforementioned 
peristaltic pump. Flow rates were calculated from the change in weight 
of tne reservoir as measured by a Mettler·top loading balance, (p 1200). 
The flow rate was set at O.S g of saline per 100 g of tail tissue weight. 
Mean measured flow rate was 0.495 ± 0.002 ml per 100 g tail tissue (mean 
± 1 S.E.M.; n = 86). 
The saline delivery system contained a bubble trap constructed from 
a nylon T piece of low volume (- 0.5 ml), which by regUlation of the gas 
space at the top allowed adjustment of the 'pulse' pressure. The 
traditional inverted vial used as a bubble trap was unsatisfactory 
because mixing of the incoming saline with that in the vial was incomplete. 
When perfused with an Evan 's blue dye solution, the system used delivered 
from the venous cannula a dye concentration of 95% of the input solution 
within 150 s. 
was produced. 
In just over 30 s, 50% of the dye solution concentration 
After four minutes the concentration stabilized at 98% 
to 100% of the initial concentration. The inverted vial only 
delivered 85% of the reservoir concentration after 12 minutes. 
These data are important when considering the time course of tne 
responses of the preparation to drugs delivered by this system. 
A stainless steel injection port of low volume (~ 0.05 ml), was 
constructed from a 'Gordh' 20 gauge intravenous needle fitting, 
(Eschmann, England). This device allowed replacement of the seal, 
(No 789168), after each preparation and had a very small dead space. 
A coil of tubing in the bath allowed equilibration of bath and 
perfusate temperatures. 
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II.3.3 Measurement of perfusion parameters 
Flow. During vertical tube perfusion flow was calculated by 
drawing a tangent to the pressure record with time at the desired 
pressure and calculating flow from the linear relation between pressure 
and flow in such a set up. Flow is thus the dependent variable. 
For pump perfusion the change in reservoir weight with time, when 
corrected for specific gravity of the perfusate (1.0090 g.ml- 1) gave the 
flow. Because the reservoirwas constantly bubbled with 95 °2/5% CO2 
evaporation may not be insignificant. 
Outflow in drops was recorded by placing a ceramic gramophone 
cartridge (BSR X5H, Phillipps), in the path of the falling venous outflow. 
Each time the drop deflected the stylus, the piezioelectric crystal 
produced a signal which was displayed on the recorder. Drop weight 
varied between preparations because of different absolute flow rates 
and was measured gravimetrically for each preparation. 
Pressure. Both input and output pressures were measured with Bell 
and Howell type 4-327-0010 pressure transducers which were filled with 
saline and calibrated against the internal standard in the recorder. 
Checks on this calibration were made periodically with a column of 
saline connected to the other port of the transducer head. The level 
of the saline in the bath was maintained by a constant inflow and over-
flow and was taken as zero pressure. 
Lymph heart. During perfusion it was not possible to see movements 
of the lymph heart as in the intact animal because of the absence of 
blood. To record lymph heart beat a fine glass extension was fitted 
over the end of a Devices 4751 100 force displacement transducer. 
When the glass extension was lightly rested against the area of skin 
lateral to the lymph heart the body wall movements produced a record. 
This mode of recording did not allow accurate or absolute measurements 
of amplitude. Consequently any changes in amplitude are relative to 
those before experimental manipulation. 
was reliably and accurately recorded. 
Frequency of the lymph heart 
Oxygen tension. Oxygen tension in the saline was measured with 
a Beckman Field Lab Oxygen Analyser with 3995 sensor. Reservoir and 
'venous' oxygen tensions were measured in 12 preparations. 
pH. pH of the perfusion medium was determined with a Metrohm 
E488 pH meter. 
All parameters except pH were recorded continuously on a Devices 
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MX4 four channel recorder for full analysis after the experiments. 
ll.3.4 Drugs and chemicals 
Drugs used in experiments on these preparations were: Heparin, 
ammonium salt (Sigma Chemical Co.) Z-adrenaline, free base, (Sigma 
Chemical Co.), Z-noradrenaline, free base (Sigma Chemical Co.), Z-
noradrenaline, bitartarate (Koch-Light Laboratories), Z-isoprenaline, 
bitartarate (Sigma Chemical Co.), phentolamine, mesylate (ClBA), 
propranolol, (ICI Ltd., Pharmaceuticals Division), dichloroisoproterenol, 
hydrochloride (Eli Lilly and Co. Ltd., Bassingstoke, England). 
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II.4 Ringer 
II.4.1 Saline 
The saline solution used throughout this study was fresh water eel 
Ringer's solution after Rankin and Maetz (1971). Glucose and poly-
vinylpyrrolidone were omitted from the bathing ringer. All salines 
used for perfusion were vacuum filtered through watman GFC filter paper 
immediately before use. 
Eel plasma was collected from five eels and Na+ and Cl-
concentrations determined. Sodium concentration was measured with an 
Eel flame photometer and chloride concentration was measured with a 
+ Corning Eel Chloride meter, (potentiometric titration) . Mean Na 
concentration was 0.142 ± 0.001 M (mean ± 1 S.E.M.), which is close to 
+ .. . 158 the Na concentratlon ln the rlnger of O. M. Mean Cl- concentration 
was 0.111 ± 0.001 M (mean ± 1 S.E.M.) compared to 0.119 M in the saline. 
II.4.2 Viscosity 
The viscosity of the saline was increased with polyvinyl-
pyrrolidone (PVP) of 360,000 average molecular weight (Sigma Chemical 
Co.), to a value near half way between the whole blood and plasma 
viscosities (see Whittaker and Winton, 1933; Wood, 1974a). Blood was 
collected in dried heparinised syringes from the bulbi of nine eels and 
was pooled in the case of three pairs thus obtaining six samples. The 
mean haematocrit of the six samples was 40.15 ± 0.93%, (mean ± 1 S.E.M.) 
which is slightly higher than reported by McArthur (1977) for this 
species. To measure the viscosity the blood samples were passed through 
an Oswald viscometer with a bore diameter of 0.428 mID. This size bore 
was calculated to have less than 1% effect on the relative viscosity of 
the solutions (Burton, 1965). The mean time taken for the blood to 
pass through the viscometer was 1138 ± 69.7 s (mean ± 1 S.E.M.) giving 
a relative viscosity of 6.05. The blood was then centrifuged at 5000 
rpm for ten minutes and the plasma taken off. Two pairs of plasma 
samples were pooled leaving four samples. The mean time taken for plasma 
to pass through the viscometer was 407.0 ± 21.4 s (mean ± 1 S.E.M.; n = 4), 
a relative viscosity of 2.15. The viscosity of distilled water and 
-) -I 
solutions of 8.6 gl; 10 gl, 15 gl and 20 gl PVP were measured. Half 
the difference between the time taken for whole blood and plasma is 
added to the time taken for plasma which gives a time of 772~5 s, or a 
relative viscosity of 4.10. This is very close to the time for the 
10 gl-l PVP solution. Subsequently 10 gl-l PVP was used to increase 
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the viscosity of the ringer to near physiological values. 
Specific gravity of short-finned eel blood and ringer with 10 gl-l 
PVP added were calculated to be 1.0503 gml-1 and 1.0090 gml-1 respectively. 
Human serum was supplied by the Haematology Laboratory Christchurch 
Public Hospital. Addition of 5% serum to the saline did not significantly 
alter its viscosity. 
II.4.3 Experimental protocol 
For each preparation no drugs were introduced until after the 
measurement of flow/pressure differential profiles, baseline resistance 
and changes in resistance with venous pressure. These measurements were 
only made after the preparation had been perfused for 15 to 30 minutes to 
allow a period of stabilization. Before each set of drugs and inter-
mittently between various concentrations blank saline samples were 
prepared and administered in the same manner as drugs. Administration 
of blanks and drugs was by the perfusion line (infusion) or as a bolus 
of O.l ml (injection). None of the blanks produced significant responses. 
Dose response curves were calculated from the responses to cumulative 
addition of increasing concentrations (van Rossum, 1963). In no case 
was a dose response curve constructed from a preparation treated with 
any other drug. For the experiments involving antagonists about half 
the preparations had previously had dose response curves constructed from 
their responses. 
II.4.4 The use of human serum in the saline 
Regulation of blood flow through vascular beds requires that the 
resistance to flow can be increased or decreased. Isolated saline 
perfused vessels and some vascular beds often assume a baseline 
resistance that is equivalent to maximal dilation, that is complete 
relaxation in the absence of any vascular tone (Waugh and Shanks, 1960i 
Bohr and Johansson, 1966). From this baseline it is impossible to 
elicit any further dilation. Therefore the in vivo situation must 
surely be a normal tone near the midpoint resistance to achieve effective 
regulation. Vascular tone is defined by Mellander and Johansson (1968) 
as " ••• the average level of contractile state in the musculature within 
a region or section of the peripheral vasculature." Folkow (1960) 
stated that circulating vasoconstrictor substances play an insignificant 
part in the maintenance of tone in mammals. He maintained that the 
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sympathetic nervous system played a dominant role in tone maintenance. 
There are however many reports of non-neurogenic tone in isolated 
perfused vascular preparations which is the result of unknown vasoactive 
substances in the blood (Bohr, Verrier and Sobieski, 1971). 
Isolated mammalian perfused kidney, skeletal muscle, and blood 
vessel preparations have been the subjects of intensive study of 
autoregulation of vascular resistance (Waugh and Shanks, 1960; Stainsby, 
1964; Johnson, 1964). One important finding of these investigations 
was that effective regulation of blood flow was maintained by the presence 
in the perfusate of small amounts of plasma or serum. Cardioactive 
substances from plasma of between 4000 and 8000 mwt have been described 
by Naylor, Robertson, Price and Lowe (1965). Bohr et al. (1971) reported 
an even lower molecular weight fraction from protein-free plasma that 
maintained skeletal muscle resistance vessel autoregulation. Very large 
proteins, cardioactive globulins, were described by Hadju and Leonard 
(1961) . Bullivant (1978a,b) described the use of human serum and bovine 
serum albumin to maintain autoregulation in isolated perfused rat kidneys. 
It appears that the addition of plasma to the perfusate confers upon 
isolated perfused preparations characteristics that are observed in whole 
intact animals. Extensive observations by Waugh and Shanks (1960), 
Hadju and Leonard (1961), Stainsby (1964) and Bohr et al. (1971) have 
shown that the multiple effects of plasma on perfused preparations are 
not the result of the cellular fraction but are elicited by plasma, 
serum and protein free serum. The effects of these various fractions of 
plasma are not similar to the effects of any vasoactive agents so far 
described (Bullivant, pers. comm.). catecholamine blocking agents and 
metabolic inhibitors had little or no effect on the serum induced tone 
(see Bohr et al., 1971). 
plasma in the perfusate at low concentrations (0.25 to 1.0%) also 
+ ++ had the ability to potentiate the responses to ions (K ,Ca ) and 
humoral vasoactive agents (noradrenaline, angiotensin), (Bohr and 
Johansson, 1966). Recently Smith and Rozengurt (1978) have discussed 
the molecular basis for the effects of serum proteins upon membrane 
function. They maintain that certain ionophores present in serum 
+ increase membrane permeability to Na. In muscle cells, increased 
intercellular Na+ would lower the threshold for contraction. Thus more 
muscle cells are likely to be recruited for a given stimulus, enhancing 
the response. 
Blood proteins, particularly albumin, have been suggested to have 
transport or protective functions for labile vasohumours. Callingham 
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and Barrand (1976) stated that catecholamines are more stable in plasma 
than in saline. Binding of catecholamines to albumin is slow (> 18 hrs) 
but a significant proportion (> 40%) occurred immediately. The half 
life of noradrenaline and adrenaline in mammalian blood has been estimated 
to be around 20 s (Ferriera and Vane, 1967). The blood bath technique 
and bioassays used by Ferriera and Vane mean that they measured the amount 
of active drug available to the tissue. That greater quantities are 
present but are unassayable, perhaps because of protein binding, remains 
a possibility. Binding of drugs to plasma proteins and tissues increases 
the half life of other drugs (Gibaldi, Levy and McNamara, 1978) and 
increases the apparent volumes of distribution (Gibaldi and McNamara, 
1978) . A chemical equilibrium between plasma protein-drug complexes 
and free drugs which are accepted to be the active agents, and receptor-
drug complexes is conceivable which could explain the prolonged action of 
drugs despite the rapid disappearance of the assayable free fraction. 
Busacker and Chavin (1977) studied the uptake and turnover of radio-
labelled catecholamines in goldfish. They were quick to point out 
that they followed the radiolabel of the drugs which may not reflect the 
movements of the active agents. They stated that degradation products 
of adrenaline and noradrenaline are not known to be taken up by the 
tissues examined. Subcutaneous injections of low doses of adrenaline and 
noradrenaline resulted in rapi4 « 2 min) appearance of the catecholamines 
in the plasma. The interesting point is that both adrenaline and 
noradrenaline persisted in the plasma for long times. Plasma adrenaline 
levels were maintained for 128 minutes and plasma noradrenaline levels 
peaked at 32 minutes after injection. 
Fish have very permeable capillaries, (Hargens, Millard and 
Johanssen, 1974). An increase in capillary blood pressure would result 
in extravasation of fluid and subsequent oedema. Thus we could expect 
either a strict control of blood pressure or an efficient means of tissue 
fluid recovery. Changes in colloid osmotic pressure represent less of 
a problem in fish. Leaky capillaries would result in rapid equilibration 
of blood and tissue colloid osmotic pressures. This would relieve the 
need to alter blood pressure in response to blood protein concentration 
changes. Myhre and Steen, (1977) reported that albumin and horse serum 
assist in maintaining normal capillary permeability in the perfused eel 
rete preparation. Landis and Pappenheimer (1963) suggested that serum 
proteins bound loosely to capillary endothelium. Levick and Michel 
(1973) supported this idea and Fry, Mahley, Weisgraber and Oh (1977) 
have measured the amount of labelled albumin bound to canine aortic walls. 
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The binding of albumin appears to be non-uniform, localised at the cell 
junctions, the purported sites for pores (Landis and Pappenheimer, 1977). 
Hadju and Leonard (1961) found that their globulin fraction could not be 
washed out from a heart that had been exposed to them. Movement of 
proteins through capillary walls, the most significant barrier to their 
movement (Courtice, 1971), is generally accepted to be through pores. 
Many models of pores including their sizes and areas in capillaries have 
been suggested (see Landis and Pappenheimer, 1963; Stray-Pedersen and 
Steen, 1975). The endothelium cell junction appears to be the most 
likely site for such pores. The model proposed by Stray-Pedersen and 
steen (1975) has many attractions in that the large pore filled with 
fibrous material can act as a molecular sieve. This model offers 
explanations as to the mode of action of the plasma proteins in 
maintaining permeability. It is easy to conceive of a matrix of 
macromolecules being altered to allow the passage of various sized 
molecules to pass, and for plasma proteins to be part of such a matrix 
or 'filtercake', (see Mason, Curry and Michel, 1977). 
This information about the actions of blood proteins upon the 
vascular system indicates that an investigation of an isolated perfused 
vascular preparation that is concerned with resistance, the responses to 
catecholamines and the production of extravascular fluid could benefit 
from the addition of serum or blood 'proteins to the perfusate. The 
isolated perfused eel tail is just such a preparation ana 5% human serum 
has been added to the perfusate in 36 of. the preparations. 
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II.5 Results 
II.5.1 General results 
One hundred and one isolated perfused eel tail preparations were 
prepared. Twelve preparations were discarded because venous outflow was 
less than 80% of the inflow (efficiency of perfusion) . Three were 
discarded because gas bubbles were inadvertently let into the perfusion 
line. The results presented here are from 86 satisfactory preparations. 
Units used in the results follow the suggestions of Kappagoda and 
Lindin (1976) for the use of SI units in cardiovascular research. 
Consequently all pressures (p) are in kilopascals (kPa) , flows (Q) in 
ml.min- 1 , resistances (K) in kPa.ml-1.min, and drug concentrations in 
molar (M) concentrations or doses. The free base was taken for the 
molecular weight of the drugs. Pressure differential (Pd) was measured 
across the vascular bed from the caudal artery to the caudal vein. 
Changes in any of the above parameters are indicated by delta (~). All 
values are quoted as means plus or minus the sample standard error of the 
mean, unless otherwise stated. 
The tissue perfused amounted to 45.15 ± 1.53% (n = 86) of the total 
body weight of the fish. This calculation includes the small amount of 
tissue at the anterior end of the preparation which was excluded from 
perfusion by the tourniquet. The efficiency of perfusion was 87.16 ± 
2.31%, (n = 86) • In twelve of these, at the end of experiments, the 
input and output cannulae were connected by a short length of tubing and 
inflow and outflow recorded. The mean value was 96.35 ± 2.61%. This 
somewhat lower than expected value for maximum efficiency indicates that 
not all the fluid that is lost from the reservoir emerges from the venous 
cannula. As noted before evaporation may be significant. 
All tails gained weight during perfusion, the mean increase was 
+12.48 ± 1.85% (n = 86) • Perfusion stimulated mucus production and upon 
wiping the excess slime off 11 preparations the weight gain was reduced 
to +7.59 ± 1. 45% (n = 11). Although there was an increase in tissue 
weight there was no concommitant increase in baseline resistance with 
time. 
After all experiments were completed the input and output cannulae 
were dissected free with the ligatures still in place and connected by a 
short length of tubing (short circuit perfusion) • The pump setting was 
not altered and the resistance of the delivery and collection system 
was measured. The mean system resistance (Ks) was 0.619 ± 0.85 kPa ml- 1 
min (n = 86) and was equivalent to about 40% of the mean baseline tail 
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vascular resistance. This quantity was measured for each preparation 
and was subtracted from each resistance measurement (see Wood, 1974a). 
Deterioration of perfused preparations as indicated by increasing 
baseline resistance with time of perfusion has been a problem in 
previous investigations (see Rankin and Maetz, 1971; Wood, 1974a). In 
the perfused eel tail no such problems were encountered. Filtration of 
the medium through Whatman GFC glass paper was adequate to remove the 
problem of slowly increasing baseline resistance caused by particulate 
matter. In several preparations where no experiments were performed 
for several hours, a very slight decline in baseline resistance « 2%) 
was observed. Baseline resistance was taken between 30 minutes and 
one hour after the start of perfusion when a stable level was achieved. 
II. 5.2 Baseline resistance 
Pump perfusion of 50 tails with the basic saline, (fresh water 
eel saline plus 10 g[} PVP), was performed at venous pressures of zero 
and 1. 33 kPa. Thirty six preparations were perfused with 5% human serum 
added to the perfusate at a venous pressure of 1.33 kPa. These experiments 
gave the mean baseline resistances tabulated below (see table 11.1). 
Table 11.1 Baseline resistance of isolated saline perfused eel 
tails, in kPa ml- 1 min. 
Venous 
pressure 
kPa 
zero 
1.33 
Basic saline 
1.827 ± 0.083 (n 50) 
1.120 ± 0.057 (n = 50) 
5% serum saline 
2.097 ± 0.447 (n = 8) 
1.754 ± 0.092 (n = 36) 
When the venous pressure was raised from zero to 1.33 kPa there was a 
significant drop in resistance of 38.68% (P < 0.0001). On addi tion of 
5% human serum to the perfusate a resistance increase of 44.62% was 
recorded which is also significant at the P < 0.0001 level (Student's t-
test) • Baseline resistance was determined in eight experiments at zero 
venous pressure during perfusing with 5% serum saline. 
When baseline resistance is plotted against weight of fish, an 
inverse relationship is seen (figure 11.4). The equations of the lines 
fitted to the data are given with each figure. The relationships are 
similar to those found by Payan and Matty (1975) for perfused rainbow 
FIGURE II.4a 
FIGURE II. 4b 
FIGURE II .4c 
Weight versus perfused eel. tail. basel.ine resistance during 
perfusion with caudal venous pressure at 1.33 kPa and 
without serum in the perfusate. 
Fitted line has the equation 
Error bars = ± 1 S.D. 
-1 . -0.899 KI (kPa ml nun) = 285 Wt (g) 
F value for linearity of regression of transformed data = 
31. 7 for 1,48 d.f. (FO•OOI [1,40] = 12.6) 
Weight versus perfused eel tail baseline resistance during 
perfusion with caudal venous pressure at zero and with 5% 
human serum added to the perfusate. 
Fitted line has the equation 
KI(kPa ml-1min) = 426 wt(g)-0.902 
Error bars = ± 1 S.D. 
F value for linearity of regression of transformed data = 
47.6 for 1,43 d.f. (FO•OOI [1,40] = 12.6) 
Weight versus perfused eel tail baseline resistance during 
perfusion with caudal venous pressure of 1.33 kPa and 5% 
human serum added to the perfusate. Greater scatter of 
points (see standard deviations) and a poorer fit of the 
line to the data indicates that resistance of preparations 
perfused with serum saline is less sensitive to weight. 
Error bars = ± 1 S.D. Fitted line is 
-1 -0 619 ~(kPa ml min) = 68.7 Wt(g) • 
F value for linearity of regression of transformed data 
4.581 for 1,35 d.f. (FO•025 [1,35] = 3.91) 
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trout head preparations and those reported by Wood and Shelton (1975) for 
perfused trout trunks. The points on the graph for eel tails perfused 
with 5% serum saline have a greater scatter as indicated by the standard 
deviation. Although baseline resistance regressed against 7 ht 
. welg 
produced significantly linear lines, better fits were obtained when logs 
were taken of both resistance and weight. Expression of resistance on 
a per weight basis would require different corrections for each set of 
perfusion conditions. Responses are expressed as either changes in 
resistance from baseline resistance (6K), or as percentage changes over 
baseline resistance (6K%). It is unclear whether or not 6K or 6K% is 
inversely proportional to weight. Consequently no manipulation of the 
data to compensate for the weight of the tissue was used. 
In eight preparations pump perfused with the basic saline the 
venous pressure was raised in 0.5 kPa steps from zero to 4.5 kPa. The 
results of these experiments are shown in figure II.5. As venous 
pressure was raised resistance fell by approximately 10% per 0.5 kPa. 
No myogenic increase in resistance was observed (see Johnson, 1977) and 
the vascular bed behaved to some degree as a set of distensible tubes 
(Folkow and Lofving, 1957). The change in resistance for the 50 tails 
These perfused at a venous pressure of 1.33 kPa lies close to the curve. 
results are similar to those reported by Wood (1974a) from isolated 
vertical tube perfused trout gills where the output pressure was raised 
from zero to around 3.9 kPa. When the venous pressure was raised above 
3.5 kPa three of the eight perfused tail preparations exhibited zero 
outflow from the output cannula. Decreased outflow is to be expected 
during adjustment to increases in pressure since vascular volume increases 
(distensibility) • Greater transmural pressure will result in more fluid 
passing into the tissues. At non-physiologically high venous pressures 
severe oedema could follow producing a short period of zero outflow. 
Very high venous pressures were maintained only until stable input and 
output pressures were attained, (one to two minutes) after which the 
venous pressure was lowered. 
II.S.3 Saline experiments 
II.S.3.1 Introduction and methods 
As controls for the use of human serum in the perfusate, three tails 
were tested with a variety of salines. The resistance of the preparations 
were measured after ten minutes of perfusion with each of the salines and 
compared to the resistance with the basic saline. Adrenaline (AD) was 
FIGURE II.5 Percentage changes in resistance in response to caudal 
venous pressure increments. Baseline resistance fell by 
approximately 10% per 0.5 kPa caudal venous pressure 
increment. The value for the percentage change in 
resistance after increasing venous pressure for all 
preparations perfused with the basic saline falls very 
close to the interpolated line (see ~) • Mean initial 
baseline resistance at zero venous pressure for prep-
arations used in these experiments was 2.692 ± 0.0882 
kPa ml-1min (n = 8). Error bars = ± 1 S.E.M. The 
symbol t indicates that three preparations showed zero 
outflow at this caudal venous pressure (for discussion 
see text). Two preparations only were subjected to 
caudal venous pressures of 4.5 kPa. 
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administered at three low doses, 50 pmoles, 100 pmoles and 200 pmoles in 
a bolus of 0.1 ml of the appropriate saline. Low doses were chosen so 
that the least possible desensitization with repeated administration would 
occur (Waud, 1968). 
The salines were prepared as follows: 
Salines 1 and 2. Twentyfive mls of human serum was thawed and placed 
into dialysis tubing, (Arthur Thomas, Philadelphia, No 4465 - A12) which 
permitted the movement of molecules of around 12000 molecular weight and 
less through the walls. The tubing was ligatured and placed into 30 mls 
of fresh water eel saline without PVP and stored at 4oC. After four 
hours the bathing saline was drained off and retained and the tubing washed 
twice in five mls of saline. The washings were retained with the bathing 
saline. This process was repeated twice more at eight and ten hours. 
After 12 hours of dialysis the contents of the tubing and the washings 
were reconstituted to make up separate salines containing 5% non 
diffusable serum proteins (tubing contents) and 5% dialysate. 
Saline 3. Three g.l-l bovine serum albumin, (fraction V powder, Sigma 
Chemical Co.) in the basic saline. 
5% human serum in the basic saline. Saline 4. 
Saline 5. Eel blood collected after heparinization (see section II.2.l) 
was centrifuged at 5000 rpm for ten minutes. The plasma was drawn off 
and added to the basic saline at a concentration of 5%. 
Saline 6~ Whole eel blood was used as the sixth perfusate in this 
series of experiments. 
In all of the preparations serum sub samples were taken from the 
same original batch of serum. Preparation of the salines was repeated 
for each perfused tail preparation. 
II.5.3.2 Results and discussion 
The mean resistances for the preparations tested with the salines 
above are presented in table II.2. All of the test solutions increased 
resistance. The human serum protein saline increased resistance most 
and the bovine serum albumin the least. 
Serum was dialysed to separate the high molecular weight proteins 
from the low molecular weight compounds and ions. Hargens et ale (1974) 
reported that fish proteins were retained across a dialysis tubing 
designed to retain compounds of 10,000 mwt or greater. Dialysis against 
the basic saline had the effect of only partially separating the two 
fractions. After the twelve hours and three changes of bathing saline 
the concentration of the low molecular weight fraction in the tubing is 
Table 11.2 Mean bas line resistance (kPa ml- 1 min) of three 
preparations perfused with a range of different salines. 
Normal 
saline 
o 
Serum Serum 
proteins dialysate 
1 2 
3 gl 
BSA 
3 
5% 
serum 
4 
5% Eel 
plasma 
5 
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Baseline 
resistance 0.7192 1.8728 1.0289 0.9044 1.7822 1.1647 
± 1 S .E. ±0.0107 ±0.0389 ±0.01203 ±0.0674 ±0.0507 ±0.0408 
assumed to be reduced about eightfold. The results show that the high 
molecular weight fraction retained its activity and increased resistance 
above the level obtained by perfusing with 5% serum ringer. The low 
molecular weight fraction increased resistance to about half the resistance 
for perfusion with 5% eel plasma. This suggests that some low molecular 
weight substances in human serum have the ability to increase resistance. 
The resistance increase on perfusion with blood was 37.4% ± 9.8% (n = 5). 
It must be noted that most preparations tested with blood had undergone a 
full range of dilatory (3) or constrictory (1) responses to ISO or AD 
respectively. This treatment possibly lowered the reactivity of .the 
vascular bed to perfusion with eel blood. 
Responses of the preparations perfused with four of the test 
salines to low doses of adrenaline are presented in figure 11.6 The 
greatest responses in absolute terms were found where serum proteins 
were present in the perfusate. When perfused with the basic saline, 
3 gl-l bovine serum albumin and 5% dialysate in the basic saline the 
responses to adrenaline were all very similar. If these results are 
expressed as percentage changes in resistance over baseline resistance, 
then the responses to each of these doses of adrenaline were similar for 
all the perfusates. This suggests that a higher baseline resistance 
results in a greater response to adrenaline as has been suggested by 
Wood (1974a). 
The points to emerge from these controls are that the presence of 
serum in the ringer increases the vascular tone and the magnitude of the 
response to adrenaline of the isolated perfused eel tail. This tone is 
not caused by ions or low molecular weight « .12000) compounds such as 
catecholarnines in the serum. The responses to low doses of adrenaline 
were larger, but relative to baseline resistance were similar to the 
responses in the absence of serum. The possible mechanism by which 
serum proteins enhance responses to AD and other catecholarnines was 
FIGURE II.6 Mean resistance responses to 50, 100, and 200 pmoles 
adrenaline in three preparations per~used with four 
different salines. The enhanced responses when perfusate 
contains 5% human serum is partially due to elevated 
baseline resistance (for discussion see text). 
~ Basic saline 
~Basic saline plus 5% human serum 'proteins' 
~ Basic saline plus 5% 'dialysate' of human serum 
~ Basic saline plus 3 g.l-lbovine serum albumin 
Error bars are ± I S.E.M. 
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discussed in section 11.6.2.6. Potentiation of responses does not 
appear to be solely the result of elevated baseline resistance. 
11.5.4 Flow versus pressure profiles 
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The vertical tube method of perfusion was used on 15 preparations. 
In each of the preparations at least two flow versus pressure 
differential (Q/Pd) profiles were constructed; one at a venous pressure 
of zero and the other at a venous pressure of 1.33 kPa. Nine of the 15 
preparations were perfused with the basic saline, the other six had 3% 
serum added to the perfusate. Figure 11.7 shows the curves for 
preparations without serum at zero and 1.33 kPa venous pressure. Figure 
11.8 shows the curves for tails perfused with 3% serum added at the same 
two venous pressures. Profiles were always determined after ex-
sanguination and before any drugs had been administered. The profile 
at zero venous pressure was constructed first in all but two preparations. 
The two preparations where venous pressure was set to 1.33 kPa for the 
first profile produced results qualitatively the same as for the others. 
The marked curvilinearity present in the Q/Pd profiles of trout 
gills (Wood, 1974a) is not seen in these curves. There is however, a 
slight convexity towards the Pd axis which indicates low vascular tone 
(Kuida, 1965). The progressive fall in resistance with time observed 
for the first 40 minutes by Wood (1974a) and Wood and Shelton (1975) was 
present in the perfused eel tail for only five to ten minutes. This 
initially high resistance at the start of perfusion is evident in the 
Q/Pd curves by downturn of the profiles at high venous pressure which 
corresponded with the start of perfusion. This effect was observed 
during both profiles where a period of very low flow intervened. It 
was however much smaller at the start of the second profile. The high 
initial resistance of the eel tail is the result of the near zero luminal 
pressure during preparation of the tail and after exsanguination which 
allowed the vessels to collapse. When the alternative perfusion system 
was connected and perfusion resumed, the vasculature was in a state of 
constriction which was rapidly dispelled in the presence of 'normal' 
luminal pressure. The bore of the tube used for the profiles was 
approximately twice the size of that used by Wood and Shelton (1975). 
Consequently there is a smaller change in flow rate per unit change in 
pressure. Thus at each point of the Q/Pd profile the conditions are 
more stable which may be a factor in reducing the 'viscous' effects which 
contribute to Q/Pd variability. 
In the absence of serum,differences in flow at each pressure 
II.7 Flow versus pressU;t;"e di:t;::t;erential ::t;or pJ;'epaxations peJ;'fused 
by the vertical tube techniq:ue with the basic saline at 
caudal venous pressures of zero and 1.33 kPa. Flows are 
significantly different at all pressure. differentials at the 
P < 0.005 level (Student's t-test, n = 9) . At perfusion 
pressures above 8.0 kPa there was a convexity toward the 
pressure axis particularly in preparations perfused at 
zero venous pressure. This is interpreted as passive 
distension of the vessels at the start of perfusion after 
periods of very low flow when vessels would collapse. 
Lack of convexity over the rest of the pressure range 
suggests that there is significant resting tone (Kuida, 
1965). Error bars are ± 1 S.E.M. 
-0- caudal venous pressure = 1.33 kPa 
-e- caudal venous pressure = zero 
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FIGURE 11.8 Flow versus pressure qi:J;:J;erential.for siz preparations 
perfused by the vertical tube technique with 5% human serum 
in the perfusate at caudal venous pressures of zero and 
1. 33 kPa. There was no significant differences between 
flows at any pressure differentials. Greater variation of 
flow values at each pressure differential was typical for 
preparations perfused with serum saline. Slight 
convexity toward the flow axis s.uggests that resting 
vascular tone was greater in preparations perfused with 
serum saline than in those perfused with the basic saline. 
Error bars are ± 1 S.E.M. 
-0- caudal venous pressure = 1.33 kPa 
... caudal venous pressure = zero 
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differential between preparations perfused at venous pressures of zero 
and 1.33 kPa were all highly significant (P < 0.005-0.001; Student's t-
test) . In the presence of serum none of the differences in flow' at any 
pressure differential was significant. Addition of 3% human serum to 
the perfusate resulted in smaller changes in resistance to flow when 
venous pressure was raised. 
Resistance calculated from vertical tube perfusion at the flow rate 
later used for pump perfusion of the same preparations, and baseline 
resistance for pump perfusion were not significantly different. Without 
serum in the perfusate vertical tube resistance at equivalent flows and 
caudal venous pressures of 1.33 kPa were lower than pump perfusion base-
line resistances under the same conditions (Q/Pd K = 1.226 ± 0.1357 kPa 
ml- 1 min; pump K = 1.751 ± 0.2143 kPa ml- 1 min; n 9). When 3% 
human serum was added to the perfusate, vertical tube perfusion resistance 
was higher than pump perfusion baseline resistance at equivalent flows 
and caudal venous pressures of 1.33 kPa (Q/Pd K = 2.2799 ± 0.1327 kPa 
ml- 1 mini pump K = 2.105 ± 0.09673 kPa ml- 1 min; n = 6), and differences 
were smaller. Addition of 3% human serum to the perfusate reduced the 
effects of different perfusion methods upon estimates of vascular 
resistance in this preparation. Addition of serum to the perfusate has 
imparted a degree of vascular autoregulation to this preparation that was 
otherwise absent. 
II.5.5 X-ray study of the preparation 
II.5.5.1 Introduction and methods 
One question that remained unanswered was how well perfused was 
the preparation. As the time course of the reactions of the vasculature 
and lymph heart is dependent upon the amount of drug presented to 
appropriate area of the preparation, then this question seemed to be 
important. 
To study this, one perfused preparation was prepared as normal at 
the University of Canterbury and subsequently transported to the Princess 
Margaret Hospital, Christchurch. During transport, perfusion was 
maintained by a constant pressure head (~ 3.0 kPa), and the preparation 
was covered with saline. Once at the Radiology Department of the 
Hospital the tail was placed in a shallow plastic tray and covered with 
paper towels soaked in saline. The pump replaced the pressure head and 
the venous pressure was raised to 1.33 kPa. 
Radio-opaque medium 'Conray 280' (35% w/v meglumine bothalamate) , 
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was used at full strength and was either injected into the perfusion line, 
(0.5 ml) over a period of 30 s or was introduced by perfusion (0.5 ml) 
taking approximately 23 s. Smaller doses and dilutions of the medium 
proved insufficient to show up any but the largest vessels. The time 
that elapsed between the start of perfusion and taking the first plate 
was around 100 minutes. Although temperature was not controlled, the 
o day was cool, (10-15 C) • X-ray plates were taken at 30 s intervals for 
up to 240 s (see Mott, 1950b). 
11.5.5.2 Results and discussion 
Of the six trials, only two yielded satisfactory results. The 
four unsuccessful attempts were so because insufficient contrast medium 
was used. The two successful sets were taken with the venus pressure at 
zero and 1.33 kPa. The former, at venous pressure at zero, received the 
medium by injection, (I); the latter received the medium by infusion into 
the perfusion line, (II). The first plate from trial II showed the medium 
just entering the caudal artery. This indicates that much of the first 
30 s after the medium passed the depulsator was taken up by filling the 
dead space. Thus this point is very near time zero when compared to I. 
Injection of 0.5 ml over 30 s is equivalent to increasing the flow rate 
through the tail by ~ 40%. Thus we could expect more rapid filling of 
the vessels in trial I than in trial II. This in fact was the case. 
Trial I. Thirty seconds after the start of injection, the first 
plate reveals that all but the last 30 rnrn of caudal artery was filled 
with contrast medium and that the segmental arteries were filled or 
filling. At 60s, both the caudal artery and caudal vein contained 
medium, the artery showing up more densely. The vessels in the tip of 
the tail were most clearly seen at this time and the segmental arteries 
still contained some medium. By 90 s, the caudal artery was empty and 
the density of medium in the caudal vein was decreasing. At 120 s, only 
the most anterior part of the caudal vein contained appreciable amounts 
of medium. After the next 30 s had elapsed, at time 150 s, only a 
diffuse 'glow' could be seen in the caudal vein. Thus it is apparent 
that a large bolus injected into the perfusion line enters all arteries 
within 60 s. Vessels of the lymph heart area are filled with the bolus 
fluid within 60 s. Any agent in such a bolus would be in contact with 
lymph heart muscle within 60 s. 
Trial II. The first plate taken at thirty seconds after the 
medium passed through the depulsator is taken as time zero. Within 30 s 
all but the last 25 rnrn of caudal artery was clearly filled along with the 
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anterior segmental arteries. At time 60 s the caudal artery was 
completely filled even to the most caudal parts, (see figure II.9). By 
90 s medium was in both the caudal artery and vein. The density of the 
medium in the caudal part of the tail is greater in the artery than in the 
vein. In the cephalic part of the tail, the density was greater in the 
vein than the artery. This clearly indicates that the medium was well 
distributed throughout the vascular bed after 90 s. By 120 s both the 
caudal artery and caudal vein were clearing. The caudal 50 mIn of the 
caudal artery still seemed to contain a fair concentration of medium. 
At 150 s the vein and artery are indistinguishable and the whole tail 
has a diffuse radio-opacity. 
Although the arterial filling is more rapid in the case of an 
injected bolus, the circulation time through the perfused eel tail is 
of the order of 150 s. The arteries including the resistance vessels 
are filled within the first minute while the veins are filled within 
120 s. The results also show that there were no parts of the tissue that 
received little or no perfusate. The tissue is well perfused and has 
a circulation time of 60 to 90 s. The estimated circulation time of 
rainbow trout is around 60 s (Davis, 1970). 
FIGURE II.9 Photograph from an X-ray plate 60 s after infusion of 0.5 ml of radiopaque medium into the caudal artery. 
The caudal artery appears completely filled as are most of the segmental arteries. 
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11.6 Vasoactive Drugs and Vascular Resistance 
11.6.1 Introduction 
Vascular tone is controlled by three principal mechanisms; the 
autonomic nervous system (Folkow, 1960; Mellander and Johansson, 1968; 
Burnstock, 1969): circulating vasoactive hormones, (Kirby and Burnstock, 
1969; Burnstock, 1969): and localised myogenic and metabolic factors 
(Johnson, 1977). Blood borne catecholamines appear to play a major 
role in fish circulatory regulation (Randall and Stvens, 1967; 
Burnstock, 1969; Campbell, 1970; Wood and Shelton, 1975; Capra and 
Satchell, 1977c). Burnstock (1969) suggested that during vertebrate 
evolution the autonomic nervous system assumed a greater degree of 
control over vascular functions and that circulating catecholamines 
represent a more primitive type of control system. The two naturally 
occurring catecholamines identified in fish, adrenaline and nor-
adrenaline, are both capable of stimulating alpha and beta adrenergic 
receptors. The alpha stimulating potency of adrenaline (AD) is greater 
than that of noradrenaline (NAD), which is in turn much greater than 
that of the synthetic beta agonist isoprenaline, (ISO); AD > NAD» ISO. 
For betal receptors, ISO »NAD > AD and beta2 receptors, 
ISO »AD > NAD, (Furchgott, 1967). Because adrenergic receptors are 
defined as alpha or beta according to the potency of the drugs above the 
only way to define an adrenergic receptor in a new preparation is by 
potency comparisons (Arnold, 1972; Wood and Shelton, 1975). The use 
of selective alpha or beta antagonists often provides additional support 
for one or other type of receptor but cannot strictly be taken alone to 
delineate between adrenergic receptor types. 
Teleosts show increased plasma adrenaline and noradrenaline 
concentrations in response to stressful situations. Nakano and 
Tomlinson (1967) stressed rainbow trout by tail grasping and reported 
an increase in adrenaline concentration from 2.3 x la-aM at rest to 
7.2 x 10-7M after stress. Noradrenaline concentration changed under this 
stress from 1.7 x la-aM to 1.4 x 10-7M• Mazeaud, Mazeaud and Donaldson 
(1972) exposed three species of salmon, the coho (Oncorhynchus kisutch), 
sockeye (0. nerka), and chinook (0. tshawytscha) to a variety of stimuli 
including struggling in air, hypoxia and thermal stress. These authors 
reported similar increases in plasma catecholamine concentrations for 
all stimuli. Adrenaline concentration rose from 3.5 x la-aM to 7.6 x 
-7 -9-7 10 M, and noradrenaline rose from 6.2 x 10 M to 1.6 x 10 M. The cod 
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showed plasma adrenaline concentration increases from 4.4 x lO-8M to 
2.3 x lO-7M and noradrenaline concentration increases from 5.9 x lO-SM 
to 6.2 x lO-8M when exposed to air (Nilsson, Abramsson and Grove,' 1976) . 
Recently Butler, Taylor, Capra and Davison, (1978) have reported similar 
changes in catecholamine concentrations in the dogfish (SaytiorhinuB 
aaniauta) during hypoxia. All of these reports show consistent increases 
in plasma catecholamine concentrations of around 15 times during stress. 
Despite the problems in assay the reported catecholamine concen-
tration changes are able to explain changes in gill circulatory behaviour 
in vivo, and allow calculations to be made which compare well with 
results from isolated perfused gill preparations (Wood, 1974a; Payan 
and Girard, 1977). 
The compatability of these sets of results from gills contrasts 
sharpl¥ with similar comparisons made with results from the systemic 
vasculature of teleosts. Data to date suggest that the predominant 
response of the systemic vasculature to catecholamines is an increase in 
resistance (see Wood, 1976). During swimming when catecholamine 
concentrations could be expected to rise, a fall in systemic resistance 
has been reported (see Kiceniuk and Jones, 1977). Increased cardiac 
output which could account for much of the resistance change has been 
postulated to be the result of either a decrease in vagal inhibition 
(Randall, 1966) or to excitatory adrenergic innervation, (Gannon, 1971; 
Holmgren, 1977). Circulating catecholamines appear to play a minor 
role in regulation of teleost cardiac output. 
Responses to exogenous catecholamines may reflect the effects of 
these drugs upon receptors which normally receive AD or NAD from 
adrenergic nerve terminals. Whatever the natural mode of delivery of 
catecholamines to the gill vasculature, responses are in accord with in 
vivo results. In the absence of well defined decreased systemic 
resistance responses to catecholamines from isolated preparations it is 
difficult to explain the rather sparse in vivo results which indicate 
that resistance across the systemic vascular beds falls when blood 
catecholamine concentrations are naturally elevated (Kiceniuk and 
Jones, 1977). 
Studies on the systemic adrenergic system of fish are numerous. 
Within the teleosts three groups have received particular attention, 
namely trout, cod and eels. All reports show the presence of alpha 
adrenoreceptors. Studies that provide evidence for alpha receptors 
only include those by Keys and Bateman (1932); Mott (1951); Fange 
(1953); Stevens and Randall (1967a); Johansen and Reite (1968); 
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Reite (1969); Stevens, Bennion and Randall (1972); Nilsson (1972); 
Holmgren and Nilsson (1974); Forster (1976a). Since Chan (1967) provided 
evidence for beta adrenoreceptors in the systemic vasculature of the 
european eel, there have been a growing number of reports which support 
their presence in fish systemic vessels: Chan (1969); Stray-Pedersen 
(1970); Gras, Perrier, Perrier and Gudefin (1971); Helgason and Nilsson 
(1973); Holmgren and Nilsson (1974); Capra (1975); Chan and Chow 
(1976); Wood (1976); Capra and Satchell (1977a,c); Holmgren (1978). 
Apart from Gras et ale (1971) whose study was primarily on extracellular 
space in muscle slices, beta dilation in the trout systemic vasculature 
has been very difficult to demonstrate (Wood, 1976). Only against 
adrenergic tone produced by adrenaline could Wood elicit a beta dilatory 
response. Wood (1976) also made the observation that d-isoproterenol 
has alpha antagonistic effects. He mentioned that previous studies often 
used the d-, 1- raecemic mixture and could cast doubt on whether the 
dilation observed was beta mediated or simply antagonism of an already 
present alpha tone by the d-optical isomer. This study of the perfused 
eel tail has used the laevo rotatory optical isomer of isoproterenol 
exclusively, which has virtually no alpha antagonistic activity, and is 
the active beta agonist in the raecemate (Jenkinson, 1973). Many of 
the above-mentioned studies used isolated organs or vessels (coeliac 
artery, swimbladder, spleen) which may only playa small part in the 
natural decreases in systemic resistance. Thus a beta dilatory response 
should not be expected from all the variety of tissues within the fish 
trunk. Furthermore in the absence of any vascular tone (see Wood and 
Shelton, 1975; Wood, 1976) it would be very difficult to produce a 
dilatory response to any stimulus. 
Autonomic control of fish vasculature has been suggested to be 
totally lacking or to be only rudimentary (Burnstock, 1969). Recent 
work by Holmgren (1978) and Smith (1978) suggests that it may be better 
developed than was previously thought. The effects of metabolites and 
local changes in pH may well play an important role in systemic vascular 
resistance control especially if flow through active tissues (e.g. 
muscles) is reduced (Johnson, 1977). Lastly we should bear in mind 
that catecholamines not only effect vascular tone but also modify 
extravascular space (Gras et al., 1971; Pic,Mayer-Gostan and Maetz, 
1974) and levels of free fatty acids and glucose in the blood (Mazzeaud, 
1972; Mazzeaud et al., 1977). Liberation of metabolic substrates and 
their movement through extravascular space may well be an important 
function of catecholamines during exercise. 
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11.6.2 Dose response curves for adrenaline, noradrenaline and 
isoprenaline 
11.6.2.1 General Results 
Cumulative dose response curves were prepared for three sympathet-
omimetic drugs, adrenaline, (AD), noradrenaline, (NAD), and isoprenaline, 
All doses are expressed as molar concentrations in the perfusate, 
or as moles of drug given as a bolus. Response is expressed either as 
change in resistance, (6K) in units of kPa ml- 1min or as the percentage 
change in resistance over baseline resistance, (~K%). Adrenaline and 
noradrenaline both caused increases in resistance, Isoprenaline caused 
decreases in resistance at concentrations below 1 x 10-4M• Threshold 
concentrations for AD and NAD were between 1 x 10-10 and 1 x 10-9 M• The 
threshold for ISO was between 1 x 10-11and 1 x la- 10M. All data from 
which the curves were constructed are tabulated in appendixes A.l - A.20. 
It will be seen that not every preparation was tested at each concentration. 
In some cases a dose near that required to produce a half maximal response, 
(ED50) was administered without preceding doses (see appendix A.3 for 
AD) • The effect of this method was to remove any desensitization of the 
receptors by previous administrations (Waud, 1968). The randomization 
test for two independent samples was applied to the data from the responses 
of the preparations to 5 x 10-7M AD (Siegel, 1956). This test revealed 
that there was no significant difference between responses from 
preparations that had been exposed to a full series of AD and those that 
received the same dose without previous drug administrations (p > 0.1). 
There is no significant desensitization of the receptors during the 
construction of AD cumulative dose response curves in this preparation. 
It was not possible to prepare full dose response curves for the 
bolus method since doses of 10 and 100 n moles of all drugs often 
initiated violent muscular contractions of the tail suspended in the 
bath. Skeletal muscle contraction in response to high concentrations 
of catecholamines was noted throughout this study. Occasionally 
swimming movements were apparent (see figure 11.10) especially when drugs 
were administered via the perfusion line. Wood and Shelton (1975) also 
noted this in the trout trunk but were unable to offer an explanation. 
Catecholamines can elevate the general level of excitability of the 
mammalian central nervous system and could offer an explanation in terms 
of spontaneous motor discharges (see Vogt, 1973). Two preparations 
which failed to give muscular contractions in response to 100 nmoles ISO 
were given 1 ~mole doses of the drug. This caused muscular contractions. 
FIGURE I1.lO -~ Record oJ; a response to. inftl.sion of 1 x ~O M adrenaline 
in which at the end of the ten minute period of infusion 
regular flexions of the tail were recorded as deflections 
of the mechanotransducer rested against the lymph heart. 
The tip of the tail was pinned to the wax block to 
facilitate lymph heart records, however when. particularly 
violent contractions of the tail occurred the tail was 
pulled from the block. giving a spurt of outflow from the 
venous cannula as it contracted. This swimming response 
was only observed in preparations where large doses of 
sympathetomimeticagents were administered. Mean 
frequency of tail flexion was 8.25 ± 0.24 cycles per 
minute (n = 17) • swimming at 15 em s-1 was accomplished 
by live intact unanaesthetised eels at a tail flexion 
frequency of about 25 cycles per minute. Preparation 
number A203. Tail weight = 229 g. Tail resistance 
change ~ +129.87%. 
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The resistance responses were in agreement with an extrapolation of the 
dose response curves for these preparations (see appendix A.17 and A.18) • 
II.6.2.2 Analysis of dose response curves prepared from responses 
to infused drugs 
Full dose response curves are often sigmoid in shape (Arunlakshana 
and Schild, 1959; Waud, 1968). In trying to describe the response in 
terms of the amount of drug administered, strictly speaking, nothing 
should be assumed about the relationship. However in the light of the 
above information, from experience with similar experiments (Holmgren 
and Nilsson, 1974; Wood and Shelton, 1975) and from qualitative assess-
ment of the results to be described here, the curves were assumed to be 
sigmoid. 
For the simplest model of drug receptor interaction the following 
equation is adequate, 
The 
A+R~AR-+E 
where A is the drug, 
R is the receptor, and 
E is the response. 
response can be described by the logistic equation 
E = M 
yP 
yP + KP 
where M is the maximum response 
p reflects the slope of the curve 
y is the fractional receptor occupancy, and 
K is an empirical location constant 
1 
2 
(Waud, 1968, 1975; Volund, 1978). The tissue under observation in this 
study however contains more than one receptor. The facts that AD and 
NAD caused increased vascular resistance and ISO caused decreased 
resistance to flow suggested the presence of both alpha and beta 
receptors. Thus description of the response in terms of one set of 
receptors is not applicable. An empirical approach to the description 
of the dose response curve was therefore used. A logistic equation was 
chosen because it provides a good fit, is reasonably flexible and is 
easily calculated. The form of the equation contains elements of the 
curve which provide useful information about the response and is as 
follows, 
3 
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where E is fue response 
M is fue maximum response 
A is fue concentration of drug 
K is the ED50, ~d 
P reflects fue slope of fue curve 
This equation is derived from fuat given by Waud (1975) to describe 
sigmoid dose response curves in fue presence of an antagonist. When zero 
antagonist is substituted throughout equation 52 of Waud (1975) equation 
three results. Curve fitting was performed by an iterative process using 
fue least squares process. The values of M, p, and K were allowed to vary 
until fue best fit was found, as measured by the sum of fue squares of fue 
differences between observed and estimated responses. The search 
procedure for fue parameter values is that of Powell (1964). Me~ responses 
for each drug concentration were calculated and used to fit the model 
(see Volund, 1978). Since responses are measured as differences of 
resist~ce from baseline resist~ce, all data points have equal weights. 
In addition to these points the curves were constrained to pass through 
the origin. It is logical to expect zero response when no drug is 
administered. The dose ~d the response at fue origin were set to very 
small values and given weights of 100 times the weight of fue ofuer 
points. 
Curves fitted to fue data had multiple correlation coefficients of 
greater fuan 0.97 (0.988 ± 0.0046, mean ± 1 S.E.M.; n = 10) indicating 
fue propriety of the model for these data. 
Comparisons of the response to the same drug under different 
perfusion conditions and comparisons of responses to different drugs under 
fue same conditions are facilitated when estimates of parameters such as 
ED50, maximum response ~d slope are derived from all the information 
simultaneously. Tests to determine the significance of differences 
between fue nonlinear parameters slope ~d ED50 are not possible wifu 
this mefuod. Similarly ~alysis of covariance of the regression lines 
is not possible because fue regression is nonlinear and fue search 
procedures may have lead to biased estimates of the parameters. However, 
fue st~dard error of the response estimate, when multiplied by 1.96 
gives the 95% confidence limits and allows fue comparison of responses 
to equal doses from two fitted curves. Should the point on one curve 
fall outside fue limits of the ofuer, then at fuat point there is 
deemed to be a signific~t difference between responses. Confidence 
limits for dose, the independent variable, were taken as horizontal 
excursions within the 95% response confidence limits. 
dose response curves are presented in table 11.3. 
Data from fue 
Table II.3 Summary of results fram perfusion line administration dose response curves. 
Drug M.IM.% Serumj Maximum ED50 Slope Calc. response Time to S.E. of response 
No serum 95% confidence limits at 1 x 10- sM peak s estimate 
AD 11K No serum 2.640 5.152 x 10-
7 
9.935 1.703 ±0.048 4.16 - 6.02 x 10-7 176.4 
M.% No serum 287.170 2.602 x 10-
7 
13.297 241.798 ±35.4 ±2.921 1.78 - 3.09 x 10-7 
11K Serum 3.285 5.157 x 10-
7 
6.733 2.224 ±0.032 3.71 - 7.58 x 10-7 162.3 
M.% Serum 225.966 3.042 x 10-
7 
10.577 184.967 ±31.1 ±2.286 1.99 - 3.24 x 10-7 
NAD 11K No serum 2.942 5.887 x 10-
7 
6.172 1.691 ±0.029 1.12 - 6.30 x 10- 7 241.9 
I1K% No serum 285.280 1.348 x 10-
6 
4.984 133.900 ±76.2 ±4.984 1.00 - 1.90 X 10-6 
ISO M. No serum -0.171 1.218 x 10-
8 
5.776 -0.0786 ±0.0045 1.04 - 1.44 x 10-8 285.0 
I1K% No serum -18.760 8.549 x 10-
9 
5.878 -10.021 ±72.5 ±0.578 6.30 - 11.21 x 10-9 
11K Serum -0.367 9.079 x 10-
9 
5.949 I -0.1918 ±0.0128 6.76 - 12.58 x 10-9 252.6 
M.% Serum -22.018 8.194 x 10-
9 
6.584 -12.137 ±36.1 ±1.162 5.12 - 12.02 x 10-9 
ED50 ratios AD NAD Potency ratio at 1 x 10-SM AD NAD 
11K 1.00 1.141 K 1.00 1.040 
M.% 1.00 4.431 K 1.00 0.723 
Resistance in kPa ml- 1min, concentrations in moles Z-l, time in s. 
-..J 
co 
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11.6.2.3 Infusion dose response curves for AD 
The dose response curves for adrenaline were consistently steeper 
than those for NAD or ISO (see table 11.3; figure 11.11). The dose 
required to produce a half maximal response (E050), occurs at the point 
of inflection where the slope is steepest. Small changes in dose around 
this point results in larger changes in response than at any other point 
on the curve. The E050s for the four AD curves are between 2.6 and 5.2 
Perfusion of 1 x 10-lOM and 1 x 10-9M AD resulted in dilatory 
responses in two preparations (see appendix A.3) • 
Addition of 5% human serum to the perfusate elevated baseline 
resistance (see section 11.5.2) . When AD was administered to serum 
treated preparations the following changes were noted. 
1. The slope of. the curves was depressed. 
2. The maximum absolute change in resistance (~K), was 
significantly larger. 
3. The maximum change in resistance relative to the baseline 
resistance (~K%), was significantly smaller. 
4. The Eo50 estimates from either the ~K or ~K% curves were 
unchanged by the presence of serum. 
11.6.2.4 Infusion dose response curves for NAD 
The dose versus absolute response curve for NAD administered by 
perfusion line has a E050 of 5.8 x 10-7M, a slope of 6.17 and a maximum 
response of 2.94 kPa ml-lmin. The maximum was greater than that for AD 
under identical perfusion conditions; that is without serum. From the 
curve of dose versus ~K% the E050 was 1.3 x 10-~ the slope was 4.98 and 
the maximum response was +285.28% (see figure 11.12) • The E050 of this 
curve was the greatest for any drug under any conditions tested and the 
slope the lowest. The maximum percentage change in resistance is very 
similar to that obtained for AD without serum. 
The ratios of the doses that produce half maximal responses are 
given in table 11.3. When the E050s of AD and NAD without serum are 
compared, AD is found to be more potent giving dose ratios of between 
1.00 : 1.14 (~K) and 1.00 : 4.43 (llK%). When the absolute 
responses to the same molar concentrations of the two drugs are compared 
(1 x 10-sM) they are found to be almost equipotent, (AD : NAD, 1.00 : 
1.04) • When ~K% is compared in this manner AD gives a greater response 
(1.00 : 0.723), AD : NAD. 
FIGURE II.II Dose response curve,s constructed from peak responSe to 
infusion of 1 X la-11M to 1 x la- 3M adrena1ine. Data 
from these curves are summarised in table II.3. All 
responses-were recorded while perfusing at caudal venous 
pressures ofl.33 kPa. Stippled area indicates the 95% 
confidence limits of the response estimates. 
a. Responses expressed as kPa ml-Imin. No serum in 
the perfusate. 
b. Responses expressed as % changes in resistance over 
baseline resistance, ~%. No serum in the perfusate. 
c. 
-1 Responses expressed as kPa ml min. 
added to the perfusate. 
5% human serum 
d. Response expressed as % change in resistance over 
baseline resistance. 5% human serum added to the 
perfusate. 
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FIGURE II .12 Dose response cUl;ves constructed fl;Qm peak responses to 
infusion of 1 x 10-l1~ to 1 x lO-3M noradrenaline. Data 
from these curves are summarised in table II.3. All 
responses were recorded while perfusing at caudal venous 
pressures of 1.33 kPa and without serum in the perfusate. 
-3 Note that the responses to 1 x 10 M noradrenaline were 
smaller than to 1 x 10-4M. This was not observed in the 
analogous experiments using adrenaline and is interpreted 
as stimulation of beta two dilatory adrenergic receptors 
only at very high doses of noradrenaline. Stippled area 
indicates the 95% confidence limits of the response 
estimate. 
a. Responses expressed as kPa ml-lmin. 
b. Responses expressed as % change in resistance over 
baseline resistance. 
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11.6.2.5 Infusion dose 'response curves for ISO 
Isoprenaline in the perfusate at concentrations below 1 x 10-4M 
decreased resistance. Concentrations of 1 x 10-4 and 1 x 10-3M ISO 
caused increased resistance (see figure 11.13). ISO dose response curves 
have slopes between 5.7 and 6.6. The ED50s were between B.l and 12.2 
x 10-9M• Addition of 5% human serum to the perfusate caused the following 
changes in the ISO dose response curves. 
1. The ED50s were depressed slightly. 
2. The maxima were significantly greater by 2.15 (~K) to 1.17 
(~%) times. 
Records of responses to each of these drugs are presented in 
figure 11.14. 
To summarise, dose response curves to AD, NAD, and ISO are sigmoid. 
Adrenaline is 1.14 to 4.43 times more potent an alpha agonist than NAD. 
Isoprenaline decreased resistance at concentrations below 1 x 10-4M• 
Perfusate containing 5% human serum enhanced the responses to AD and ISO 
but had little effect upon the values of the ED50s of these drugs. 
11.6.2.6 Bolus dose response curves to AD, NAD,and ISO 
The dose response curves for bolus administered AD, NAD, and ISO 
are presented in figures 11.15 to 11.17. Data from which the curves 
were prepared are tabulated in appendices A.5-A.B (AD), A.ll and A.12 
(NAD) and A.17-A.20 (ISO). Body contractions prevented determination 
of maximal responses by this method, consequently the curves are fitted 
by eye. Typical responses to boli of AD, NAD and ISO are presented in 
figure II.IB. Table 11.4 summarises the information from bolus dose 
response curves and is equivalent to table 11.3 for infused drugs. 
11.6.2.7 Bolus dose response curves for AD and NAD 
Bolus dose response curves for AD are presented in figure 11.15, 
and those for NAD in figure 11.16. The curves for AD and NAD are very 
similar. Treshold doses for AD were slightly lower than for NAD. 
When perfused with 5% human serum in the saline, the responses to AD 
were smaller than with the basic saline (see section 11.6.3.1) • 
11.6.2.8 Bolus dose response curves for ISO 
Bolus dose response curves for ISO are presented in figure 11.17. 
The curves from preparations perfused with the basic saline show 
FI GURE II .13 Dose response curves cQnstructed from pea,k responses to 
-11 -5 infusion of 1 x lO * to 1 x lO * isoprenaline. Data 
from these curves are summarised in table 11.3. All 
responses were recorded while perfusing at caudal venous 
pressures of 1.33 kPa. Responses to l x 10-4* and 1 x 
10-3M isoprenaline were omitted since they were increases 
in resistance. It is likely that these increases in 
resistance at very high isoprenaline concentrations 
reflected significant alpha constrictory adrenergic 
receptor stimulation by this predominantly beta agonist, 
(see appendices A.13-A.16 for the magnitude of 
resistance increases in response to high concentrations 
of isoprenaline) • Stippled area indicates the 95% 
confidence limits of the response estimates. 
a. Responses expressed as kPa ml-1min. 
perfusate. 
No serum in the 
b. Responses expressed as % change in resistance over 
baseline resistance. No serum added to perfusate. 
c. Responses expressed as kPa ml- 1min. 
added to the perfusate. 
5% human serum 
d. Responses expressed as % changes in resistance over 
baseline resistance. 5% human serum added to the 
perfusate. 
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FIGURE II.14a 
FIGURE II.14b 
FIGURE II .14c 
Typical record of ~esponse to 5 ~ lO-7M adrenaline. Note 
the decrease in caudal artery pressure after the initial 
peak. Preparation number ADB203. Tail weight = 272 g. 
Tail resistance change = +94.16%. 
Typical record of response to 1 x 10-4M noradrenaline. 
There is no initial peak in caudal artery pressure as for 
adrenaline responses. Preparation number Nll3. Tail 
weight = 302 g. Tail resistance change = +191.75%. 
Typical record of response to 1 x 10-7M isoprenaline. 
Note the slower development of the response compared to 
the constrictory responses above. Preparation number 
1202. Tail weight = 263 g. Tail resistance change 
-21.27% • 
LH lymph heart beats 
CA caudal artery pressure, kPa 
CV caudal vein pressure, kPa 
OQ outflow, drops 
02 venous oxygen tension 
a 
LH 
5 x 10-7M AD 
V 
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FIGURE 11.15 Dose response cqrves constructed from peak responses to 
injection of 1 pmole to 100 nmoles of adrenaline. Data 
from these curves are summarised in table 11.4. All the 
responses were recorded while perfusing at caudal venous 
pressures of 1.33 kPa. 
bars = ± 1 S.E.M. 
CUrves were fitted by eye. 
a. 
-1 Responses expressed as kPa ml min. No serum in 
perfusate. 
b. Responses expressed as % change in resistance over 
baseline resistance. No serum in perfusate. 
Error 
c. Responses expressed as kPa ml-Imin. 
added to the perfusate. 
5% human serum 
d. Responses expressed as % resistance change over base-
line resistance. 5% human serum added to perfusate. 
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FIGURE II .16 Dose response curves constructed irQm peak responses to 
injection of 1 pmole to 100nmoles noradrenaline. Data 
from these curves are summarised in table II.4. All 
responses were measured while perfusing at caudal venous 
pressures of 1.33 kPa and without serum in the perfusate. 
Curves were fitted by eye. Error bars are ± 1 S.E.M. 
a. Responses expressed as kPa ml-1min. 
b. Responses expressed as % change in resistance over 
baseline resistance. 
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FIGURE 11.17 Dose response curves constructed from peak responses to 
injection of 1 pmole to 100 nmoles of isoprenaline. Data 
from these curves are summarised in table 11.4. All 
responses were recorded while perfusing at caudal venous 
pressures of 1.33 kPa. Curves were fitted by eye. 
Error bars are ± 1 S.E.M. Curves in figure II.l7b and 
II.17d show a trend toward a maximum response at the two 
highest doses. This may indicate some alpha adrenergic 
constrictory stimulation at these doses (see figure 
II.l3a-d) • 
-1 
a. Responses expressed as kPa ml min. No serum in 
perfusate. 
b. Responses expressed as % change in resistance over 
basline resistance. 
-1 
c. Responses expressed as kPa ml min. 5% human serum 
added to the perfusate. 
d. Responses expressed as % changes in resistance over 
baseline resistance. 5% human serum added to perfusate. 
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FIGURE IL18a 
FIGURE IL18b 
FIGURE II.18c 
Typical response to injection of lO nmoles adrenaline. 
Preparation number A25l. Tail weight = 186 g. 
Resistance change = +62.66%. 
Typical response to injection of 10 nmoles noradrenaline. 
Preparation .number N158. Tail weight = 180 g. 
Resistance change + 62.66%. 
Typical response to injection of 10 nmoles isoprenaline. 
Note the first injection is a blank saline injection. 
Preparation number 1256. Tail weight = 282 g. 
Resistance change = -28.0%. 
LH lymph heart beat 
CA caudal artery pressure, kPa 
CV caudal vein pressure, kPa 
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Table II.4 Summary of results from bolus administration dose 
response curves. 
no serum 
Adrenaline Noradrenaline Isoprenaline 
Maximum ~K (lOOnM) 
-1 KPa ml min 
Maximum ~K% (lOOnM) 
Threshold dose 
4.39 ± 0.47 
267.4 ± 33.2 
10-20 pmoles 
Dose to produce ~K 10.6 nmoles 
half maximal response ~K% 11.8 nmoles 
Time to peak response s 
5% serum 
Maximum ~K (lOOnM) 
Maximum ~K% (lOOnM) 
Threshold dose 
74.1 ± 7.35 
Adrenaline 
+2.65 ± 0.45 
+147.5 ± 21.84 
5-10 pmoles 
Dose to produce ~K 12.5 nmoles 
half maximal response ~K% 11.8 nmoles 
Time to peak response s 66.2 ± 5.8 
3.57 
239.3 
20-50 
2.1 
9.1 
1l0.8 
± 0.74 -0.226 ± 0.053 
± 65.5 -21.6 ± 6.7 
pmoles 5-10 pmoles 
nmoles 95 pmoles 
nmoles 59 pmoles 
± 9.54 231.6 ± 21. 7 
Isoprenaline 
-1.15 ± 0.067 
-46.4 ± 2.5 
1-5 pmoles 
29 pmoles 
85 pmoles 
265.0 ± 23.6 
Time to peak response for all doses are tabulated in appendices A.2l -
A.22. 
attentuation of the dilatory response at doses between 10 nmoles and 100 
nmoles. Addition of 5% human serum to the perfusate increased responses 
to ISO by two (~K%) to five (~K) times. 
II.6.3 Discussion of responses to sympathetomimetic drugs 
II.6.3.1 The effects of serum on dose response curves for AD and 
ISO 
Despite elevated baseline resistance, in the presence of serum, AD 
elicits greater absolute changes in resistance. We could envisage 
resistance vessels to have finite constriction limits. If serum produced 
a partial constriction, as indicated by increased baseline resistance, 
then there should be less potential for further vasoconstriction. The 
90 
fact that this is not the case demands a reappraisal of the action of 
serum on the vascular bed which enhances reactivity to AD. Serum could 
act to suppress the beta dilatory component of the AD response and allow 
AD to exhibit its full constrictory potential. However serum markedly 
enhanced the dilatory responses to ISO.· Thus the development of beta 
responses appears to be in no way suppressed by serum, in fact quite the 
reverse. 
It is well established that serum proteins can afford some 
protection to labile drugs, (see section 11.4.4) and that transport of 
large molecules through capillary walls and interstitial spaces is faster 
in the presence of serum proteins. I propose that the increased 
reactivity of this preparation to sympathetomimetic drugs in the 
presence of serum is a result of two factors, namely protection, and 
enhanced mobility. Since we have no data available on the concentration 
of drugs in the immediate vicinity of the receptor sites, we assume that 
this concentration is the same as, or at least directly proportional to 
the concentration introduced. If catecholamines are associated with 
serum proteins then less free drug is available for catabolism and 
binding to non-reactive membranes, whilst more protein-drug complexes 
are being delivered to receptor sites more quickly. 
Association of drugs such as AD and ISO with proteins and non-
specific membranes in the tissue is assumed to be much weaker than 
receptor-drug binding (Gibaldi et al., 1978). Dissociation of drugs 
from protein molecules in the vicinity of receptors would result in the 
formation of relatively more stable receptor-drug complexes that would 
reduce the protein-drug complex concentration in the immediate area. 
The process is envisaged to be in equilibrium, and so drugs will be 
transported from non-reactive membranes, in association with mobile protein 
molecules that afford them some measure of protection, to receptors where 
the response will be enhanced by 'increased effective concentrations of 
hd 'I d ++ .. 11 t e rugs. st1mU ate Na K pump act1v1ty maya so pay. some part at 
the muscle level (Smith and Rozengurt, 1978). 
The fact that in the presence of serum larger absolute responses 
are developed indicating that without serum proteins the pr~paration fails 
to develop its full alpha or beta potential to exogenous catecholamines, 
despite supramaximal doses. This questions the concept that development 
of responses to active agents introduced via the perfusion line is 
limited by perfusion rather than diffusion across the capillary-cum-
interstitial barrier. If responses to perfused drugs were delivery 
limited then the presence of serum should have little or no effect upon 
the maximum response observed. 
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The enhanced response to ISO in the presence of serum raises fewer 
questions. Elevated baseline resistance with serum should provide 
greater dilatory potential. Indeed maximum resistance changes are some 
two times greater when 5% human serum is added to the perfusate. Part 
of this may be due to the elevated baseline, but the possibility exists 
that part is also due to the protection and mobility effects of serum 
proteins. 
Bolus administration of ISO in the presence of serum produced 
greater absolute and percentage resistance decreases. Adrenaline however 
was less potent when serum was added. One possible explanation for 
this could be that within the bolus, there is a higher proportion of 
drug to serum protein molecules. Given that the association between 
these molecules is weak, fewer drug molecules would be associated with 
proteins. Mixing of the bolus once administered with subsequent dilution 
was minimal. Reduced constrictory potential and greater dilatory 
potential caused by elevated baseline resistance could depress the 
responses of AD to a far greater extent and outweigh the enhancement 
effects of serum. In support of this notion it is noted that at low 
doses of AD, less than 50 pmoles, when the proportion of drug to serum 
protein is lower, the responses to AD in serum treated preparations is 
greater than those from preparations perfused with the basic saline. 
Whatever the mechanism, serum increases the responsiveness of this 
preparation to AD and ISO. It should be noted that the ED50 estimated 
from 6K or 6K% changes very little when serum is added. Only in the 
case of AD 6K do the two ED50s fall outside their respective confidence 
limits, (see table 11.3) • In contrast to this ED50 estimates of 
different drugs are generally excluded from the limits of each other. 
The exception to this is provided by comparison of the ED50s of AD and 
NAD (6K) in the absence of serum, where the curves are very similar. A 
possible reason for this could be that the greater alpha adrenergic 
potency of AD is being masked by the simultaneous beta stimulation 
thereby reducing the responses fortuitously close to those elicited by 
NAD. 
11.6.3.2 Comparison of responses to AD and NAD 
Adrenaline is a more potent alpha agonist than noradrenaline. 
Comparison of ED50s from the infusion data show AD to be 1.14 to 4.31 
more potent than NAD for 6K and 6K% estimates respectively. The use of 
ED50 comparisons is preferable when only one receptor is being 
investigated. However when two receptors are present the situation 
requires closer examination. 
The data points for the NAn curve show a rather marked deviation 
from sigmoidicity at higher concentrations (see figure II.12). At 
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1 x lO-~M the response is above the estimated assymptotic maximum, while 
at 1 x 10-3M it is well below the curve. This behaviour suggests that 
an insignificant proportion of beta receptors are stimulated by NAn at 
concentrations below 1 x 10-3M and the response is almost entirely due 
to alpha stimulation alone. However at the highest concentration, 1 x 
10-3M, some beta stimulation is evident. When this is superimposed upon 
maximal alpha stimulation the result is a downturn in the dose response 
curve. .Adrenalineon the other hand elicits significant beta activity 
at much lower doses, and certainly at 5 x 10-~M (see section II.7) 
causing the dose response curve to be depressed along its entire length. 
The downturn at high concentrations of An is not so marked. This 
indicates that An is a considerably more potent beta agonist than NAn 
and the beta receptors must be of the beta two variety (Ahlquist, 1948; 
Furchgott, 1967; Arnold, 1972; Wood, 1976). 
The greater beta activity of AD seems likely to be the cause of 
the lower maximum constriction when compared to NAn, (2.64 kPa ml-1min 
and 2.941 kPa ml-1min, AD and NAn respectively). Despite the greater 
response depression by beta stimulation, the An EDSO is lower than that 
of NAn. -5 If the responses at 1 x 10 M are compared, then the absolute 
responses are very similar, but the percentage change in resistance over 
baseline resistance is greater for An by ~ 1.38 times. 
Comparisons of responses to equimolar bolus doses of An and NAn 
(1 nmole), in the absence of serum show that An is ~ 1.38 times more 
potent a constrictor than NAn, which is in accord with the results from 
the curves prepared from infusion of the drugs. 
II.6. 3.3 Comparison of the two methods of drug administration 
To compare the two methods of drug administration, the half 
maximal response was calculated from the curves when the drugs were 
'administered by the perfusion line. The half maximal response was then 
located on the ordinate of the appropriate bolus dose response curve and 
the dose required to produce this response read off. 
Since the peak response times are less than, (AD and NAn), or of 
the same order as (ISO) the circulation time through the tail (see section 
II.S.4) all of the drug contained in the bolus is assumed to be within 
the preparation vascular space. The concentration of drug in the 
vascular space at the peak of the response during perfusion administration 
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is assumed to be the concentration made up. These assumptions are crude 
but in the absence of detailed knowledge of the exchange kinetics of the 
vascular space and other spaces within the preparation they must serve 
as a first order approximation to the real situation. If we assume that 
the vascular space is about three mls per 100 g of tissue, (see Thorson, 
1961 and section 11.7.2) and the average tail weight to be around 200 g, 
then the amount of drug present in the tail is 6 x 10-3Z times the 
concentration in moles per litre for perfusion administration. The 
results from these estimates are presented in table 11.5. 
Table II.5 Comparison of ED50 for AD, NAn, and ISO when 
administered as a bolus and by infusion at constant concentration. 
Mean ED50 perfusion line 
Mean ED50 bolus 
Adrenaline 
24 nmoles 
ll.6 nmoles 
Noradrenaline 
58 nmoles 
5.6 nmoles 
Isoprenaline 
57 pmoles 
67- pmoles 
Responses to the same amount of drug are surprisingly similar for 
the two methods of administration except in the case of NAn. NAn given 
as a bolus appears to be about ten times more potent than by perfusion. 
If however the ED50 estimate from the ~K curve alone is used then the 
perfusion line ED50 is about 3.5 nmoles. Because of the low slope of 
the NAn ~K% curve, the ED50 estimate would be expected to be less accurate. 
Thus the difference could be due to this, rather than a real difference 
in action of the drug introduced by different means. Within the 
limitations of this comparison there appears to be no difference in 
response to the same amount of drug given as either a bolus or via the 
perfusion line. 
11.6.4 Sympathetomimetic antagonists 
11.6.4.1 Introduction 
To further elucidate the adrenergic system in the eel tail 
vasculature three adrenergic blocking agents were employed. Phentolamine 
(Phent) and propranolol (Prop) were the principal alpha and beta blockers 
respectively. Dichloroisoproterenol (DCI) was occasionally used for 
beta blockade. Each of these antagonists acts in a competitive manner 
(McDevitt, 1977). These studies also revealed that the blockers had 
effects on tail vascular resistance in the absence of any agonist. 
11.6.4.2 Phentolamine blockade of the response to AD 
Eight preparations, each of which had previously shown a vaso-
dilatory response to ISO were given various combinations of AD and 
Phent. The responses to Phent alone were determined in three 
preparations at least two hours after the last drug administration. 
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Three low doses of AD (50 pmoles, 100 pmoles, 200 pmoles) were given to 
the preparation. These control responses were compared to the responses 
to the same dose of AD when Phent was present. After the blockade 
experiments the control doses of AD were again administered and the 
response was always found to be diminished by 30% to 50% compared to 
the initial controls. This could be the result of either incomplete 
washout of Phent or the loss of sensitivity of the receptors to AD. 
Loss of sensitivity to AD is not apparent in the absence of blockers 
especiallY at the low doses that were chosen to specifically avoid the 
problem. The other reasons for the choice of low doses of AD is 
that in order to obtain AD to Phent concentration ratios of up to 
1 : 1000 at even moderate doses of AD the amounts of Phentnecessary 
caused muscular contractions. Muscular contractions were most 
undesirable since they produced wildly fluctuating pressure records and 
unreadable lymph heart records. 
After the control responses were recorded, the amount of Phent in 
the 0.1 ml bolus was raised to give ratios of AD to Phent of between 
1 : 1 and 1 : 1000. The results from these experiments are presented 
graphically in figure 11.19 and tabulated in appendix A.23. The 
increase in resistance caused by AD was diminished by the presence of 
Phent. At each of the three doses of AD used the null response 
occurred at a concentration ratio of AD to Phent of 1 : 35 to 1 : 45, 
suggesting that effective alpha blockade occurred at this level. At 
higher agonist to antagonist concentration ratios the response changed 
from vasoconstriction to vasodilation. The control doses of Phent 
alone caused dilation. The magnitude of these response~ was however 
too small to account for the dilatory response to AD plus Phent at 
concentration ratios above 1 : 45 (see appendix A.24). 
demonstrate AD mediated dilation during alpha blockade. 
These results 
To further investigate the nature of the dilation caused by 
AD plus Phent, the beta blocker DCI was used. When AD plus Phent plus 
DCI were given simultaneously at concentrations of 200 pmoles, 40 nmoles, 
40 nmoles respectively, (dose ratio of 1 : 200 : 200) to two 
preparations, the dilatory response was abolished or markedly diminished. 
By further increasing the dose of DCI the response was always abolished, 
FIGURE II.19 Effects of increasing concentration ratios of phentolamine 
on the % resistance responses to 50, lOO, and 200 pmoles 
adrenaline. Responses to control doses of phentolamine are 
presented on the same graph. The constrictory responses 
to adrenaline at these doses were reversed to dilation at 
a concentration ratio of about l : 40 adrenaline 
phentolamine. Dilatory responses to adrenaline in the 
presence of the alpha blocker phentolamine may be partly 
due to the antagonist alone. 
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( l: 200: 300) • The administration of both and alpha and beta blocker 
to the preparation represents a terminal experiment and was performed 
at the end of a preparation's useful life. Because of the contrived 
nature of the conditions and the fact that the preparation had been 
exposed to AD, ISO and Phent before DCI was administered, these results 
must be accepted with caution. They do however indicate that the 
dilatory response to AD during alpha blockade was the result of beta 
stimulation. 
In two preparations AD and Phent were administered simultaneously 
via the perfusion line. When 1 x lO-8 M AD was given with Phent at a 
concentration of 1 x 10-7M (1 : 10) there was a slight reduction in the 
response from +20.4% to +18.8%. When a concentration of 1 x 10-6M 
Phent was used (1 : 100), a dilation of -10.2% was observed. When a 
concentration of 1 x 10-sM Phent was used (1: 1000), gross muscular 
contractions ensued making measurements of resistance very difficult. 
No rise in resistance above that produced by 1 x 10-aM AD was seen 
during these experiments • 
control doses of 1 x 10-7M and 1 x 10-6M Phent had no detectable 
effect on resistance. At 1 x 10-sM Phent there was a small decrease of 
-4.08 ± 2.27% (n = 4) (see appendix A.24) • 
-6 -S One preparation was perfused with 1 x 10 M, 1 x 10 M, and 1 x 
10-~M Phent sequentially. After ten minutes of perfusion with each 
concentration, 300 pmole doses of AD were administered. The responses 
to AD were decreased to about 40% of the control response but the 
effects of increased Phent concentrations were not apparent (see 
appendix A.25). 
Two features emerge from the use of AD plus Phent. The first is 
that Phent did not abolish the resting tone found in preparations perfused 
with plain ringer or ringer that had 5% human serum added to it. The 
basal tone is not solely the result of any residual alpha adrenergic 
stimulation. control doses of Phent elicited small dilatory responses. 
This could be due to the blockade of the small part of the resting tone 
that is due to alpha stimulation (incomplete washout of alpha agonists), 
or to some non-specific stimulation of beta receptors by the alpha 
antagonist Phent. Since the responses to Phent were always recorded 
after the administration of AD and Phent is a highly selective alpha 
antagonist the former explanation seems the most likely. 
The second point is that AD mediated vasodilation in the presence 
of an alpha blocker was difficult to demonstrate. The most convincing 
evidence came from administration of AD and Phent together in a single 
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bolus. Although this evidence is clear, it is still complicated by the 
effects of the antagonist alone and cannot be rated as unequivocal. An 
alternative method to demonstrate AD mediated beta stimulation is to apply 
a selective beta blocking agent during the response of the preparation to 
AD and watch for potentiation of the constrictory response. 
will be considered separately, (section 11.6.4.4) 
11.6.4.3 Beta blockade of ISO mediated vasodilation 
This approach 
The effect of propranolol (Prop) and dichloroisoproterenol (DCI) 
on the dilatory responses to ISO of eight preparations were recorded. 
Responses to control doses and concentrations of Prop and DCI are 
tabulated in appendix A.29. Administration of a single bolus containing 
200 pmoles ISO plus Prop at concentration ratios of l' I to 1 : 20 
reduced the magnitude of the dilatory responses by 40 - 70% (appendix 
A.26) • The residual dilatory responses at high concentrations of Prop 
could have been due to Prop alone (see appendix A.29) • The rapid 
return to baseline resistance after dilation in response to Prop alone 
« 5 minutes) led to injection of Prop at similar concentration ratios 
as the single boli experiments ten minutes before injections of ISO at 
doses of 200 pmoles (appendix A.26) • The magnitude of the dilatory 
responses to ISO in these experiments was reduced by 90-97%. ISO plus 
DCI in single boli at concentration ratios of 1 : 100 to 1 : 1000 showed 
reduced dilatory responses compared to control responses (appendix A.27) • 
The reduction of the magnitude of the dilatory responses was smaller 
than with propranolol (- 65%) • control doses of DCI also resulted in 
dilatory responses which were reversed to constriction at higher doses 
and concentrations (> 1 llmole, > 1 x 10-4M). Because of the reversal 
found in responses to control doses of DCI, indicating lack of receptor 
specificity, the use of DCI was not favoured. Prop, although having 
greater inherent dilatory activity was a more potent beta antagonist, 
consequently it was used in most experiments requiring a,beta antagonist. 
When the tail was perfused with 1 x 10-7M ISO plus 1 x 10-6M DCI, 
(concentration ratio, 1 : 10) the dilatory response was about one tenth 
of the response to 1 x 10-7M ISO alone. On increasing the concentration 
ratio to 1 : 100, there was no detectable response. At a ratio of 1 : 
1000 an increase in resistance of about +35% over the baseline was 
observed. A similar trend was noted when 1 x 10-SM ISO was used and 
the concentration of DCI raised progressively (see appendix A.28) • 
The constriction in the presence of high concentrations of DCI could be 
due either to alpha stimUlation by ISO in the absence of available beta 
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receptors, or to a non-specific stimulation of alpha receptors by DCI. 
The former explanation is likely since at the concentrations of ISO used 
the beta response is at or near its maximum in unblocked preparations. 
At higher ISO concentrations constriction was found which may well be 
the result of alpha stimulation. If beta sites were blocked by DCI 
then the effective ISO activity may be sufficient to initiate 
constriction. In the presence of the alpha antagonist Phent, ISO 
dilatory responses were potentiated (see appendix A.30). 
The effects of the beta antagonists Prop and DCI on the dilatory 
responses of the eel tail to ISO was to diminish them. Prop was a 
more potent beta antagonist than DCI and reduced the magnitude of 
responses to ISO by 70-97% at concentration ratios of 1 : 1 to 1 : 10. 
II.6.4.4 propanolol and the response to AD 
Prop was found to be a potent beta antagonist in this preparation. 
The response to AD is assumed to be the sum of the opposed alpha 
(constrictory) and beta (dilatory) responses. Blockade of the alpha 
component failed to clearly reveal substantial beta activity. The 
alternative was to block the beta response and from the above hypothesis 
we could expect to see an enhanced vasoconstriction in response to AD. 
Such an enhanced constriction would be against the inherent dilatory 
activity of Prop on its own, and thus if observed could not be explained 
by the presence of the antagonist. 
Nine preparations were used to study the effects of Prop on the 
response of the tail to AD. Prop and AD were administered as a single 
bolus or as separate boli. In the case of separate boli Prop preceding 
AD by 5 minutes, which was the time taken for the recovery of the 
preparation from Prop alone. These methods always produced a smaller 
rather than larger constrictory response to AD (see appendix A.31) • 
The dose of AD was varied between 10 pmoles and 1 nmole at concentration 
ratios of AD to Prop of 1 5 to 1 : 100 yet the nature of the response 
remained the same, namely a depression of the constriction caused by AD 
(see figure II.20) . The only indication that Prop was present was the 
decreased resistance caused by Prop, as observed in Prop controls, 
superimposed upon the smaller increases caused by AD, (see figure II.21). 
When DCI was used instead of Prop similar results were obtained. 
These results are at variance with the 'proposed hypothesis for the 
action of AD and need to be carefully examined. The time to reach peak 
responses to control doses of both AD and Prop were of the order of 45-
70 s. The time to peak responses to ISO were around 200-250 s. This 
FIGURE 11.20 Effects of propranolol, a beta aqrenergic antagonist, on 
the responses to 5 pmoles to 1 nmole aarenaline. 
Propranolol diminished the constrictory responses to 
adrenaline when compared to the control responses from 
the same preparations. If propranolol blocked only the 
beta dilatory adrenergic receptors then an enhanced 
constrictory response to adrenaline might be expected. 
That this was not the case suggests that propranolol 
has significant alpha blocking potential in the eel tail 
(for discussion see text). Propranolol was administered 
at 100 times the concentration of adrenaline 
simultaneously with adrenaline (see appendix A.3l) • 
-8-Control responses 
-O-AD plus Prop 
Q) 
Cl 
C 
220 
200 
~ 150 () 
~ 
c 
~ 
'iii 
Q) 
II: 
~100 m 
1:: 
Q) 
~ 
&: 
50 
/ 
II 
II 
II 
.1 
I 
/111 
99 
/ 
/ 
O~~----~----~------~----~----~--~--L---~ 
5 10 20 50 100 300 500 1000 
Dose pmoles 
THE LIBRARY 
UNIVf'f,;ITt (W CANTEI\IiHJR'r 
CHRISTCHURCH, N.Z. 
FIGURE II. 21 Typical record of response to a single bolus containing 
adrenaline plus propranolol at doses of 500 pmoles and 
50 n~oles respectively. The reasons for depression of 
the constrictory response to adrenaline by propranolol are 
discussed in the text. 
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raises the question of where the dilatory response to Prop originates. 
If Prop causes some beta stimulation then the qualitative features of 
the response (for example the shape of the response trace) and the time 
course could be expected to fit with these features of the response to 
ISO stimulated dilatory responses. The time course and the shape are 
markedly different from those of the responses to ISO. An alternative 
is that Prop could be blocking the alpha response causing the observed 
decrease in resistance. The time course and the shape of the response 
to Prop is very similar to that of AD, but in the opposite direction. 
Thus if we assume Prop to have some alpha antagonistic activity, then to 
demonstrate greater alpha activity during beta blockade with these drugs 
then we could first occupy as many of the alpha sites with AD before the 
introduction of Prop. 
To this end five preparations were perfused with 5 x 10-7M AD for 
10 to 20 minutes. After this perioq the perfusate was immediately 
changed to the following solutions, each being perfused for 10 minutes. 
5 x 10-7M AD plus 5 x -7 10 M Prop (1 1) 
II II 2.5 x 10-6M Prop (1 5) 
II II 5 x 10-6M Prop (1 10) 
5 x 10-7M AD 
The results of these experiments are presented in tables 11.6, 11.7 and 
in figure 11.22. The elevated resistance level caused by AD was raised 
even higher in the presence of 1 : land 1 : 5 AD to Prop. However when 
1 : 10 AD to Prop was infused, the resistance fell to a level near that 
of the response to 1 : 1 AD to Prop. When Prop was removed from the 
perfusate and only AD was perfused through the preparation the greatest 
resistance increase was observed and was significantly greater than the 
control resistance increase (p < 0.01, Student's t-test). 
peaked at around 330 s after Prop was removed. 
This response 
The peak of the response to 5 x 10-7M AD occurred at ~ 145 s. For 
ISO at the same concentration the peak response occurred at ~ 300 s. 
The beta response is slower to develop than the alpha response. Thus 
for the first 300 s of perfusion with Prop free 5 x lO-7M AD after 
solutions containing AD plus Prop, any Prop occupying alpha or beta 
sites was being washed out since Prop was no longer being replaced from 
the incoming perfusate. As Prop left the receptors, alpha or beta, it 
was replaced by AD. Howeve~because the constrictory response was more 
rapidly developed than the dilatory response there was a rise in 
resistance until the beta response developed. This explanation of the 
Table II.6 The effects of the beta antagonist propranolol on the resistance response of the perfused eel tail to 
adrenaline (n ;:::: 5). 
AD control 5 x 10-7M 1 1 1 5 1 10 AD control 
Peak Plateau AD Prop AD Prop AD Prop 5 x 10-7 
IsK. 2.59 ± 0.51 2.14 ± 0.41 2.71 ± 0.47 2.91 ± 0.33 2.61 ± 0.29 3.61 ± 0.45 
-kpaml min 
1sK.% 126.32 104.63 134.41 145.34 130.64 178.22 
Time (mins) 1.5 10 10 10 10 5.5 
Table II. 7 
II.6 (n ;:::: 41 • 
The resistance response of the perfused eel tail to propranolol at the concentrations used in table 
Propranolol concentration 5 X 10-7 2.5 X 10-6 5 X 10- 6 
IsK. kPa ml min -0.152 ± 0.037 -0.144 ± 0.059 -0.207 ± 0.034 
1sK.% -7.73 ± 2.39 -5.44 ± 1.51 -9.69 ± 0.303 
I-' 
o 
!\.l 
FIGURE II. 22 Mean resistance responses to infusion of 5 x lO-7M 
adrenaline followed by 5 x lO-7M adrenaline plus 
propranolol at concentrations of 5 x 10-7M, 2.5 x 10-6M 
and 5 x 10-6M followed by 5 x 10-7M adrenaline ,again. 
Responses to propranolol at the concentrations used are 
displayed on the same figure. Error bars are ± 1 S.E.M. 
(n = 5) • Student's t-test between mean responses to each 
drug solution combination and the initial control 
response to adrenaline alone showed that only during 
infusion of adrenaline alone (*) after infusion of 
adrenaline with propranolol was there a significant 
increase in the response (P < 0.01). 
discussion. 
See text for 
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nature of the responses representeq by figure 11.22 seems plausable and 
shows that there is a large potential for AD mediated vasodilation in 
the eel tail of about 40-50% of the alpha response to AD. 
Experiments involving the use of adrenergic antagonists support 
'-- . 
the results from agonist administration. Increased resistance in 
response to AD was blocked by the alpha antagonist Phent. Decreased 
resistance in response to ISO was blocked by Prop and DCI. Responses 
to AD were the sum of increases in resistance caused by alpha stimulation 
plus decreases in resistance caused by beta stimulation. The beta 
response to AD was about 40-50% of the magnitude of the alpha response 
to AD. Phentolamine appears to be a very selective and potent alpha 
antagonist in this preparation. Both Prop and Del exhibited partial 
alpha antagonism as well as the predominant beta antagonism. 
Propranolol was a more potent beta antagonist than Del in this preparation. 
11.6.5 Effects of AD, NAD and ISO upon venous oxygen tension of 
the isolated saline perfused eel tail 
II.6.5.1 Introduction 
In the absence of respiratory pigment, the oxygen carrying capacity 
of vertebrate blood is reduced by at least 25 times, (Steen, 1971). A 
viable isolated tissue preparation is assumed to have a low 'basal' 
metabolic rate. Fish tail muscle often functions anaerobically, (Black, 
Chin, Forbes and Hanslip, 1959). 
preparation are probably very low. 
Thus the oxygen requirements of this 
The metabolic cost of maintaining smooth muscle contractions in 
mammals is lower than that of maintaining skeletal muscle tension (Gluck 
and Paul, 1977). Vascular smooth muscle relaxes in response to 
lowered oxygen tension (Johnson, 1977), but will still maintain 
contractions in solutions containing more than 0.05 ppm (Pittman and 
Duling, 1973). Adrenaline mediated constriction depresses oxygen 
extraction of perfused tissues in a dose dependent manner (Pawlik, 
Shepherd and Jacobson, 1975). Dilation causes increased oxygen 
extraction in perfused vascular beds. Both of these changes are 
diffusion limited, rather than perfusion limited. Although perfusate 
oxygen tension may have significant effects upon the reactivity of the 
vascular bed, the results presented here clearly indicate adequate 
oxygenation of the perfused eel tail under all experimental conditions. 
The perfusion medium was bubbled vigorously with 95% °2/5% CO2 • 
This not only ensured a high input oxygen concentration but also a pH of 
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around 7.2. Increased osmolarity and decreased oxygen concentration 
and pH cause vascular dilation in mammals (Johnson, 1977). When studying 
changes in vascular tone these local ionic and I metabolic I effects must 
be considered. 
11.6.5.2 Results 
Venous oxygen tensi9n was measured as described in section 11.3.3 
in 12 preparations. The oxygen meter was zeroed in a 5% sodium 
dithionate solution and calibrated in air, and against air saturated 
distilled water before and after each preparation and found to be stable 
during the recording period. Drug solutions were always bubbled with 
95% °2/5% CO2 for two to three minutes before the start of infusion and 
throughout infusion. Mean initial and final venous oxygen tensions 
were 11.21 ± 0.51 ppm and 11.41 ± 0.82 ppm (n = 12) respectively and 
were above the air saturated oxygen concentration of the ringer, (10.2 
o ppm at 10 C) . Oxygen concentration in outflowing ringer was greater 
than 28 ppm when arterial and venous cannulae were connected by a 
short length of billing, thereby excluding the tail from the circuit. 
Infusion of NAD and AD and bolus administration and infusion of 
ISO reduced venous oxygen tension slightly ten minutes after drug introduc-
tion. The greatest recorded change in oxygen concentration was a fall 
of 1.4 ppm after 15 minutes of infusion of 5 x 10-7M AD. Bolus 
administration of 20, 50, 200 and 500 pmoles of AD into one preparation 
produced small increases in venous oxygen tension after eight to ten 
minutes. The largest change was +0.8 ppm, 11 minutes after injection 
of 200 pmoles of AD. 
In seven preparations venous oxygen tension was monitored during 
ten minutes of infusion of 5 x 10-7M AD. The mean changes in oxygen 
tension are presented in figure 11.23. All falls in venous oxygen 
tension showed a lag of the start of the decline of three to four minutes 
after the start of infusion. Four preparations were perfused with 
this concentration of AD for more than ten minutes. These preparations 
showed that oxygen tension reached a minimum within 15 to 20 minutes, and 
often started to rise slowly toward preinfusion levels thereafter. 
11.6.5.3 Discussion 
Eel skin has long been recognised as a potential respiratory 
surface and has been purported to provide up to 60% of the total oxygen 
requirements of the animal (Krogh, 1904). Kirsch and Nonnote (1977) 
have shown that little benefit to other than skin tissue results from 
FIGURE 11.23 Changes in venous oxygen tension (ppM) during each minute 
of infusion of 5 x 10-7M adrenaline. Mean initial oxygen 
tension = 12.25 ± 0.66 ppM (n = 6) • Error bars are 
± 1 S.E.M. Arrow indicates peak resistance increase 
time. At no time were any of the preparations under 
hypoxic conditions. 
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cutaneous respiration. The point to note however is that eel skin is 
permeable to oxygen. The perfusate loses about 60% of its oxygen 
. , 
content in its course through the tail. Part of this could be due to 
metabolism. However some may be lost through the skin to the bathing 
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medium. A concentration gradient from the tissue to the bath persists 
during all experimental conditions. Thus it is not possible with these 
data to discuss the oxygen requirements of the preparation. What is 
clear is that at no time is the preparation under hypoxic conditions. 
Adrenaline mediated elevated vascular resistance caused a fall in 
venous oxygen tension. This qualitatively reflects increased oxygen 
extraction by the preparation. Since flow is constant, oxygen delivery 
is constant and the additional loss of oxygen must be assigned to either 
increased metabolism or to increased transcutaneous loss. Because of 
the small amount of smooth muscle involved in resistance adjustments and 
its low oxygen demand it seems unlikely that active vasoconstriction 
caused the measured venous oxygen tension falls. Thus adrenaline 
infusion seems to have caused more perfusate oxygen to be lost either 
to the bath or to the tissue in general. Increased tissue oxygen is 
almost certainly not used since the muscles are metabolically quiescent 
and the tissue is already saturated with oxygen. An alternative 
explanation is that decreased venous oxygen tension is the result of 
additional loss through the skin. 
Fish red muscle, which is used during continuous swimming (Hudson, 
1973) is located just beneath the skin (Hulbert and Moon, 1978). Should 
the red muscles receive more perfusate during AD vasoconstriction then 
their anatomical position would indeed allow more oxygen to be lost to 
the bath. Adrenaline produces an increase in tail resistance, however 
the response is biphasic: an initial increase followed by a partial 
decrease (see figure II.14a) • The beta dilatory activity of AD may be 
located within the red muscles which stand to benefit most from increased 
blood supply during swimming. The alpha constrictory component of the 
response to AD may direct blood away from the white muscles to the red 
muscles. That ISO also caused decreased venous oxygen tension lends 
some support to this notion. 
11.6.6 Discussion of the adrenergic control of the eel tail 
vascular bed 
II .6.6.1 The eel tail vascular bed and other teleost systemic 
vascular beds 
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Experimental design is especially important in pharmacological 
experiments where accuracy is often severly limited by the inherent 
variability of animal tissues. Any modification of protocol or 
conditions that increase the size of responses, without undesirable 
effects .on the preparation, decrease measurement errors thereby improving 
fidelity. Where relatively small changes in resistance are measured, 
as with ISO in this preparation, magnitude amplification is particularly 
beneficial. In preparation of dose response curves attention must be 
paid to the problem of desensitization. No significant desensitization 
of alpha receptors was found in this preparation. Significant 
reduction in beta receptor activity with time of exposure to beta 
agonists has been widely reported (see Lefkowitz, 1978). with this in 
mind fewer concentrations of ISO were given to each preparation in the 
construction of dose response curves for this drug. The accuracy of 
ED50 estimates depends largely upon the slope of the dose response curve. 
In the case of ISO, addition of 5% human serum to the perfusate had 
little or no effect upon the slope. The slope of the AD dose response 
curves was depressed. The reason for this depression is most likely to 
be the greater enhancement of beta activity resulting in AD dose 
response curves which have a larger beta component. 
Addition of serum to the perfusate caused insignificant changes in 
ED50 of AD and ISO but gave wider confidence intervals for the estimates. 
Benefits gained by the addition of serum to the perfusate such as 
larger absolute response magnitude and more qualitative features such 
as improved vascular tone, 'autoregulation' (Stainsby, 1964) and 
preparation viability (Bullivant, 1978a) have to be weighed against 
the possible loss of accuracy of pharmacological parameter estimates, 
such as ED50. In this preparation serum addition did not improve 
the fidelity of pharmacological results, however neither did it alter 
the conclusions drawn. In vascular preparations where low resting 
tone is a problem, addition of serum to the perfusate may permit 
expression of responses such as dilation where otherwise no response 
could be evoked. 
Analysis of the results as either nK or nK% should result in 
little change in estimates of parameters such as ED50 (Waud, 1975). 
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In fact the 8K% Eo50 estimates for AD are significantly smaller than the 
estimates of Eo50 from 8K curves. Similarly for ISO the 8K% E050 
estimates are also significantly smaller than Eo50 estimates for,8K 
curves. On the other hand 8K% Eo50 for NAD is larger than the Eo50 from 
the 8K curve, but not by a significant amount. Why this should be so 
is unclear since the same data were used in both cases. In a situation 
such as this the use of transformed data for analysis demands careful 
consideration (see Latham, 1978). 
The baseline pressure differential across the perfused trout trunk 
is much lower than that measured in vivo, (see Wood and Shelton, 1975). 
The mean pressure differentials across the perfused eel tail were between 
1.75 kPa and 2.17 kPa. From section 111.3.1 tail pressure differentials 
in the short-finned eels are between 1.97 and 2.29 kPa in unrestrained 
unanaesthetised eels of slightly larger size. Martel and Cech (1978) 
reported pressure differentials across the tail (caudal artery to caudal 
vein) of anaesthetised and unrestrained conscious winter flounders 
(PseudopZeuronectes americanus) , of 2.0 kPa and 2.8 kPa respectively. 
These values are in excellent agreement, in contrast to dorsal aortic, 
postcardinal venous pressure differentials of around 3.3 kPa in asiatic 
eels (Chan and Chow, 1976). The size of the eels used by Chan and Chow 
was similar to those used for the perfused eel tail. The values given 
for dorsal and ventral aortic pressures in section III are similar to 
dorsal and ventral aortic pressures of the asiatic eel (Chan and Chow, 
1976). However venous pressures were recorded from different sites 
in the two reports. Chan and Chow recorded very low venous pressures 
from the posterior cardinal vein whereas in section III higher venous 
pressures were recorded from the caudal vein, the point of cannUlation 
for the perfused eel tail preparation. Between the two venous recording 
sites are the renal and hepatic portal vascular beds which would 
necessitate a positive pressure at the caudal vein to maintain blood 
flow through these vital organs. Caudal venous pressures recorded 
from live fish provide an a posteriori rationale for arbitrarily setting 
the caudal venous pressure of the perfused eel tail to 1.33 kPa for the 
pharmacological studies. Thus there appears to be no inconsistency 
between data from these two reports after careful examination of the 
methods. Likewise it is clear that baseline pressure differentials 
across the eel tail in intact unanaesthetised eels are in agreement with 
estimates of the pressure differentials across the same vascular bed in 
the isolated saline perfused eel tail. This is in distinct contrast 
with the results from the trout trunk perfusion experiments. 
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The alpha adrenergic receptors of the eel tail show classical 
potencies to sympathetomimetic drugs of AD > NAD » ISO (Ahlquist, 1948; 
Furchgott, 1967). The mean potency ratio of AD to NAD of ~ 2.78 : 1.00 
is very close to that reported for mammalian alpha receptors of 3.2 : 1.0 
(Furchgott, 1967), and to those reported in rainbow trout (see Wood and 
Shelton, 1975; and Wood, 1976). 
On examination of the ED50 concentrations for AD and NAD from 
Wood and Shelton (1975) it is apparent that around ten times the 
concentration of agonist used for the eel tail is required to elicit 
a half maximal response from the perfused rainbow trout trunk. The 
fact that the eel tail is an order of magnitude more sensitive to both 
AD and NAD is rather surprising. It is also surprising that helical 
strips of coeliac artery from rainbow trout gave ED50s of 1.1 x 10-8M 
(AD) and 2.2 x 10-8M (NAD), (Holmgren and Nilsson, 1974), which are about 
one fifteenth of the ED50 concentrations of the perfused trout trunk. 
Holmgren and Nilsson also gave ED50 concentrations for cod coeliac artery 
-7 -7 
strips of 3.7 x 10 M (AD) and 8.7 x 10 M (NAD), which are close to 
those from the perfused eel tail. The poor agreement of data for 
rainbow trout could simply be the result of the different preparations. 
Cumulative addition procedures were used in both studies. Restraint 
should be exercised when comparing results from different preparations 
from the same species, let alone different species. 
Threshold doses of AD and NAD in the eel tail were 10-20 pmoles 
and 20-50 pmoles respectively. These are similar to threshold doses 
required to elicit pressor responses from perfused european eel systemic 
vasculature (Forster, 1976a), but are an order of magnitUde higher than 
thresholds for AD and NAD in the perfused trout trunk (Wood and Shelton, 
1975). 
Eel tail alpha receptors exhibit significant activity in response 
to ISO at high concentrations. Systemic pressor responses to ISO 
in the cod and asiatic eel during beta blockade by propranolol were 
reported by Helgason and Nilson (1973) and Chan and Chow, (1976). 
Mammalian alpha receptors exhibit similar behaviour (Jenkinson, 1973). 
No alpha activity in response to ISO was observed in the trout trunk by 
Wood and Shelton, (1975) or Wood (1976), despite very high concentrations 
of ISO (up to 1 x 10-IM) • It is clear that the trout systemic alpha 
type receptors described by Wood and Shelton (1975) and Wood (1976) are 
sufficiently different from other fish and mammalian alpha receptors that 
only limited comparisons should be made. 
The beta adrenergic receptors of the eel tail appear to be of the 
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beta two variety since the potency of ISO » AD > NAD (Furchgott, 1967). 
This finding supports the theory that mammalian peripheral beta 
receptors are homologous to, and phylogenetically derived from the 
systemic receptors of lower vertebrates (see Wood, 1976). Similarly 
the beta one type of receptors in the coronary circulation of mammals are 
homologous to, and derived from the beta one type receptors in fish 
gills (Keys and Bateman, 1932; Rankin and Maetz, 1971; Wood, 1974a). 
The specific alpha antagonist, phentolamine elicited small 
insignificant decreases in resistance when administered alone. This 
could be due to blockade of the small component of baseline resistance 
caused by incomplete washout of alpha agonists. 
Phentolamine is a highly specific alpha antagonist in the eel 
tail preparation. The beta antagonist propranolol is a potent beta 
antagonist in the eel tail. Reports of significant alpha blockade by 
propranolol are provided by Kirby and Burnstock (1968) and Holmgren and 
Nilsson (1974). In the eel tail propranolol controls elicited a 
small fall in resistance. The qualitative features (time course and 
shape of trace) suggests alpha blockade rather than partial beta 
agonistic activity. Partial beta stimulation is common in beta 
antagonists (see McDevitt, 1977) and is a particular feature of 
dichloroisoproterenol. 
Effective blockade of alpha responses to AD was achieved at 
agonist to antagonist concentration ratios of around 1 : 40, which is 
similar to effective ratios in other teleost systemic preparations (see 
Forster, 1976b). Propranolol produced effective beta blockade at 
ratios of ISO to Propranolol of around l : 20, which is similar to the 
effective ratio quoted for mammalian beta two receptors (Osnes, 1976). 
Effective blockade of the beta component of the response to AD was 
achieved at concentration ratios of AD to propranolol of 1 : 5 to 
1 : 10. The response to AD in the eel tail is the sum of opposed 
alpha constriction and beta dilation. Alpha stimulation by AD near 
the ED50 during effective beta blockade caused an increase in resistance 
of 38% when compared to the response to AD without beta blockade. 
Therefore if the observed responses to AD, (no blockade) are let equal 
100% then the response is the result of + 138% (alpha constriction) 
- 38% (beta dilation) • 
The eel tail vascular bed has the potential to manipulate vascular 
resistance by differential stimulation of alpha and beta adrenergic 
receptors. The next two sections are discussions of how this could be 
accomplished. 
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II.6.6.2 Why is the beta dilatory response slower than the alpha 
constrictory response? 
The time course of alpha and beta responses are distinctly different. 
Perfusion of low concentrations of AD, « 1 x 10-7M), into the eel tail 
results in a gradual rise in resistance over the first 180 s. As higher 
concentrations are infused the time to peak response becomes shorter 
(see appendix A.2l), and the biphasic response becomes more pronounced 
(see figure II.14a). During infusion, particularly of low concentrations, 
the development of the alpha response is perfusion limited, that is 
limited by the rate of delivery to the tissues. Development of the 
response to NAD is slightly slower and exhibits no small initial peak 
(see figure II.14c) • The decrease to a stable elevated resistance level 
after the initial peak is attributed to the slower development of the 
beta response, rather than to overshoot phenomena. It is noted that the 
records of responses to infusion of AD into the perfused trout trunk 
(Wood, 1976) do not show this feature. Infusion of ISO produced a 
decrease in resistance at around 220 s after the start of infusion, and 
the development of the response was not limited by the rate of delivery 
of the drug to the tissue. In fact the time taken to reach maximum 
change in resistance increased slightly as the concentration of ISO is 
increased. There was no initial peak resistance fall which if present 
would indicate partial alpha stimulation at concentrations below 1 x la-sM. 
Time zero for infusion experiments was taken as the time when the test 
solution passed through the bubble trap. The dead space between the 
bubble trap and the fish vessels was ~ 0.43 mlswhich would provide a 
delay of around 27 s, depending on the perfusion rate. Thus the 
recorded response time in these experiments is in fact longer by some 
27 s because of this dead space. Since development of constrictory 
responses at low concentrations is perfusion limited, and at high 
concentrations the dilatory response to ISO is masked by constriction, 
there is little to be gained from a comparison of the response times for 
infusion of drugs. 
Administration of a bolus of 1 nmole is equivalent to perfusion of 
the preparation with 0.1 mls of 1 x 10-sM solution. Bolus administration 
effectively overcomes the problem of perfusion limitation and since by 
the end of injection all the drug is in the arteries, there is 
effectively no dead space. Thus it is preferable to compare response 
time of boli of active agents rather than infused drug concentrations. 
The differences between the mean response times for all doses of AD and 
-s ISO up to 1 x 10 M are highly significant (p < 0.001, Student's t-test) I 
'; 
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the beta dilatory response being slower to develop. Several reports of 
responses to AD in fish vasculature have shown a rapid alpha constriction 
(- 60 s), followed by a slow beta dilatory response (- 500 s), (see 
Girard and Payan, 1976; Capra and Satchell, 1974; 1977a). 
The reasons for the slower expression of the beta dilation in 
comparison to alpha constriction may lie either inside or outside the 
smooth muscle cells. The rate limiting step for the beta dilation could 
be anyone of a number of steps, three of which will be considered here. 
The intermediary steps between beta receptor stimulation and 
muscle relaxation involve cyclic-AMP. stimulation of beta adrenergic 
receptors causes elevated c-AMP levels which subsequently act on free 
intracellular ca++ concentrations thereby inducing tone changes in 
vascular smooth muscle (Osnes, 1976). Alpha stimulation however apppears 
, mb ab'l't 'th + + + d - ( to lncrease me rane perme 1 1 Y to el er K or K , Na an Cl see 
Jenkinson, 1973) which directly initiates muscle depolarization (Osnes, 
1976; Lefkowitz, 1978). That an additional step involving c-AMP slows 
the beta response is unlikely since beta mediated ionotropic effects 
on the rat heart are rapidly developed, yet proceed via the same inter-
mediate steps (Osnes, Refsum, Skomedal and Oye, 1978). 
Alternatively within the cells, smooth muscle contractile elements 
may simply take longer to relax than contract. Restoration of resting 
(relaxed) intracellular concentrations of ca++ and trans-membrane K+ and 
Na+ gradients could take considerably longer to establish than the 
sudden influx of ions observed on contraction (Luttgau, 1963). 
Extracellularly, the delay in expression of the beta response may 
be due to the physical separation of the two populations of receptors. 
For example if alpha receptors were located on the intimal surface of 
smooth muscle layers and beta receptors were on the adventitial surface, 
then the alpha and beta responses to circulating catecholamines could 
be temporarily separated. Holmgren (1978) reported that cod coeliac 
arteries have adrenergic innervation extending only to the border 
between the media and adventitia. Stimulation of these nerves elicited 
both contraction and dilation in the presence of suitable antagonists. 
Calculations of diffusion times of AD from vessel lumen to medial and 
adventitial smooth muscle reveals too small a difference to account for 
the different response times (Wayland and Silberberg, 1978). Thus 
should an extracellular cause be sought for the response time difference, 
then an additional barrier to the access of AD to beta receptors must be 
postulated. If beta receptors were to be found within sympathetic 
nerve synaptic clefts then a slower beta response would result. Indeed 
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a slower return to baseline resistance levels after beta dilation would 
also be explicable. Reports show however that beta receptors form 
high affinity slowly dissociating complexes with antagonists (Lefkowitz, 
1978). This last alternative is supported by the work of Holmgren 
(1978) on the cod. Holmgren in this paper suggested that beta 
dilation of cod coeliac arteries may be nerve-mediated. 
11.6.6.3 Is teleost systemic vascular tone controlled by 
sympathetic nerves or circulating catecholamines? 
Recent studies reported by Capra and Satchell (1977a,b,c) have 
shown that elasmobranch fishes possess the ability to manipulate their 
cardiovascular system by-differential release of AD and NAD. When 
combined with evidence of differential distribution of alpha and beta 
receptors, this system has sufficient flexibility to regulate cardio-
vascular parameters within physiological limits. The teleost 
cardiovascular system was thought to be controlled in a similar manner 
(see Randall and Stevens, 1967; Randall, 1970; Wood, 1974a), however 
a number of studies have shown that sympathetic nerves play an 
important part in regulating blood flow and pressure, especially at the 
heart (Gannon, 1971; Holmgren, 1977). More recently several reports 
indicate that normal resting systemic vascular tone may be due to 
sympathetic nerve activity (see Smith, 1978). 
The teleost heart appears to be largely controlled by vagal 
cholinergic inhibitory and adrenergic excitatory sympathetic nerves. 
Circulating catecholamines are also believed to play an important part 
in the regulation of the cod heart (Holmgren, 1977). Teleost gill 
vascular resistance changes in vivo agree well with changes that could 
be expected from elevated circulating catecholamine levels during say 
exercise (Wood, 1974a, 1975; Payan and Girard, 1977). The systemic 
vascular beds of the trout however seem to be under the control of 
the sympathetic nervous system. On the basis of insensitivity to 
measured levels of circulating catecholamines in blood, and the absence 
of significant beta dilatory responses, Wood and Shelton (1975) and Wood 
(1976) asserted that blood borne catecholamines are likely to play an 
insignificant part in trout systemic resistance regulation. The 
discrepancies between ED50s for AD between Wood and Shelton (1975) and 
Holmgren and Nilsson, (1976) have already been noted. Additional evidence 
in support of sympathetic control o~ systemic resistance in trout is 
provided by the presence of Mayer waves in the rainbowttout (Wood, 1974b). 
Mayer waves indicate phasic sympathetic activity. Smith (1978) described 
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experiments on rainbow trout using antihypertensive agents, phentolamine 
(alpha blocker) and bretilium (sympathetic release blocker) • 
/ 
Pretreatment of fish with either the specific alpha blocker, phentolamine, 
or the adrenergic release blocker, bretilium caused a drop in blood 
pressure when the fish were subjected to five minutes of strenuous exercise. 
Normally trout show a marked hypertension in response to such a stimulus 
(Stevens and Randall, 1967a). The conclusions drawn from these 
experiments were that the pressor response to swimming for a short period 
was mediated by sympathetic nerves as both the alpha blocker and the 
adrenergic release blocker reversed the response. Quite the opposite 
conclusions were drawn by Wahlqvist and Nilsson, (1977) who subjected cod 
to alpha (yohimbine), and beta (propranolol), blocking agents and to 
6-hydroxydopamine (chemical sympathectomy), and reserpine (adrenergic 
store depletion) • From the results of resting blood pressures after 
the various drug treatments these authors concluded that the 'adrenergic 
tonus' that controlled the heart rate and blood pressure in cod was 
caused mainly by circulating catecholamines rather than sympathetic nerve 
activity. Smith (1978) has criticised these experiments on the basis of 
the inappropriate choice of pharmacologically active agents. However 
in so far as evidence from heavily 'drugged' fish can be accepted, the 
results from both of these sets of experiments are not mutually exclusive. 
Since the trout systemic vasculature as described by Wood (1976) 
exhibits very weak beta dilatory responses to exogenous catecholamines, 
it is hardly surprising that resistance decreases are accomplished by a 
reduction in neural tone rather than active beta dilation. 
In mammals peripheral resistance is decreased principally by 
reduction of sympathetic vascular tone. This is accomplished largely 
by the baroreflex whereby an increase in systemic blood pressure 
However inhibits sympathetic outflow (see Willems and Bogaert, 1978). 
sympathetic stimulation of peripheral beta two receptors causes 
significant dilation with consequent reduction in vascular. resistance, 
especially in muscles (Viveros et al., 1968; Rengo et al., 1976) • 
. This response may however be aimed at transcapillary exchange processes 
rather than resistance (Lundvall and Jarhult, 1976). In addition to 
reduction in sympathetic tone, sympathetic and parasympathetic 
cholinergic nerves also cause vasodilation (Mellander and Johannson, 
1968) • Several other mechanisms for peripheral vasodilation in mammals 
have been reported such as histamine (Owen, 1977), dopamine (Lang, Bell, 
Conway and Pudanyl, 1976) and purinergic mechanisms (Su, 1975). 
Within teleosts,baroreceptors in the pseudobranchs may reflexly 
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decrease sympathetic outflow (Laurent, 1967; Laurent and Rousseau, 
1972) • In trout this is probably a most important cardiovascular 
homeostatic reflex since resting tone seems to be largely the result of 
sympathetic nerve activity (Smith, 1978). In fish such as cod and eels 
there appears to be little resting sympathetic tone and peripheral 
resistance seems to be maintained by circulating catecholamines. Under 
these conditions the baroreflex could only be effective through increased 
activity of sympathetic dilatory nerves. Fish vascular cholinergic 
sympathetic and parasympathetic nerves elicit vasoconstriction (Burnstock, 
1969; Wood, 1977), consequently vasodilation by this route is not possible. 
Significant purigenic dilation remains a possibility although in the 
trout ATP caused vasoconstriction (Wood, 1977). 
The results of this study of the eel tail vascular bed cannot show 
whether the beta response is the result of sympathetically released 
neurohumours or circulating catecholamines, the preceeding discussion 
however suggests the former. A consideration of how systemic 
vasodilation might be accomplished in the eel tail by circulating 
catecholamines is informative. 
Increased plasma AD would cause vasoconstriction. Only at very 
low concentrations « 1 x lO-9M) could there be dilation in response to 
AD, and even then it would be very small. After the constriction, 
partial dilation by direct beta stimulation could represent autoregulatory 
escape from vasoconstriction as observed in mammals (Lundvall and 
Jarhult, 1978). Within the eel tail there could be differential 
distributions of alpha and beta receptors as seen in dogfish (Capra, 
1975) . If alpha receptors were primarily located in white muscle 
vasculature and beta receptors in the red muscle vasculature then 
increases in plasma AD levels would redirect blood from the white 
muscles to the red muscles. Given that red muscles are more active 
during sustained swimming this hypothesis is not unreasonable. This 
might also explain the slow release of lactate into blood observed in 
exercising fish (Driedzic and Kiceniuk, 1976). Stevens however reported 
no significant redistribution of blood in the musculature of the 
swimming trout. If beta receptors were present in low concentration 
in the white muscle vasculature, then the dilatory responses of the eel 
tail would be largely the result of red muscle vessel dilation only. 
Despite the fact that red muscle contains about three times the blood 
volume per gram than white muscre, the sheer bulk of the white muscles 
means that over 96% of the vascular volume of the tail resides in the 
white muscle. The magnitude of the dilatory responses of the eel tail 
117 
to ISO and AD in the presence of an alpha blocker make this extremely 
unlikely. Clearly there is no significant differential alpha and beta 
receptor distribution between the red and white muscles of the eel tail. 
From this brief consideration of beta stimulation by circulating 
catecholamines it seems unlikely that dilation of the tail vessels of 
the eel could be efficiently accomplished by circulating catecholamines. 
" To summarise, it is apparent that in trout there is significant 
positive sympathetic vasomotor tone in the systemic vasculature and that 
alteration of the level of sympathetic tone is the principal mechanism 
whereby systemic resistance adjustments are made. In eels and perhaps 
cod, circulating catecholamines play an important role in the maintenance 
and regulation of systemic vascular tone. Increases in resistance 
are probably the result of alpha stimulation by blood borne catecholamines 
and decreases in resistance may be the result of sympathetic nerve 
activity. 
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11.7 Blood Volume and Capacitance Responses in Vascular Beds 
11.7.1 Introduction 
The vascular volume of fish has been estimated by many authors. 
Holmes and Donaldson (1970) provide an extensive review of the early 
literature. More recently refer to Avtalion, Gorlin, Gutwirth and 
Wojdani (1974). Two aproaches are regularly employed to determine 
vascular volume. The first involves dilution of the formed elements 
or cells in the blood by a known amount of isotonic saline (cell 
dilution) . The second utilizes the distribution of a marker in the 
plasma. since blood consists of cells and plasma each method 
corrects for the volume of cells or plasma not measured using the 
haematocrit. Cell dilution methods give lower values for total blood 
volume than plasma marker methods. For a discussion of the problems 
involved in the two methods see Gregerson and Rawson (1959). Levick 
and Michel (1973) have shown that in the presence of albumin, the common 
plasma marker Evans Blue move through frog capillary walls at 
approximately twice the rate of the dye alone. Binding of the dye to 
the vessel walls will also lead to over-estimates of blood volume by 
this method. Significant quantities of Evans blue do bind to vessel 
walls according to Fry et al., (1977). Dye is found in the lymphatic 
fluid in concentrations near that found in the blood and will have 
similar effects to the measurements of blood volume as extravasation 
of Evans blue. 
Fish blood volumes are reported to be larger in cyclostomes than 
in elasmobranchs. within the bony fishes, Chondrostei and Holostei 
appear to have larger blood volumes than Teleostei (Thorson, 1961; 
Holmes and Donaldson, 1970). Randall (1970) gave a mean blood volume 
for all teleost species measured of around 3 mls per 100g body wt (3%). 
Estimates of blood volume should use both methods to arrive at a 
volume near the true volume, and an accuracy of ±5% is the best that 
can be expected. 
The distribution of blood throughout the body has been estimated 
before and after exercise in the Rainbow trout by Stevens (1968). 
Stevens reported minimal changes in distribution between the two 
conditions. In agreement with Gorkiewicz (1948), Stevens found that 
lateral red muscle contained two to three times more blood per gram 
than white muscle and that about 60% of the total blood volume was 
contained within the large vessels. 
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In mammals veins are largely responsible for vascular volume 
changes (see Oberg, 1967; Mellander and Johansson, 1968). Less than 
10% of the blood volume in a vascular bed is contained in the resistance 
vessels (arterioles). However these small vessels produce about 80% of 
the resistance adjustments. The maximum volume change that could be 
accomplished by precapillary vessel diameter changes, assuming a four-
fold increase in resistance, is less than 5% of the blood volume of the 
vascular bed (Mellander, 1960; Oberg, 1967). Measurements of volume 
changes (Mellander, 1960; Rose, Kot, Cohn, Freis, and Eckert, 1962; 
Oberg, 1967) revealed that this represents only 10% of the recorded 
changes. These results indicate that up to 90% of the capacitance 
changes originate from alterations in venous tone. Fish veins are 
reported to be aneural and lack smooth muscle (Burnstock, 1969). 
Consequently capacitance changes in a fish vascular bed should be the 
result solely of precapillary vessel diameter changes. Such changes 
should also be small, less than 5% of the vascular volume of the 
vascular bed. Capacitance effects as discussed here are those 
resulting solely from changes in vessel radius. Alterations in tissue 
fluid volumes and pressures which could have appreciable effects upon 
vascular volume are considered in section 11.7.5. 
II.7.2 Vascular volume of the perfused eel tail 
Vascular volume of the tail was measured during perfusion by two 
separate methods; dilution of red blood cells and by inulin dilution. 
11.7.2.1 Red blood cell vascular volume of the perfused eel 
tail 
Three perfused eel tails were prepared in the normal manner. The 
blood that was collected after heparinisation was stored at 40 C and 
allowed to settle. During the first hour of perfusion with basic saline 
at a venous pressure of 1.33 kPa the efficiency of perfusion was measured 
several times. The preparation was then perfused with the blood cell 
suspension in ringer and the effluent from the caudal vein replaced into 
the reservoir. The reservoir was continuously and vigorously bubbled 
with 95% °2/5% CO2 which stopped cell settling. This type of system 
is a simple closed two compartment model with exchange in both 
directions (see Shippley and Clark, 1972). The two compartments will 
eventually reach equilibrium and from the change in concentration in 
the reservoir and its initial volume, the volume of the other compartment 
is calculable. Haematocrit (concentration), was measured at time zero, 
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1 min, 2, 5, 10, 15, 20 30 minutes in duplicate 10 ~l microhaematocrit 
tubes and centrifuged at 2600 rpm for 5 minutes. In the analysis of 
the results the loss of perfusate from the preparation, or leakage (I) 
must be taken into account. The concentration of cells in the fluid 
leaked from the preparation is assumed to be the same as the concentration 
in the vasculature. 
this system. 
Figure II.24a illustrates the model that applies to 
Total cells initially = total cells finally 
H .• Y. 
l. l. 
H •• Y. 
l. l. 
t 
Cells lost = 1. Ht.dt 
o 
Where H. = initial haematocrit 
l. 
Y. = initial reservoir volume 
l. 
Hf = final haematocrit 
x = vascular volume 
Y f =: final reservoir volume 
1 = leakage rate 
Ht = haematocrit in the vessels 
To estimate the cells lost, Ht is assumed to be the reflection of H 
about the equilibrium concentration. Mean Ht is calculated from this 
curve and when mUltiplied by the leakage rate, 1, gives the cells lost 
and allows the computation of the vascular volume, X. 
A graph of the reservoir haematocri t against time is presented in 
figure II.25a, with the corresponding assumed Ht , haematocrit of the 
vascular cell suspension. From these graphs it is clear that H H' 
t 
at or before 20 minutes. Thus 20 minu~es was chosen as the final or 
equilibration time. Calculations of tail vascular volume by this method 
are presented in table 11.8. 
II.7.2.2 Inulin vascular volume of the eel tail 
After the determination of the red blood cell volume in each of 
the tails, at least two hours was allowed to remove any of the cells 
still remaining in the vessels. A solution of 3H-radiolabelled inulin 
(Radiochemical Centre, Amersham, England), was then perfused through the 
tail in the same manner. 3H-inulin concentration in the reservoir was 
measured at 0, 1, 2, 5, 10, 20, 30, 40,50 and 60 minutes by removing 50 ]ll 
and counting the disintegrations per minute in a Unilux liquid 
FIGURE II.24a 
FIGURE II.24b 
Diagram of simple two compartment model for estimating 
vascular volume of the perfused tail. From the initial 
and final volumes and red blood cell concentrations the 
vascular volume can be calculated. Leakage was estimated 
from the change in reservoir volume with time. 
Y reservoir volume 
X vascular volume 
I leakage rate from the preparation 
Multi-compartment model for vascular and extravascular 
spaces in the eel tail. From the information available 
it is not possible to estimate the sizes of all the 
compartments, however movement of 3H-inulin into the 
interstitial, lymphatic and cellular spaces was slow 
relative to the vascular compartment enabling estimates 
of vascular volume to be made in a similar manner to the 
red blood cell method. 
Y volume of the open external reservoir 
X vascular volume 
I interstitial volume 
L lymphatic volume 
C cellular volume 
I leakage rate from the preparation 
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FIGURE II.25a 
FIGURE II.25b 
Graph of external reservoir red blood cell concentration 
(haematocrit) versus time during short circuit perfusion. 
Little change in haematocrit was observed after 10 
minutes of perfusion indicating equilibration of red 
blood cells between the vascular space and the external 
reservoir. Amount of cells lost due to leakage was 
estimated from the leakage flow rate and the haematocrit 
of the vascular fluid. Haematocrit of the vascular 
fluid was assumed to be the reflection of the reservoir 
haematocrit about the equilibration haematocrit. 
___ reservoir haematocrit 
~assumed vascular haematocrit 
Graph of 3H-inulin concentration versus time during 
short circuit perfusion. Equilibration of 3H-inulin 
between the tail and external reservoir was slower than 
red blood cells, however after 20 minutes vascular 
equilibration was assumed to be complete and the fall 
in reservoir 3H-inulin concentration thereafter probably 
reflects movement of 3H-inulin into compartments other 
than the vascular space (see figure II.24b). Vascular 
3H-inulin concentration and H-inulin vascular volume of 
the tail were estimated as in the red blood cell method. 
Mean vascular volume of three perfused eel tails 
estimated by these two methods was 3.1 ml per 100 g tail 
tissue weight (see table 11.8). 
~reservoir 3H-inulin concentration 
-o-vascular 3H-inulin concentration 
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Table 11.8 Vascular volume of the isolated saline perfused eel 
tail as measured by red blood cell dilution and 3H-inulin dilution 
(for details see text). 
~d blood cell dilution 
vascular volume 
3H-inulin dilution 
vascular volume 
. 
Fish number mlllOO g 
1 3.13 
tail wt mlllOO g tail wt 
4.48 
2 
3 
Mean vascular volumes 
Overall vascular volume 
2.61 
2.75 
2.83 ± 0.15 
3.065 ± 0.298 
2.95 
2.47 
3.30 ± 0.60 
scintillation counter for 60 seconds. The size of the reservoir was 
minimized to ensure large changes in concentrations yet had to be large 
enough to last for the required time. The volume needed was between 5 
and 15 ml; the greater the leakage rate and the larger the tail, the 
larger the reservoir volume required. 
The raw counts were used to construct the graphs of 3H-inulin 
concentration against time (see figure II.25b), and an approximation of 
the 3H-inulin concentration in the vascular compartment was drawn for 
these graphs ,as in the red blood cell dilution analysis. The graph of 
3H-inulin concentration versus time showed, not surprisingly, a slow 
uptake of inulin into a non-vascular compartment or compartments. 
the model outlined in figure II.24b, it is clear that there is 
insufficient information available to completely analyse the inulin 
From 
spaces. The information from these experiments can however be used as 
a check on the vascular volume obtained by cell dilution. 
Analysis of these data was carried out in a manner somewhat similar 
to the red blood cell dilution, except that a further correction for the 
loss of 3H-inulin into the 'slow' compartment, whatever its nature, had 
also to be made. The loss of 3H-inulin to the slow compartment was 
estimated from the semilog plot of the 3H-inulin concentration against 
time which allows extrapolation back to time zero provided that the two 
compartments have markedly different time courses, (Shippley and Clark, 
1972) • Thus the equation for the 3H-inulin in the system is 
[3HTI i'Yi = [3HD f (X + Yf ) +~HIt·dt + 3HI in slow cpt, 
o 
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where square brackets represent concentrations and all other symbols are 
the same as for the red blood cell dilution analysis. 
The volume of the delivery system (1.287 ml) was subtracted from 
values of the volume X from the inulin dilution and the red blood cell 
dilution methods. The results in table 11.8 are expressed as mls per 
100 g tissue weight and provide a working figure of 3% of tissue weight 
for the vascular volume. 
reported values. 
This is very close to most of the previously 
II. 7.3 Changes in vascular volume of the isolated perfused eel 
tail in response to catecholamines 
Changes in the vascular volume of isolated perfused tissue 
preparations have been measured by several means, (marker transit times, 
plethysmography, changes in volume of extracorporeal reservoir). 
Perfusion at constant inflow while simultaneously measuring the outflow 
rates allows calculation of the fraction of perfusate 'lost'. Once the 
efficiency of a perfused eel tail has stabilised then it is remarkably 
constant throughout the life of the preparation, (± 2%). Lower outflow 
rates should indicate an increase in vascular volume (dilation) whereas 
higher outflow rates should indicate an expUlsion of vascular fluid as 
would occur during vasoconstriction. Such changes should be 
simultaneous with resistance changes since the fluid is incompressible, 
although vascular compliance may accommodate some of the volume changes. 
Complete outflow records are available for 39 preparations. out-
flow represents about 86% of the fluid passing through the vascular bed 
and as a consequence volume adjustments calculated from them will be 
conservative. Graphs of mean outflow changes with time during infusion 
of different concentrations of AD and ISO are presented in figures 11.26 
,and II. 27 respectively, (see also appendices A.32 (AD), and A.33 (ISO». 
The vascular volume change is calculated from the sum of the 
outflow changes that occur during resist~ce increase or decrease. 
?ercentage vascular volume changes are given on figures 11.26-11.29. 
Calculated vascular volume changes in the eel tail are small. 
Constriction is the dominant response to catecholamines in the 
systemic vasculature. The largest volume decrease during constriction 
was observed when 1 x 10-7M AD was administered. The volume change 
represents a decrease of about 1.4% of the tail vascular volume. 
is considerably smaller than the 30% decrease reported by Mellander 
(1960) and Rose et al. (1962). 
This 
Bolus administration of drugs produced a pronounced increase in 
FIGURE II. 26 Changes in venous outflow with time during infusion of 
adrenaline at concentrations between 1 x 10-8M and 1 x 10-3M• 
Estimated % changes in vascular volume (V) were based on a 
tail vascular volume of 3 ml per 100 g tail weight and are 
the sum of the outflow changes during resistance changes. 
Estimates of % changes in interstitial volume (I) were 
based on a tail interstitial volume of 10 ml per 100 g tail 
weight and are the sum of changes in outflow after resistance 
changes. Vasoconstriction, by definition implies a decrease 
in vascular volume, therefore it is logical to view a decrease 
in outflow during vasoconstriction as extravasation of fluid, 
that is an increase in interstitial volume rather than an 
increase in vascular volume. Consequently changes in vascular 
and/or interstitial volumes have been calculated only where 
appropriate. Mean initial outflow and mean changes in outflow 
during infusion of adrenaline are tabulated in appendix 
Arrows indicate times of peak resistance responses. 
a. 
b. 
c. 
d. 
e. 
1 x 10-8M adrenaline. lJ.V = -0.78% 
1 x 10-7M adrenaline. lJ.v = -1.36% 
1 x 10-sM adrenaline. lJ.V = -0.314% 
lJ.I = +0.123% 
This concentration was the only one in which the two 
components of the outflow change were clearly 
delineated. 
1 x 10-sM adrenaline. 
1 x 10-4M adrenaline. 
lJ.I = +1. 57% 
lJ.I = +2.78% 
Histogram on the abcissa of the graph indicates the 
number of preparations I swimming' (see right hand 
ordinate, n = 9) • 
f. 1 x 10-3M adrenaline. lJ.I = + 0.372% 
Histogram on abcissa of the graph indicates the 
number of preparations I swimming' (see right hand 
ordinate, n = 6) • 
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FIGURE II. 27 Changes in venous oQ.t:l;),ow versus time during infusion of 
-9 isoprenaline at concentrations between 1 x 10 M and 
1 x 10-3M• Estimated % changes in vascular volume were 
based on a tail vascular volume of 3 ml per 100 g tail 
weight and are the sum of outflow changes during resistance 
adjustments. Increases in vascular volume occurred 
during vasodilation (I x 10-9M to 1 x 10-sM isoprenaline) 
and decreases in vascular volume occurred during 
-It -3 
constriction (l x 10 M and 1 x 10 M isoprenaline) • Mean 
initial outflow and changes in outflow are tabulated in 
appendix A.33. Arrows indicate times of peak resistance 
responses. 
a. 1 x 10-9M isoprenaline. b.v == +0.651% 
b. 1 x 10-aM isoprenaline. b.v = +0.B70% 
c. 1 x 10-7M isoprenaline. b.v = +0.7B3% 
d. 1 x 10-sM isoprenaline. b.V == +0.634% 
e. 1 x 10-sM isoprenaline. b.v = -0.521% 
f. 1 x 10-ItM isoprenaline. b.V = -0.499% 
g. 1 x 10-3M isoprenaline. b.v == -0.596% 
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FIGURE 11.28 Cha,ilges in venous out:l;low with time a:l;ter injection 0:1; 
O.S- 100 nmoles 0:1; adrenaline. Changes in venous out-
flow due to the 0.1 ml vehicle have been accounted for in 
the calculation of changes in vascular volume. Estimates 
of % changes in vascular and interstitial volumes were 
calculated as previously explained (see figure 11.26 and 
II.27) . Mean initial venous outflow and mean changes in 
outflow for blanks and all doses of adrenaline are 
tabulated in appendix A.34. 
peak resistance responses. 
a. SOO pmoles (O.S nmoles) 
b. 1 nmo1e adrenaline. 
d. 10 nmo1es adrenaline. 
e. 100 nmoles adrenaline 
Arrows indicate times of 
adrenaline. 6.v = -0.S7S% 
6.1 = +0.0123% 
6.V == -0.293% 
6.1 = +0.278% 
6.v = -0.351% 
6.1 = +1. 34% 
(6.V = +0.OS64%) 
6.1 = +S.9S% 
Note that during vasoconstriction in response to 100 nmo1es 
adrenaline extravasation of fluid was greater than the 
decrease in vascular volume expected with vasoconstriction. 
This will result in an underestimate of the change in 
interstitial volume. 
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FIGURE II.29 Changes in venous outflow with time after injection of 
0.5 - 100 nmoles of noradrenaline. Changes in venous 
outflow due to the 0.1 ml vehicle have been accounted for 
in the calculations of changes in vascular volumes. 
Estimates of changes in vascular and extravascular volumes 
were calculated as previously explained (see figure II.26 
and II.27) • Mean initial venous outflow and mean changes 
in outflow for blanks and these concentrations are 
tabulated in appendix A.35. 
peak resistance responses. 
Arrows indicate times of 
a. 500 pmoles (0.5 nmoles) noradrenaline. ~V -0.822% 
~I = +0.218% 
b. 1 nmole noradrenaline. ~V =:: -0.818% 
~I ;; +0.589% 
c. 10 nmoles noradrenaline. ~V = -0.511% 
~I ;: +1. 73% 
d. 100 nmoles noradrenaline. ~V = -0.932% 
~I ;; +10.57% 
Note that during vasoconstriction in response to 100 nmoles 
extravasation was not as great as the decrease in vascular 
volume as was the case for this dose of adrenaline. 
also that the ordinate scale is half that of the above 
graphs. 
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outflow when the 0.1 ml bolus was injected into the preparation, (see 
figure II.18c) . Blank injections of 0.1 mls of saline, without any 
active agents, were delivered throughout all experiments and have been 
used to correct for the change in outflow due solely to the vehicle for 
each set of experiments. Graphs of mean outflow changes with time after 
injection of different doses of AD and NAD are presented in figures 
II.28 and II.29 respectively, (see also appendixes A.34 (AD), A.35 (NAD), 
and A.36 (ISO». 
The maximum decrease in vascular volume when a bolus of AD or NAD 
caused vasoconstriction was 0.8% for a dose of 500 pmoles NAD. since 
all bolus injections of AD or NAD resulted in a decrease in outflow 
after 60-180 seconds, the positive values during this short initial 
period were summed to estimate decreases in capacity. The peak resistance 
response times are indicated on the graphs and were around 1 to 1.5 
minutes for all bolus doses of AD and NAD analysed. 
Isoprenaline caused vasodilation in the eel tail. Thus we could 
expect a decrease in outflow whilst this dilation occurred. When ISO 
was infused into the preparations there were consistent, but small 
increases in vascular volume of around 0.73 ± 0.06% for the four 
concentrations that produced the most marked dilations (see figure II.27) . 
Administration of ISO as a bolus revealed no clear trend in outflow 
adjustment. All the volume changes were small « 1%) there being 
increases in vascular volume at three concentrations (20 pmoles, 200 
pmoles, 100 nmoles) and decreases in volume at the other six 
intermediate concentrations tested (see appendix A.36) . 
II.7.4 Discussion of vascular volume changes in the isolated 
perfused eel tail 
These results confirm that an increase in vascular resistance is 
accompanied by a decrease in vascular volume. Conversely a decrease 
in resistance is often accompanied by an increase in vascular volume. 
The magnitude of these changes, as measured here, are easily explained 
in terms of changes in radius of precapillary resistance vessels and 
require no capacitance functions of veins for their explanation. 
It is clear from these studies that although the white muscles 
of the tail of an eel contains a large volume of blood (around 70% of 
total vascular volume) it is not readily mobilised by catecholamines 
under these conditions. Teleosts have a small blood volume per body 
weight compared to other vertebrates (Thorson, 1971). Mobilization of 
this large volume of blood might be expected when increased circulatory 
efficiency is required, for example during swimming. These results 
suggest that this could not be accomplished by elevated blood 
catecholamine levels in the short-finned eel. 
II. 7.5 Extravasation of fluid and lymph formation in the 
perfused eel tail in response to catecholamines 
II. 7.5.1 Introduction 
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Capillary filtration and resorption processes are significantly 
affected by resistance adjustments through changes in capillary pressures 
and capillary filtration coefficient (see Pappenheimer and Soto-Rivera, 
1948 and section 1.1.1) . Increases in arterial pressure during 
vasoconstriction will increase mean vascular pressure and result in 
greater ultrafiltration of fluid from the capillaries. Greater 
vascular pressure will be transmitted through the interstitium to the 
lymphatics causing higher lymphatic pressures to prevail (Granger and 
Taylor, 1978). Increased capillary permeability in response to AD and 
NAD (Payan and Girard, 1977; Reichel, 1977), will also increase ultra-
filtration of fluid from within the capillaries. Thus during 
vasoconstriction in response to AD and NAD it seems likely that the 
Starling equilibrium at the capillaries is displaced and interstitial 
fluid formation occurs. Furthermore AD not only raises arterial pressure 
and increases capillary permeability but also has been reported to 
increase the measured size of the interstitial space in many animal 
tissues, including teleosts (Gras, et al., 1971; Isaia, Maetz and 
Haywood, 1978; see also Vaccari and Maura, 1978). 
Analysis of the outflow data revealed that following the initial 
vascular volume adjustment there was a decrease in outflow when high 
doses of AD and NAD were given (see figures 11.26, 11.28 and 11.29) . 
This effect was more pronounced when boli of drugs were administered. 
No consistent trend was observed for ISO. This secondary decrease in 
outflow could be due either to extravasation of perfusate or redirection 
of the perfusate through the vessels in the neural arch which provided 
most of the leakage. The near constant value for efficiency before and 
after drug administrations, and throughout the life of a preparation 
argue against the latter. The arguments outlined above strongly 
suggest that the decrease in outflow from the preparation after the peak 
or steady elevated resistance has been reached in response to high 
concentrations or doses of AD or NAD indicates movement of perfusate into 
the interstitial space. 
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The clearly different time course and different directions of the 
fast vascular volume adjustment and slower extravasation of fluid allows 
separation of the two effects. The facts that outflow reflects both 
vascular and extravascular volume adjustments, and that the two 
components of the outflow change act in opposite directions during 
constriction means that for the time when the two effects overlap, 
outflow rate will give smaller estimates of volume changes in the two 
compartments. That the two components are temporarily separated is 
fortuitous in that it allows calculation of each. 
Measurements of interstitial space in fish are sparse. Holmes 
and Donaldson (1970) provide figures for an . ' average' teleost whole 
body interstitial space of around 12%. This value is calculated from 
the sucrose (extracellular) space minus the vascular space. Chan, 
Chester-Jones, Henderson and Rankin (1967) gave values for the sulphate 
space in fresh water eel tongue and parietal muscle. The sulphate 
space of tongue muscle was 10.5 ± 0.5%, and for the parietal muscle, 
4.8 ± 0.4%. The size of this compartment was not measured in the 
perfused eel tail but for the purposes of these experiments will be 
taken as 10 ml per 100 g tissue, (10%). 
II.7.5.2 Results 
Interstitial volume changes were calculated from the sum of out-
flow changes that occurred after resistance adjustments had ended. 
Percentage interstitial volume changes are given with figures II.26 -
II. 29 • 
Continuous infusion of 1 x 10-~M AD produced a retention of 0.32 
ml of fluid over the first seven minutes. This is equivalent to an 
increase of - 2.7% in the extravascular extracellular space and was the 
largest change recorded from continuously infused preparations. 
Although a steady elevated resistance was reached within 60 to 120 s 
the outflow fell to a minimum at 250 to 300 s. After this minimum 
there was a steady trend back toward outflow values recorded before 
introduction of the drug. This return to resting outflow rates 
appears to be assisted by the gross muscular movements that occurred 
in response to 1 x 10-~M and 1 x 10-3M AD (see figures II.26e and 
-3 11.26f) • In the case of 1 x 10 M AD after three minutes all (6) 
preparations were • swimming' . At AD concentrations of 1 x 10-6 M and 
1 x 10-SM the return toward the baseline outflow levels was seen within 
5 minutes of the start of infusion in the absence of any swimming 
movements. 
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Injections of AD and NAD of I, 10, and 100 nmoles all resulted in 
secondary decreases in outflow. The magnitude of the falls in outflow 
were rather higher in the case of bolus injections than with continuous 
infusion. Larger estimates of the increase in interstitial volume 
result. Injection of 100 nmoles of AD caused an estimated 5.9% increase 
over ten minutes, and 100 nmoles NAD caused a 10.5% increase over the 
same time. In all but one case of injection of I, 10, 100 nmoles AD 
and NAD there was a trend back toward preinjection outflow levels four 
to five minutes after administration. With bolus injection it must be 
remembered that the drug is continuously being washed out from the 
preparation and so the response should be expected to diminish. 
II. 7.5.3 Discussion 
From the literature on transcapillary fluxes and factors that 
affect these fluxes it is clear that during vasoconstriction, an increase 
in interstitial fluid volume could be expected. Increased weight of 
perfused tails after perfusion with vasoconstrictory drugs provides some 
support for this notion. The time lag between peak arterial pressure 
and peak outflow change was 60-120 s. A similar time lag of 90 s 
between arterial pressure peak and interstitial fluid build up was 
recorded by Poole (1977) in isolated perfused dogfish gills after alloxan 
administration. Alloxan is believed to increase capillary permeability 
(Goetzman and Vischer, 1969). Thus it seems reasonable that the 
observed outflow changes reflect extravasation of perfusate. 
About five minutes after AD or NAD infusion or injection there was 
a trend back toward pre-administration outflows. This probably 
represents equilibration of the vascular bed to a new set of capillary 
exchange conditions whereby higher interstitial pressure increases 
resorFtion at the venous end of the capillaries (Jacobsson and 
Kjellmer, 1964). Swimming movements of the tail with high concentrations 
and doses of AD and NAD probably assist interstitial fluid recovery (Gnepp 
and Sloop, 1978). Although a trend toward greater fluid retention ,with 
increased AD concentration is apparent only a small fall in outflow was 
These small changes in outflow do 
not necessarily imply less extravasation of perfusate. Muscular 
contractions increase venous return in elasmobranch fish (Satchell, 
1965, Birch, Garre, and Satchell, 1969). It is clear that body-
movements augment interstitial as well as blood circulation in the tails 
of fishes. 
At e~evated capillary pressures and transcapillary flows when the 
,) 
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interstitial pressure ano space is increaseo, more lymphatic fluid would 
be formed (McMaster, 1946). Increased lymph production should be 
reflected in increased lymph heart activity. Increased frequency andl 
or strength of contraction could be expected as a response to the 
greater volume of lymph to be handled. Increased venous capillary 
resorbtion and the capacity of the interstitium to buffer the effects of 
increased extravasation of fluid mean that changes in lymphatic flow 
will be considerably smaller than changes in perfusate efflux from the 
capillaries. However the effects on the lymph heart should occur soon 
after the fall in outflow and should occur only when relatively large 
changes in interstitial fluid volume are recorded. 
11.8 The Effects of AD, NAD and ISO upon Lymph Heart Frequency and 
Amplitude 
11.8.1 Introduction 
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Translocation of body fluids in the tails of fish appears to have 
presented problems. Pumps other than the true or branchial heart have 
emerged in all fish classes. The portal venous heart of lampreys 
(Myxine spp.) (see Fange, Bloom and Ostlund, 1963) and the venous tail 
pump in certain elasmobranchs (Birch, Carre and Satchell, 1969) are 
examples of accessory pulsatile structures involved in blood circulation 
(see section 1.6.2) . In addition to these specific mechanisms, skeletal 
muscle contraction assists venous return to the heart (see Carlsten and 
Grimby, 1966). 
Caudal lymphatic hearts actively pump lymph from collecting vessels 
into the blood stream by muscles specifically assigned to this role. 
Whether the fluid pumped by the caudal heart was blood or lymph was 
disputed in the early reports, however Hyrtl (1843 cited in Kampmeier, 
1969) resolved the question and subsequent reports clearly established 
that they do pump lymph (Wharton-Jones, 1868; Favaro, 1905, 1906). 
From these accounts it is clear that one function of the lymph heart is 
to pump lymph, but the significance of this rather small organ in .this 
role has never been investigated. The close proximity of the urophysis, 
which secretes hormones into lymphatic fluids, and the stimulatory action 
of urotensins I and II upon the lymph heart beat of the asiatic eel was 
investigated by Chan (1971). The lymph heart could assist the movement 
of urophysial secretions into the blood stream. Destruction by thermal 
cauterization of the lymph hearts of toads resulted in their death within 
four days (Zwemer and Foglia, 1943). These authors reported that, 
"The failure of oedema fluid to return to the blood vessels in 
these experiments is a primary and uncomplicated cause of death". 
The four anuran lymphatic hearts are large and the lymphatic spaces 
beneath the skin contain much more fluid than in eels (Thorson, 1964). 
Furthermore the multiple connections of the lymphatic vessels of the 
eel with the blood system provide alternative routes for fluid return. 
Eels maintainedinthe laboratory occasionally contracted fungal 
and bacterial infections such as those described by Hine and Boustead 
(1974) . Often the fungus was concentrated at the tip of the tail and 
resulted in the loss of the tip including the lymph heart. If treated 
with 'Furanace' or malachite green these infections usually cleared up 
leaving the fish without a functional lymph heart. These animals 
survived in the laboratory for as long as fish that had not been 
infected. Loss of the lymph heart in the most acute manner was not 
fatal to the short-finned eel. For these reasons the function of, the 
lymph heart was studied by the use of the isolated perfused tail 
preparation rather than by ablation of the heart. 
II.8.2.1 General results 
135 
Lymph heart frequency and amplitude were recorded continuously in 
as many preparations as possible. In some cases no lymph heart beat 
record could be obtained and visual inspection revealed that it was 
inactive. Occasionally records could only be obtained when the tip of 
the transducer was pressed against the overlying skin at a force 
sufficient to produce a sustained depression in the body. This often 
resulted in a gradually diminishing amplitude and rendered the records 
unreadable. To alleviate this the transducer was withdrawn from its 
position between experiments to allow the lymph heart to recover. The 
anaesthetic used (Benzocaine) eliminated lymph heart muscle contraction. 
Thus records of the lymph heart were often absent or erratic for the 
first 15 to 25 minutes 6f perfusion. Records were often erratic when 
preparations were perfused without serum in the ringer. The size of 
the record was always enhanced by the addition of 5% human serum to the 
perfusate (see figure II. 30) • 
After 20 to 40 minutes the lymph heart beat stabilized. Lymph 
heart records were seldom taken during tube perfusion. Where they were 
taken they were invariably of lower frequency and often erratic. This 
may indicate premature commencement of the Q/Pd profile experiments. 
During the course of the experiments on each preparation there was 
no significant change in lymph heart frequency (LHf) as can be seen from 
table II.9. In this table the lymph heart frequency before the 
infusion of each concentration of AD is tabulated. Later it will be 
seen that AD administered in this manner increased both the frequency 
and amplitude of the lymph heart. 
II.8.2.2 Response of the lymph heart to 5% human serum 
Most preparations were either perfused with the basic saline or 
saline containing 5% human serum. In 14 preparations the saline was 
changed from the basic medium to that containing serum. The resistance 
response was biphasic. A small initial drop occurred at 1.6 ± 0.2 
minutes, followed by a rise to reach a peak at 18.4 ± 3.2 minutes, (see 
figure II. 30) • This elevated resistance stabilised to a new baseline 
FIGURE II. 30 Typical reco~d of the response of a perfused eel tail to 
addition of 5% human serum to the perfusate showing 
particularly the changes in lymph heart amplitude. 
Lymph heart frequency also increased after addition of 
serum to the perfusate. 
~ymph Heart Beat 
...... 
5% serum 
V 
-s-:u -Caudal Artery Pressure 
4.5- kPa 
4.0 -
2.0-Caudal vein Pressure 
kPa 
1.5-
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1.0-
11 -Venous Oxygen Tension 
136 
-
h 
10 '~~m~'--______________ -r __ ~~---------r---------
9 
8 
Table 11.9 Mean lymph heart frequency ± 1 S.E.M. (n = 8) 
immediately before the introduction of AD during the course of 
construction of cumulative dose response curves. 
Concentration of AD Mean lymph heart frequency 
± 1 S.E.M. 
1 x 10-8M 62.12 ± 3.8 
1 x 10-7M 63.87 ± 4.0 
1 x 10-sM 63.0 ± 2.17 
1 x 10-sM 66.5 ± 4.07 
1 x 10-4 M 68.2 ± 3.63 
1 x 10-3M 65.6 ± 7.06 
over the following 30 minutes. The relatively long time course of 
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this response and the need to operate the recorder at a high chart 
speed to obtain readable lymph heart records, (25-50 rom per minute) 
prevented continuous recordings of the responses in the interests of 
economy. Only one continuous record was taken from which the 
frequency can be read. In other preparations only occasional records 
were taken or the frequency was not readable leaving only amplitude. 
Efficiency increased during the change to perfusion with serum 
ringer by 2.99 ± 0.38% which was not significant despite its occurrence 
in all but one of the fourteen experiments. Venous oxygen tension 
decreased by 0.26 ± 0.04 ppm (at 10 minutes, n = 4) during the rise in 
resistance but was consistently higher after perfusion with serum ringer, 
(+0.89 ± 0.08 ppm, at 30 minutes, n = 4) . Lymph heart frequency and 
amplitude increased when the preparation was perfused with serum ringer, 
(see figure 11.30). The amplitude change reached a stable level 
between 5 and 10 minutes. Frequency did not start to increase until 
after the first 10 minutes of perfusion with serum ringer. Initial 
lymph heart frequency for preparations perfused with the basic saline and 
saline containing 5% human serum were significantly different, (p < 0.001) , 
the means being 53.54 ± 4.24 (n = 50) and 63.48 ± 5.14 (n = 30) 
respectively. 
The mechanism of these responses is obscure. It could be 
suggested that the presence of serum proteins in the perfusate increases 
the force of contraction of the lymph heart beat by some non-specific 
means, (see section 11.4.4, and Smith and Rozengurt, 1978). The 
frequency increase is likely to result from increased tissue fluid 
FIGURE II. 31 Typical record of response of a perfused eel taLl, to 
perfusion with whole eel blood. Lymph heart frequency 
and amplitude responses were developed more rapidly 
« 120 s) than responses to addition of 5% human serum 
(see figure 11.30). 
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volume and pressure which would occur during the slow resistance rise. 
The frequency of the contractions in the presence of serum was more 
regular than in its absence. These features proved to be essential to 
accurately count the individual beats in the analysis of the records. 
II. 8. 2.3 Response of the lymph heart to whole eel blood 
Six preparations were perfused with whole eel blood previously 
collected from the fish during preparation for perfusion. Blood was 
stored for no more than five hours at 40 C before being used. The 
small quantities collected allowed only brief periods of perfusion (4-6 
minutes) but the response of the lymph heart was striking, (see figure 
II .31) • Resistance increased by 21.05 ± 2.82% or 0.433 ± 0.108 kPa 
ml-1min after 56.2 ± 1.8 s (n = 6). Resistance then fell slightly to 
a plateau level that continued until the blood was replaced with saline. 
Amplitude of the lymph heart record increased to almost twice the 
initial values within the first two minutes and thereafter decreased. 
Lymph heart frequency rose by 5.54 ± 1.70 beats per minute within three 
minutes and remained higher than initial frequencies even after blood 
perfusion ceased, (see appendix A.37) • concomitant with the resistance 
rise was an increase in outflow which stablised at around three to four 
minutes. The outflow increase was maintained after blood perfusion 
ceased and was indicative of an increase in efficiency of - 6.62%, 
despite the fall in resistance which should decrease the outflow. The 
mechanism of this response is also unknown but the direction of the 
changes suggests that some factor or factors in human serum produce 
responses that are similar to those produced by blood perfusion. 
II.8.3 Effects of AD, NAD and ISO upon lymph heart frequency and 
amplitude 
Data on lymph heart frequency and amplitude changes are pooled 
from preparations perfused with and without serum in the ringer. 
Because of different initial lymph heart frequencies mean changes in 
frequency (6LHf) from the initial value were used for the analysis. The 
absolute size of the record in rom was used as a measure of amplitude. 
II. 8. 3.1 Lymph heart and AD administered by constant infusion 
-6 At concentrations of less than 1 x 10 M AD no consistent changes 
in LHf or amplitude were observed. Higher concentrations produced 
increases in LHf and amplitude. Mean changes in LHf and amplitude with 
time during perfusion of AD at concentrations of 1 x 10-6M AD and greater 
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are presented in figure 11.32. Mean changes for all concentrations 
are tabulated in appendix A.38. Time taken for frequency and amplitude 
to peak or reach plateau levels is of the order of five to eight minutes 
after the start of perfusion. Amplitude of the records approximately 
doubled and peaked a minute or so before maximum frequency changes. 
Mean frequency increases of five to ten beats per minute were recorded 
for these higher concentrations. 
11.8.3.2 Lymph heart and AD administered by bolus 
Below 1 nmole AD no consistent changes in LHf or amplitude were 
observed. The greatest mean increase in LHf was 35 beats per minute 
and occurred nine minutes after injection of 10 nmoles AD. Five minutes 
after injection of 100 nmoles AD LHf increased by 15 beats per minute. 
This elevated frequency persisted for at least another ten minutes 
without further increase in the case of 100 nmoles AD, (see figure 11.33 
and appendix A.39) . 
11.8.3.3 Lymph heart and NAD 
Insufficient records of LHf and amplitude during NAD infusion were 
available to construct graphs equivalent to those in figure 11.34. 
Often only intermittent records were taken. Qualitatively however, LHf 
and amplitude increased when high concentrations of NAD were perfused 
through the preparations. Bolus administration of NAD produced results 
similar to those from bolus administered AD, (see figure 11.34 and 
appendix A.40) • The mean frequency increase for 100 nmoles NAD was - 10 
beats per minute and is less than that for 10 and 100 nmoles of AD. 
These responses reached maxima at 5-10 minutes after injection. 
II.8.3.4 Lymph heart and ISO, phentolamine and propranolol 
Infusion or injection of ISO at concentrations or doses less than 
1 x 10-qM and 10 nmoles respectively produced small and unpredictable 
changes in lymph heart frequency and amplitude, despite extensive 
records. When large quantities of ISO were administered consistent 
small increases in LHf and amplitude comparable to those of AD and NAD 
were observed. The cause of these responses is believed to be the alpha 
constriction rather than beta stimulation which resulted from very high 
concentrations and doses of ISO. 
Phentolamine and propranolol both reduced lymph heart amplitude, 
but had no effect on lymph heart frequency. Amplitude increases in 
response to alpha agonists occurred slightly before frequency responses 
FIGURE II.32 Changes in lymph heart frequency and amplitude during 
infusion of adrenaline at concentrations between 1 x IO-aM 
Mean initial lymph heart frequency and 
mean changes in lymph heart frequency and amplitude are 
tabulated for all concentrations in appendix A.38. 
Amplitude changes occurred before frequency changes. 
a. Changes in lymph heart frequency during infusion of 
I x IO-~ adrenaline. 
b. Changes in lymph heart frequency during infusion of 
1 x IO-7M adrenaline. 
c. Changes in lymph heart frequency during infusion of 
I x IO-6M adrenaline. 
d. Changes in lymph heart amplitude during infusion of 
I x lO-6M adrenaline. 
e. Changes in lymph heart frequency during infusion of 
I x IO-sM adrenaline. 
f. Changes in lymph heart amplitude during infusion of 
I x IO-sM adrenaline. 
g. Changes in lymph heart frequency during infusion of 
I x IO-*M adrenaline. Histogram on abcissa 
inaica tes the number of preparations 'swimming' 
(see right hand ordinate) • 
h. Changes in lymph heart amplitude during infusion of 
i. 
Histogram on abcissa indiates 
the number of preparations 'swimming' (see right hand 
ordinate) • 
Changes in lymph heart frequency during infusion of 
I x IO-3M aarenaline. Histogram on abcissa 
inaicates the number of preparations 'swimming' (see 
right hand ordinate) . Because of the 'swimming' 
response it was not possible to measure lymph heart 
amplitude during infusion of I x IO-3M adrenaline. 
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FIGURE II. 33 Ch,qnges in lymph heart :J;requency with time after injection 
of 1, 10 and 100 nmo1es adrenaline. Mean initial lymph 
heart frequency and mean changes in lymph heart frequency 
for these doses are tabulated in appendix A.39. 
a. Changes in lymph heart frequency with time after 
injection of 1 nmo1e adrenaline. Lymph heart 
frequency changed little in response to doses less 
than 1 nmo1e. Note that ordinate scale is five times 
that of the following two graphs, b/c. 
b. Changes in lymph heart frequency with time after 
injection of 10 nmo1es adrenaline. 
c. Changes in lymph heart frequency with time after 
injection of 100 nmo1es adrenaline. 
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FIGURE 11.34 Changes .in lymph heart trequency and amJ?litude with time 
after injection of I, 10 and 100 nmoles of noradrenaline. 
Mean initial lymph heart frequency and amplitude and mean 
changes in frequency and amplitude for these doses and 
500 pmoles are tabulated in appendix A.40. 
a. Changes in lymph heart frequency with time after 
injection of 1 nmole noradrenaline. Lymph heart 
frequency and amplitude changed little in response 
to doses less than 1 nmole, (see appendix A.40) • 
b. Changes in lymph heart frequency; with time after 
injection of 10 nmoles noradrenaline. 
c. Changes in lymph heart amplitude with time after 
injection of 10 nmoles noradrenaline. 
d. Changes in lymph heart frequency with time after 
injection of 100 nmoles noradrenaline. 
e. Changes in lymph heart amplitude with time after 
injection of 100 nmoles noradrenaline. 
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(see figures II.32-II.34), and when combined with the observations of 
Davie, (1975; see section I.4.3) indicate positive ionotropic responses 
resulting from adrenergic stimulation of some part of the control system 
of the lymph heart. Reduction of lymph heart amplitude by phentolamine 
and propranolol may be due to alpha blockades since evidence of partial 
alpha antagonistic activity by propranolol has been produced, (see 
section II.6.3.4) • That ISO has no effects upon lymph heart frequency 
or amplitude indicates that propranolol induced amplitude depression is 
not the result of beta blockade. As the alpha antagonistic potential 
of phentolamine is greater than propranolol a larger drop in lymph heart 
amplitude in response to phentolamine could be expected. In fact from 
the few complete sets of records available, propranolol reduces lymph 
heart amplitude relatively more than phentolamine. A possible 
explanation of lymph heart amplitude depression by propranolol is 
provided by Larsen and Teravainen (1978) who reported that d- and 1-
propranolol have curare like effects upon cholinergic nerve terminals. 
Since lymph heart muscle appears to be excited by cholinergic nerves 
this may be significant (see section I.6.1} • Larsen and Teravainen (1978) 
reported that propranolol reduces only the size of the response and 
leaves the time course and resting muscle potential unaffected. 
Clearly there is still much to be learnt about the pharmacology 
of the lymph heart, and since amplitude records of lymph heart beat 
in this preparation are rather unreliable, further discussion is 
unwarranted. 
II.8.4 Discussion of the function of the lymph heart 
Measurement of the outflow rate changes (during administration of 
drugs) allows estimation of changes in vascular and extravascular 
volumes. The two components can be separated by their different time 
courses and directions during vasoconstriction. Vascular volume 
adjustments occur rapidly « 120 s), and are decreases. They occur 
simultaneously with resistance changes. Extravascular volume increases 
when AD and NAD are given, and peaks at three to five minutes after drug 
introduction, (see section II.7.S). Increases in extravascular fluid 
could be expected to increase lymph heart output since this is one route 
for the return of tissue fluid to the vascular system. However lymph 
heart activity could be directly influenced by the drugs AD and NAD. 
If AD or NAD directly affects lymph heart activity then the 
response could be expected at or near the time that the drug contacts the 
lymph heart tissue. The rapid perfusion of the tail vessels, including 
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those of the lymph heart muscles (- 90 s, see section II.5.4), and the 
short time taken for the resistance vessels to reach maximal 
constriction, (60-90 s) clearly shows that the drugs reach the lymph 
heart tissue within two minutes. Maximal lymph heart frequency 
increases occur at seven to nine minutes after the introduction of 
high doses of AD administered by bolus or constant infusion. Likewise 
frequency reaches maxima five to ten minutes after injection of 1, 10 
or 100 nmoles NAD, (see table II.10). Chan (1971) recorded lymph 
heart frequency after injection of approximately 30 nmoles of either 
AD or NAD into asiatic eels. A peak increase in LHf of 23 beats per 
minute was reported after 25 minutes. The time lag between contact of 
Table II .10 Time (minutes) taken to reach peak resistance, 
outflow and lymph heart changes in response to AD and NAD. 
Adrenaline (perfusion line) 
Resistance 
80Q 
8LHf 
Adrenaline (bolus) 
Resistance 
80Q 
8LHf 
2.33 
5.0 
7.0 
1 nmole 
0.975 
3.0 
7.0 
Noradrenaline (bolus) 
Resistance 
1 nmole 
1.61 
3.4 
5.0 
2.16 
5.0 
6.0 
10 nmoles 
1.18 
3.5 
9.0 
10 moles 
1.54 
3.0 
6.0 
1.56 
5.0 
8.0 
1.24 
3.0 
100 nmoles 
1.13 
4.0 
5.0 
100 nmoles 
1. 74 
4.0 
10.0 
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the drug and the lymph heart tissue and the activity change of the 
lymph heart, needs some explanation. When eel blood was perfused 
through the preparation, LHf and amplitude increased within two minutes, 
(see section 11.8.2.3) • Thus natural blood borne stimulators, (what-
ever their nature) are capable of inducing rapid increases in frequency 
and amplitude. This rapid type of response was not observed when AD 
and NAD were given. Amplitude changes reported here occurred before 
frequency changes. Thus amplitude may be controlled by a different 
+ + 
mechanism to frequency, perhaps by stimulation of the Na /K pump of 
the muscle cells (see Akasu, Ohta and Koketsu, 1978). The recorded 
changes in frequency appear to be the result of other than direct 
action of AD and NAD. Increases in frequency of the lymph heart of the 
asiatic eel in response to 5-HT were rapid and dose dependent (Chan, 
1971) . Although Chan suggested that the action of 5-HT was likely to 
be upon some part of the neural control circuit of the lymph heart, it 
is possible that 5-HT induced capillary permeability increases (Myhre, 
steen and Stray-Pedersen, 1976) may have been partly responsible for 
the frequency response. 
Increases in extravascular fluid volume and pressure appear to be 
logical causes for LHf increases in response to AD and NAD. Lymph 
heart frequency increases occurred only at high concentrations or doses 
of AD and NAD. Likewise significant changes in extravascular fluid 
also occurred only under these conditions. Table II.IO shows that the 
peak increase in extravascular volume occurred before the peak lymph 
heart frequency changes under all conditions. Should lymph heart 
frequency have increased before extravascular volume then the hypothesis 
would have had to be rejected. To look at the relationship between 
lymph heart frequency and extravascular volume the hypothesis that AD 
and NAD caused increased extravascular fluid build up and that this 
subsequently elevated lymph heart frequency was formed. To test this 
hypothesis the cumulative decreases in outflow after the .initial 
vascular volume adjustment, were calculated at each minute and are taken 
to reflect progressive increases in extravascular fluid volume. Out-
flow changes (~OQ) were then plotted against mean changes in lymph heart 
frequency, (~LHf). A model II type regression, where the independent 
variable is measured with significant error, was used to analyse the data 
and determine if a significant relationship existed between ~OQ and ~LHf, 
(Simpson, Roe and Lewontin, 1960). 
The graph of mean ~LHf versus mean cumulative ~OQ for each minute 
of perfusion with AD at concentrations of 1 x 10-6M AD and greater is 
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presented in figure 11.35. There is a significant relationship (P < 
0.05) between the two variables which is described by the equation 
with the figure. When the data were not pooled, only 1 x 10-sM AD 
revealed a significant relationship, (p < 0.05). Likewise the mean 
nIsf and mean cumulative AOQ for each minute after injection of 1, 10 
and 100 nmoles AD were treated in the same manner. There is a 
significant relationship between the two variables, (P < 0.05, see 
figure II.36). At each individual dose only 10 nmoles AD produced a 
significant relationship, (P < 0.05). The data from 100 nmoles AD 
are significantly related when the natural logs of each of the variables 
are taken, (p < 0.01) . 
For bolus administration of 1, 10, 100 nmoles NAD the pooled data 
yield a significant linear relationship between the changes in lymph 
heart frequency and cumulative changes in outflow rate, (P < 0.05, see 
figure II. 37) • At none of the individual doses is the relationship 
significant. 
The correlation coefficient for ALHf versus AOQ for all data 
from AD administered by the perfusion line and as a bolus, and NAD as 
a bolus was computed and is equal to 0.399 which is a significant 
correlation at p < 0.01, for 77 data point pairs. 
equation for all pooled data is 
ALHf - 19.23 AOQ + 0.1549 
The regression 
The slopes of the regression lines are not significantly different 
for the data from infused AD and injected AD. This suggests that the 
change in lymph heart frequency per unit change in extravascular volume 
is not dependent upon the method of administration of the drug. 
At this point it is interesting to do some arithmetic on the 
volumes of fluid transported by the lymph heart. From the dimensions 
of the lymph heart (see section 1.4.3) the volume of the lymph heart 
when distended has been estimated by the volume displacement of a scale 
model to be between 0.16 \.1l and 0.35 lll. At an average resting 
frequency of 58 beats per minute this would result in the replacement of 
9-20 ~l of lymph into the caudal vein per minute. This calculation 
assumes that all the fluid contained in the heart is expelled. In an 
average sized fish of say 400 g the extravascular extracellular fluid 
volume of the tail would be about 20 mI. Thus the lymph heart could 
pump the entire tail interstitial volume in 16 to 37 hours, which is 
comparable to the times for lymph circulation in mammals (Mayerson, 1962). 
FIGURE II. 35 Me.an changes in lymph heart frequency versus mean cumulative 
changes in venous outflow during infusion of adrenaline at 
concentrations between 1 x 10-6M and 1 x 10-3M• Linear 
model two type regression (Bartlett's 'best fit' method 
where both variables are measured with significant error) 
gave the fitted line which has the equation as follows, 
6LHf = -18.56OQ - 0.0332 
Student's t-test value for the significance of the single 
regression was = 2.977, for 7 d.f., which is significant 
at p < 0.05 (to.05 [7] = 2.365) 
1:. 1 x 10-6M AD 
II 1 x 10-sM AD 
A 1 x 10-4M AD 
o 1 x 10-3M AD 
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FIGURE 11.36 Mean changes in lymph heart frequency versus mean 
cumulative changes in venous outflow after injection of 
adrenaline at doses of 1, 10 and 100 nmoles. Linear 
model two type regression (Bartlett's 'best fit' method 
where both variables are measured with significant 
error) gave the fitted line which has the following 
equation, 
~LHf = -21.9~OQ + 6.38 
Student's t-test value for the. significance of the single 
regression was = 3.329, for 7 d.f., which is significant 
at p < 0.05. (to.OS [ 7] = 2.365; t o.OI[ 7] = 3.499). 
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FIGURE II. 37 Mean changes in lymph heart frequency versus mean 
cumulative changes in venous outflow after injection of 
1, 10 and 100 nmoles noradrenaline. Linear model two 
type regression (Bartlett's 'best fit' method where both 
variables are measured with significant error gave the 
fitted line which has the following equation, 
~LHf = -8.09~OQ + 0.958 
Student's t-test for the significance of the single 
regression was = 7.957 for 9 d.f. , which is 
significant at P < 0.001 level. (to.OOl [9] = 4.781). 
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The lymph heart responses that occurred when venous outflow 
decreased are significantly correlated. We can calculate the amount of 
extravascular fluid replaced after extravasation of a set amount of 
perfusate. For example, for each 0.1 ml of fluid lost to the tissue, 
lymph heart frequency increased by approximately two beats per minute. 
From the above figures, - 0.7 ~l of fluid would be replaced into the 
blood stream for every 100 ~l that are lost. Despite the rather gross 
assumptions about the volumes pumped by the lymph heart it is clear that 
the lymph heart would have to maintain elevated frequency and/or 
amplitude for a long time to significantly reduce the excess extravascular 
fluid produced in the conditions described in these experiments. In 
the absence of muscular contractions which would increase lymph flow to 
the lymph heart, these results are probably conservative and reflect a 
volume buffering capacity of the interstitium and lymph vessels 
(Jacobson and Kjellmer, 1964; Gnepp and Sloop, 1978). 
I believe however that the experiments described here show that one 
of the functions of the lymph heart is to assist in removal of extra-
vascular fluid in the face of impending oedema, and replace this fluid 
into the blood stream. The mechanism by which lymph heart frequency 
and perhaps amplitude increased in response to extravasation is unclear, 
although an hypothesis can be formed, and the chain of events could be 
envisioned as follows. Adrenaline or noradrenaline, when introduced 
into the preparation cause vasoconstriction thereby increasing the 
capillary pressure and permeability resulting in extravasation of 
perfusate. Build up of extravascular fluid volume and pressure results 
in greater lymphatic flow toward the lymph heart driven by higher 
extravascular and lymphatic fluid pressures. This flow would persist 
after the removal of AD or NAD because the extravascular fluid volume 
may increase in response to these drugs. Greater volumes of lymph 
reaching the lymph heart at higher pressures will increase distension 
of the lymph heart when filling. Lymph heart frequency is controlled 
by the frequency of the pulses of motor impulses transmitted from the 
spinal cord above the rostrally adjacent vertebra to the lymph heart 
muscle via the lymph heart nerve, (see section 1.5). When the lymph 
heart muscles are mechanically distended sensory spikes are observed in 
the lymph heart nerve. Thus by a simple neural feedback loop the 
frequency of the lymph heart could be modulated by changes in extra-
vascular fluid volume. 
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II. 9 Summary 
1. The arterial and venous blood system of the short-finned eel tail 
is described with detail of the blood and lymphatic vasculature in the 
seven most posterior vertebral segments of the tail which include the 
caudal lymphatic heart (section II.2) • 
2. An isolated saline perfused eel tail preparation is described which 
took approximately 30 minutes to prepare (section II.3) . Vascular 
resistance of this preparation was relatively constant during 
experiments and was free from gradually increasing baseline resistance 
with time, indicative of deterioration of the vascular bed. 
Approximately 87% of the perfusate pumped into the preparation emerged 
from the venous cannula. All tail vessels were well perfused with a 
circulation time through the tail of 60-90 s (section II.5.5). Perfusion 
by either the vertical tube method or by peristaltic pump gave estimates 
of vascular resistance that were not significantly different (section 
II.5.4). 
4. Mean baseline resistances from 86 perfused tails at caudal venous 
pressures of zero and 1.33 kPa, with and without·serum added to the 
perfusate are given in table II.l. These values agree well with the 
few in vivo measurements of trans-tail pressure differentials. Base-
line resistance was inversely proportional to the weight of the tissue 
perfused. Increased venous pressure decreased resistance by 
approximately 10% per 0.5 kPa increment. 
5. Addition of small amounts (3% or 5% vol./vol.) of human serum to 
the perfusate significantly increased baseline resistance. This 
increase in vascular tone was principally due to the high molecular 
weight (> 12000) molecules (section II.5.3). Serum in the perfusate 
conferred a degree of autoregulation of resistance to the preparations 
and increased responsiveness to catecholamines. Although serum in the 
perfusate increased responsiveness to catecholarnines, it had little 
effect upon estimates of pharmacological parameters such as ED50 
(section II.6.3.1) . 
6. Dose versus resistance response curves for adrenaline, noradrenaline 
and isoprenaline, either infused at constant concentrations in the 
perfusate or injected as 0.1 ml boli are presented. Summaries of data 
from these curves are presented in tables II.3 (infusion) and II.4 
(injection) . Administration method did not appear to alter the response 
magnitude to the same molar quantity of drug (section II.6.3.3). 
7. Adrenaline and noradrenaline caused increased tail vascular 
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resistance (vasoconstriction) at all concentrations and doses tested. 
Isoprenaline caused decreased resistance (vasodilation) at concentrations 
below 1 x 10-4M and at all injected doses tested. Concentrations of 
1 x 10-4M and 1 x 10-sM isoprenaline, increased resistance. 
8. Adrenaline was 1.14 to 4.31 times more potent a vasoconstrictory 
drug than noradrenaline (section II.6.3.2) • 
9. On the basis of the potency comparisons of these three drugs and 
additional evidence from the use of selective adrenergic antagonists 
(section II.6.4) the eel tail vascular bed was found to contain alpha 
constrictory and beta two dilatory adrenergic receptors. 
10. Responses of the eel tail to exogenous catecholamines suggest that 
control of vascular resistance in the eel tail is of a dual nature. 
Circulating catecholamines elevate resistance and sympathetic nervous 
activity probably decreases resistance (section II.6.6). 
11. The vascular volume of the perfused eel tail preparation was 
approximately 3.1 ml per 100 g tail weight (section II.7.2). The 
decrease in tail vascular volume during vasoconstriction was less than 
2% of the eel tail vascular volume for any concentration or dose of 
adrenaline or noradrenaline. Increases in vascular volume during 
isoprenaline mediated vasodilation were less than 1%. The size of the 
changes in vascular volume is explicable in terms of the changes in 
volume of the precapillary resistance vessels (section II.7.4). 
12. Mean increases in interstitial volume during infusion of adrenaline 
-6 
at concentrations greater than 1 x 10 M were less than 3% of the 
estimated interstitial volume of the perfused eel tail preparation. 
Injection of doses of adrenaline and noradrenaline greater than 1 nmole 
caused mean increases of less than 11% of the estimated interstitial 
volume. Isoprenaline caused small and inconsistent changes in 
interstitial volume at concentrations below 1 x 10-4M (section II.7.5). 
Changes in interstitial volume appear to be the result of extravasation 
of perfusate at high luminal pressures during vasoconstriction. 
13. Lymph heart frequency was reliably and accurately recorded in this 
preparation by a non-invasive technique. Because of the nature of the 
recording apparatus, lymph heart amplitude was recorded with limited 
accuracy. Mean initial lymph heart frequency was 53.5 and 63.5 beats 
per minute when the preparations were perfused without and with serum 
added to the perfusate respectively. Lymph heart frequency did not 
change significantly throughout the life of a preparation between 
experimental manipulations. Lymph heart frequency and amplitude 
increased in response to 5% serum in the perfusate (sect~on II.8.2.2) . 
Lymph heart frequency and amplitude increased when whole eel blood 
was infused into the preparation (section II.S.2.3). 
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14. Lymph heart frequency and amplitude increased when high concen-
trations (> 1 x lO-6M) and doses (> 1 nmole) of adrenaline and 
noradrenaline were administered. Isoprenaline at concentrations which 
caused dilation elicited no response from the lymph heart. At high 
concentrations (> 1 x lO-~M) slight increases in lymph heart frequency 
and amplitude were recorded. Adrenergic antagonists had little 
effect on lymph heart frequency although amplitude was depressed. 
Lymph heart amplitude may be increased by alpha adrenergic stimulation 
(section II.S.3) • 
15. Lymph heart frequency increases were significantly correlated with 
increases in interstitial fluid volume. One function of the lymph 
heart is to assist in recovery of extravasated fluid. 
PART III 
111.1 Introduction 
CARDIOVASCULAR RESPONSES TO SWIMMING 
IN THE SHORT-FINNED EEL 
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The study of circulatory responses to exercise in teleosts has led 
to significant contributions to our understanding of teleost cardiovascular 
homeostasis. Information from isolated perfused vascular preparations 
(see Wood, 1974a, 1975) and changes in plasma catecholamine concentrations 
during stress (see Mazeaud et al., 1977) have supported the hypothesis 
that resistance to blood flow in various vascular beds is controlled by 
circulating catecholamines (see Randall and Stevens, 1967; Burnstock, 
1969) . The ability of this hypothesis to explain cardiovascular responses 
to exercise is briefly considered here. 
Two sets of experiments have been reported where cardiac output and 
pressures in ventral and dorsal aortas have been measured in rainbow 
trout during swimming by Randall and Stevens (1967), Stevens'and Randall 
(1967a,b) and more recently by Kiceniuk and Jones (1977). Both of these 
studies revealed increases in cardiac output and decreases in branchial 
and systemic resistances during swimming. Cardiac output increases of 
2-4.5 fold are sufficient to account for the fall in branchial resistance 
in terms of passive distensibility, provided that there was no vascular 
tone already present which could limit distension (Folkow and Lofving, 
1957) . The large number of reports of decreased branchial resistance 
in response to exogenous catecholamines in both isolated gills (Wood, 
1974b) and holobranchs (Rankin and Maetz, 1971) and in vivo (Randall 
and Stevens, 1967) indicate that there is resting vascular tone in the 
branchial vessels. Isolated gill and holobranch preparations give 
resting values of branchial resistance that are similar to, or greater 
than, measurements of branchial resistance in vivo. Thus resting 
vascular tone in the gills seems not to be maintained by circulating 
catecholamines or by sympathetic nervous activity. Perhaps the 
structure of the gill vessels is such that it provides the resting 
vascular tone upon which dilatory responses are superimposed. The 
predominant response of the gills to catecholamines is beta one 
mediated adrenergic dilation, thus it has been proposed that elevated 
blood catecholamine concentrations caused the fall in branchial 
resistance during exercise. 
Swimming in trout is associated with a rise in dorsal -aortic 
and venous pressures. Dorsal aortic venous pressure differentials 
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when divided by the proportionally greater blood flow rates during 
exercise indicate falls in systemic resistance. Although slow release 
of lactate from muscles in exercising fish may indicate low blood flow 
rates within skeletal muscle (Black et aI, 1959; Driedsic and Kiceniuk, 
1976), Stevens (1968) found no significant differences in blood 
distribution with exercise in rainbow trout, thus we have no evidence to 
suggest redirection of blood away from the swimming muscles during 
swimming. In this species, as in mammals (Folkow, 1960), systemic 
vascular tone is probably maintained by sympathetic nervous activity 
(Wood, 1974b; Smith, 1978). Since the predominant response of the 
systemic vasculature to catecholamines is alpha mediated constriction, 
(Wood and Shelton, 1975) elevated catecholamine concentrations are 
unable to explain the falls in systemic resistance with exercise 
reported by Randall and Stevens (1967), stevens and Randall (1967a,b) 
and Kiceniuk and Jones (1977). The hypothesis outlined in the first 
paragraph clearly needs re-examination. The systemic resistance 
decreases could be due to a number of mechanisms such as decreased 
sympathetic tone, passive distensibility at elevated luminal pressures 
or local dilation caused by metabolites. 
Salmonids should be good subjects for exercise physiology studies 
in fishes because of their naturally active behaviour. Stevens, 
Bennion, Randall and Shelton (1972) provided data from the lingcod, 
(Ophiodon eZongatus), during brief swimming activity. Cardiac output 
fell during swimming, the cause of which was suggested to be vagal 
inhibition of heart activity. This response. was similar to a 
'disturbance' reaction and may not reflect a response to exercise. 
Blockade of vagal inhibition by atropine resulted in 1.25 to 2 fold 
increases in cardiac output during swimming activity. Associated with 
swimming were decreases in branchial resistance and increases in 
peripheral resistance. It is unfortunate that these authors had no 
means of inducing sustained swimming in their fishes. The initial 
brc;:tdycardia may have been overcome as the metabolic demands of exercise 
increased with time. The results from unatropinised lingcod are in 
contrast with those from trout but are hardly comparable. 
Johansen, Franklin and Van Citters (1966) reported that blood 
velocity in the ventral aortas of various elasmobranch species changed 
little during periods of exercise of up to 30 minutes. They also noted 
that after swimming there was an increase in ventral aortic blood flow. 
The results from lingcod and elasmobranchs suggest a different 
pattern of responses from those observed in trout, but the limited data 
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available provides only tentative answers as to how these responses 
were invoked. Clearly more species need to be studied to establish the 
array of events that actually occur. 
At times of high oxygen demand, changes in the pattern of blood 
flow through the gills so as to increase gas exchange have been suggested 
(Hughes and Morgan, 1973). These changes might be reflected as changes 
in branchial resistance. In this section short-finned eels were swum at 
two speeds for periods of 30 minutes or more while cardiac output, 
ventral aortic pressures, dorsal aortic pressures and caudal venous 
pressures were recorded. These data should indicate any changes in 
resistance across the gills and tail vascular beds and provide a 
suitable comparison for the data from Randall and Stevens (1967), Stevens 
and Randall (1967a,b) and Kiceniuk and Jones (1977). They should also 
provide information on the possible participation of plasma 
catecholamines in the observed responses. 
The experiments described in this section (III) are the result of 
combined work by Dr M.E. Forster and P.S. Davie with technical 
assistance from Ms H.J. Sterritt. The nature of the project 
particularly the surgery, required the combined efforts of all three 
participants. In so far as the design and interpretation of 
experiments is concerned, equal contributions were made by Dr M.E. 
Forster and P.S. Davie. 
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III. 2 Materials and Methods 
III.2.1 Test apparatus 
The experimental tank was similar to that described by Priede 
(1974), (see figure III.l). Oxygen tension was determined with a 
Beckman Field Lab Oxygen Analyser with 3995 O2 sensor and found to be 
95-100% air saturated. The upstream half of the experimental chamber 
was covered with a black cloth to eliminate visual disturbances to the 
fish. 
Each fish was placed in the experimental chamber and forced to 
swim against a current for a period of at least three hours, on the 
day prior to surgery. At this time the stainless steel grids were 
electrified and mild shocks administered if the fish failed to maintain 
station. 
Measuremehts of water temperatures of the river at collection and 
of the holding tanks were between l5.50 C and l7.0oC. Water in the 
flume was maintained at mean temperature of 16.78 ± 0.17oC. 
III. 2 .2 Surgical procedures 
Eels were anaesthetised in a 0.04% solution of benzocaine in 
water. Throughout surgery the gills were irrigated with an aerated 
solution of anaesthetic (0.008%), pumped into the buccal cavity by a 
peristaltic pump (Cole Parmer, Masterflex) • After surgery the gills 
were irrigated with tap water until opercular movements started. 
The ventral aorta, dorsal aorta and caudal vein were cannulated 
with the fish in a supine position and the three cannulae were securely 
anchored to the body wall and were tied together at intervals to 
minimise tangling. The caudal vein was cannulated via one of its 
branches which was dissected free of the connective tissue sheath of 
the right-hand side of the kidney, just caudal of the vent. The free 
end of the cannula lay in the caudal vein, about 0.5 em cephalad of 
the first haemal arch, and pointing upstream. The dorsal aortic 
cannula was tied into the gonadal artery after that vessel was 
dissected free of the overlying (i.e. ventral) pneumogastric artery. 
The free end of the cannula lay in the lumen of the dorsal aorta, 
pointing upstream. The ventral aortic flow probe and cannula was tied 
into the ventral aorta between the bulbus arteriosus and first afferent 
branchial arteries, effectively replacing c. 1.5 cm of the blood vessel. 
The ventral aorta was exposed by a ventral incision through the 
FIGURE II!.1 Diagram of flume :f;or swimminSJ :f;ish. The straight cnannel 
was 140 cm long, 20 em deep and 15 cm wide and was bounded 
at both ends by stainless steel grids which could be 
connected to a 45 V A.C. source. 
water was forced around the flume by a 1 h.p. Davies S.P. 
pump. Water speeds were measured with a Kent Lea Mini 
Flo Probe and. could be varied by a valve on the pump outlet 
between 0 and 50 cm s. Two vanes at the upstream end of 
the experimental chamber were adjusted to minimise 
turbulence and remove flat spots through the chamber. 
Water was constantly replaced by tap water from .an 
artesian supply. c.d, constant level drain; c.i, 
constant temperature water inflow; e.g, electric grid; 
f.c, flow control valve; g, grid to smoothen flow; m, 
motor and pump; p.i, and p.o, pump inflow and outflow; 
p.p, perspex panel for observation; v, vanes to direct 
flow. 
g 
c.i -----------------~ 
c.d.---------~~ 
p.i. ,p.o.---------""'-----
m 
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mesentery separating the two sets of opercular muscles. Strong finger 
pressure applied to the heart, through the body wall, at the time that 
the incisions were made in the ventral aorta, prevented blood loss from 
the aorta. Thus blood loss was limited to that volume held in the 
ventral aorta. It was also necessary to clamp the downstream end of 
the ventral aorta to prevent backflow of blood. 
The cannulae were filled with a fresh water eel saline (Rankin 
-1 
and Maetz, 1971) to which was added heparin (100 i.u. ml , ammonium 
salt, Sigma Chemical Co.) . After surgery the fish were injected via 
the caudal vein cannula with 1 mg heparin in 0.2 ml Ringer's solution 
at 12 hr intervals. While not recording the cannulae were plugged 
with short lengths of wire. 
The fish were placed in the flume and their condition checked at 
frequent intervals to minimise tangling of the cannulae. During 
recovery and at rest a low rate of flow « 5 cm sec-l) was maintained 
in the experimental chamber. 
lII.2.3 The flow probe 
The principle of the thermal flow probe is as follows. A heated, 
temperature-dependent resistor is suspended in the fluid stream. The 
temperature and thus resistance of the heated bead is proportional to 
the cooling effect of the fluid moving over its surfacei the faster the 
flow the greater the cooling. A constant voltage is applied to the 
circuit and changes in resistance are monitored as voltage changes across 
a stable resistor in series with the thermistor. This voltage was 
compared to a control circuit and plotted directly as a voltage on the 
chart recorder. 
The flow probe was a polyethylene T piece with two temperature-
dependent resistors protruding into the lumen, their surfaces being 
siliconised (see figure III. 2). An outer nylon sheath was cemented 
around the probe to provide mechanical support. A cyano~acrylate 
adhesive (Loctite) was used throughout the construction and further 
support was added with epoxyresin (Araldite). Ventral aortic pressure 
was measured through the cannula (Portex PP160) which opened into the 
centre of the probe. The upstream thermistor (Phillips 3K3 NTC 
resistor) was used to record blood temperature while the downstream 
thermistor (Phillips lKS NTC resistor) was heated and measured flow. 
Power output of the bead was 30.5 mW at lSoC. The change in blood 
temperature as measured by the upstream thermistor after activation of 
the flow meter was 0.2 ± 0.0930 C (n = 14). 
FIGURE III. 2 Diagram of flow probe. A constant voltage was applieq 
across the downstream thermistor. The current which 
passed through this temperature dependent resistor heated 
the bead. Fluid flow over the surface of the bead cooled 
the resistor producing flow dependent changes in resistance. 
Changes in resistance were recorded as voltage changes 
across a stable resistor in series with the thermistor. 
The upstream thermistor was used to record blood 
temperature. 
thermistor. 
d. t;, downstream thermistor; u.t, upstream 
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The flow probe was calibrated against three fluids. The first 
was eel Ringer's solution with 10 g l-lpvp (MW 360,000, Sigma Chern. Co.) 
added to create a viscosity approximately halfway between that of ' 
short-finned eel blood and plasma. The second fluid was a 13 g 1-1 
solution of PVP in water, approximating the bulk viscosity of eel blood. 
In the third case the flow probe was perfused with 45 ml of freshly 
collected eel blood. Fluid was delivered with a peristaltic pump at 
three different stroke volumes (Cole Parmer, Masterflex) and flow rates 
were measured gravimetrically at the outflow. The fluid reservoir, 
flow probe and heat exchange coil were immersed in a constant temperature 
water bath during calibration. Flow rates in ml min- 1 were plotted 
against voltage at 0.50 C intervals between l50 C and lSoC. Nomograms 
were constructed from the isothermal flow/voltage profiles, where the 
displacement of the curve on the voltage axis was directly proportional 
to the ambient temperature. Thus for a given temperature, measured 
with the probe, the voltage reading corresponds to a particular flow 
rate in ml min-I. 
The curve was hyperbolic, asymptotic to infinite flow and zero 
voltage and was therefore less accurate at flow rates below 1.0 ml min- I 
The accuracy of the flow probe was estimated 
over a range of pump delivery rates encompassing the flows recorded in 
the fish. The flow calculated from the nomogram was compared to 
gravimetric flow. The mean error was 4.S6% and 95% of the calculated 
flows fell within 12.2% of the gravimetric value. No detectable 
difference was observed on substitution of 13 g 1-1 PVP solution for FW 
eel Ringer's solution with 10 g 1-1 pvp added. Eel blood pumped through 
the probe in one trial produced an apparent decrease in flow of 3.5%. 
To guard against the possibility that fibrin deposition on the 
resistor bead might alter the sensitivity of the flow probe it was 
taken from two fish after trials and its performance was tested 
immediately after exposure to the fish's blood. There was no displace-
ment of the calibration curve. Additionally, microscopic checks gave 
no evidence of fibrin deposition. 
The presence of the flow probe in the ventral aorta will contribute 
to the total resistance of the vascular system. The pressure differential 
across the flow probe was determined under conditions of constant 
pulsatile flow and the total resistance calculated to be 0.059 kPa 
ml min-I. 
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III.2.4 Pressure measurement 
Bell and Howell type 4-327-0010 transducers were used in the 
measurement of blood pressures. The cannulae were all c. 1.5 m in 
length. The performances of the transducers and cannulae were 
examined by the free-vibration method (McDonald, 1974). The 
resonant frequency of the ventral aortic transducer and cannula (Portex 
PP160) was 5.9 Hz with a damping of 39% of critical. The resonant 
frequency of the dorsal aortic transducer and cannula (Portex PP50) was 
3.8 Hz and damping was close to 100% of critical. The caudal venous 
transducer and cannula (Portex PP60) had a tapered tip and was slightly 
overdamped. Thus while we could accurately record mean pressures in 
all three blood vessels cannulated the pulse pressures recorded for 
dorsal aorta cannot be considered reliable estimates. 
III. 2. 5 Experimental protocol 
Wi th two exceptions recorded below, the fish were allowed 18 hr to 
recover from the effects of surgery. During experiments, pressures and 
flows were monitored continuously on a chart recorder (Devices MX4) • 
Records were taken before exercise, when swimming against an imposed 
current and at rest after exercise. If during swimming trials ~n eel 
persistently failed to maintain station, the water velocity was reduced 
to the resting value and the fish allowed to recover. The earliest 
record of swimming was obtained 10 hr after the end of surgery, and the 
latest 48 hr after surgery. 
For all fish branchial resistance (Kb) has been calculated by 
dividing the pressure differential between the ventral and dorsal aortas 
(~Pg in kPa) by the cardiac output (Q in ml min-I). Student's t-test 
was used to establish the significance of paired differences. 
are given as mean ± 1 sample standard error of the mean. 
Values 
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III. 3 Results 
Records were obtained from ten eels. Six eels responded to 
increases in water velocity by swimming and data presented here is from 
14 trials using these fish. Fish were tested at two different 
swimming velocities. This resul ts section is divided into five parts. In 
part 111.3.1 data from resting eels before swimming is presented. In 
part 111.3.2 data derived from eels swimming at 15 cm s-1 is presented. 
This corresponds to a swimming speed of around 0.25 body lengths per 
second. Part 111.3.3 describes data from fish swimming at 22-25 em s-l. 
Following the test period one fish from each group, in two separate 
trials, was swum to apparent exhaustion at increased water speeds. Part 
111.3.4 describes cardiovascular changes after swimming stopped. As 
there were marked changes in the calculated values of Kb with time, the 
results are plotted on a logarithmic scale to facilitate comparisons. 
Part 111.3.5 describes the effects of administration of catecholamines 
to two fish. 
111.3.1 Resting values 
Mean values are given in table 111.1 of pressures and flows at 
rest in the fish used in the 14 swimming trials. Four fish did not 
swim in response to increased water current. Their values for Kb in 
kPa ml-1min were 0.040, 0.096 and 1.98 and 4.05. It is noted here that 
Kb for fish which swam ranged from 0.154 kPa ml- 1min to 0.692 kPa ml-1 
min. 
II1.3.2 Swimming at 15 cm s-1 
When fish started to swim there was a brief bradycardia for about 
60 s and with this an associated fall in Q which subsequently stabilized. 
In this group there were no significant changes in Kb, Q or ~Pg with time 
(see figure 111.3 and appendix A.4l). In five of the six eels there 
was a fall in Kb evident at five minutes. This was caused by increased 
cardiac output (increased stroke volume), and a fall in ~Pg. 
In the two trials in which fish 24 was swum to apparent exhaustion 
at 22 cm s-l, there was an increase in Kb. At the end of this period 
the fish was unable to move from the downstream grid. 
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Table IILI Mean resting values of cardiovascular ~arameters 
± 1 S.E.M. in short-finned eels (n = 14) • 
Parameter . Value ± 1 S.E.M. 
Kb 0.338 0.043 
kPa -1 ml min 
Q 
ml- 1min' 
6.87 0.821 
Q 11.43 1.35 
ml min -lkg-1 
Heart rate 51.07 1.33 
beats min -1 
Stroke volume 0.137 0.017 
ml 
Stroke volume 0.226 0.027 
ml kg- 1 
VAP 5.12 0.23 
kPa 
DAP 3.05 0.11 
kPa 
CVP 0.844 0.082 
kPa 
l\Pg 2.07 0.30 
kPa 
l\Pt 2.20 0.11 
kPa 
111.3.3 Swimming at 22-25 cm S-l 
In this group there were significant increases in Kb after 5, and 
30 minutes of swimming (P < 0.05) . The rise in Kb was caused by an 
increase in &gand a fall in Q (table III.2 and appendix A.42) . The 
increase in l\Pg was due to a rise in VAP while DAP fell slightly. 
During these trials, with marked changes in l\Pg, there was little change 
in l\Pt. On autopsy it was found that fish 29' had clotted blood in 
the flow probe, in which case we might presume that a restricted Q 
exaggerated the rise in Kb. 
In four trials the fish stopped swimming and did not move from the 
downstream grid and in three of these cases this occurred after the fish 
was subjected to an increased water current (35 cm s-l) . The points 
at which the fish stopped swimming marked the highest recorded values 
of Kb, as was the case when fish stopped swimming spontaneously at 
lower velocities (see figure 111.4) • In the nine trials where the fish 
FIGURE III .3 Branch.ial resistance versus time for fish swum at 15 em s-l 
Star indicates fish swum to apparent exhaustion. No prime 
indicates first trial, one prime second trial, two primes 
third trial. (See appendix A.42.1 
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Table III.2 Mean values of cardiovascular parameter ± 1 S.E.M. during swimming at 22-25 cm S-l (n 6). 
Kb Q /1Pg VAP DAP 
kPa m1-1min ml min- 1 kPa kPa kPa 
Resting values 0.322 ± 0.0405 6.79 ± 1.20 2.23 ± 0.300 5.26 ± 0.510 3.03 ± 0.223 
15 min swimming 0.534 ± 0.0746 6.43 ± l.16 3.33 ± 0.609 6.24 ± 0.486 2.91 ± 0.202 
Significance n = 6 Si P <; 0.05 NS . NS NS NS 
Table III.3 Mean values of cardiovascular parameters ± 1 S.E.M. after swimming brials (n = 12). 
Kb Q /1Pg VAP DAP 
kPa ml-linin ml min-1 kPa kPa kPa 
Values at end of 0.555 ± 0.084 6.25 ± 0.831 2.96 ± 0.390 6.01 ± 0.335 3.06 ± 0.126 
swimming 
15 min rest 0.382 ± 0.0696 7.18 ± 1.06 2.25 ± 0.335 5.33 ± 0.255 3.08 ± 0.127 
Significance n = 11 Sj P <; 0.01 Si P <; 0.05 S; P <; 0.05 Si P <; 0.05 NS 
..... 
0'\ 
....,J 
FIGURE III.4 Branchial resistance versus time for fish swum at 22-25 
Star indicates fish swum to apparent exhaustion. 
No prime indicates first trial, one prime second trial, 
two primes third trial. (See appendix A.43, and table 
III. 2) . 
22-25 em s-1 
35 cm s-1 
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were washed onto the downstream grid after a period of swimming this 
occurred after a significant rise in ~Pg (~Pg at rest = 1.97 ± 0.189 kPa 
rising to 3.15 ± 0.340 kPaj P < 0.05) and a significant fall in Q 
(Q at rest = 6.85 ± 0.855 ml-1min falling to 5.31 ± 0.851 ml-1minj 
P < 0.05). 
III.3.4 Recovery from swimming 
In this section results were pooled from .all trials apart from 
the second trials of fish 21, which displaced a cannula, and fish 29 
which had a blood clot in the flow probe. At the end of swimming some 
fish were apparently exhausted, some stopped swimming spontaneously 
while others were still swimming vigorously. 
After swimming ceased there was a significant fall in Kb (see 
figure 111.5). Kb fell from 0.555 ± 0.084 kPa ml-1min at the end of 
swimming to 0.394 ± 0.0742 kPa ml-1min after five minutes rest, (P < 
0.01, n = 12). Thereafter there was little change in Kb. The fall 
in Kb was due to a significant fall in ~Pg once again due to a change 
in VAP rather than DAP (table III.3 and appendix A.43). There was also 
a significant increase in Q. At this time there was an averaged 5% 
increase in heart rate but once again changes in Q were largely achieved 
by changes in ventricular stroke volume. 
III.3.5 Administration of catecholamines 
The stress of surgery and handling could have elevated blood 
catecholamine levels (see Mazeaud, et al., 1977), or alternatively the 
secretory capacity of the chromaffin tissue might be exhausted. To 
test this possibility eels 24 and 26 were injected with catecholamines 
at the end of their final period of recovery from swimming. 
Fish 24 was given an injection of adrenaline (1.8 Ug) and 
atropine (1.6 mg) in eel saline solution (0.2 ml), via the caudal vein. 
The dose of adrenaline was calculated to produce a blood concentration of 
about 5 x 10-7M, which is the dose that produces a half-maximal 
constrictory response of the isolated perfused eel tail (see table 11.3). 
The results of this treatment are shown in figure 111.6. The absence 
of irregularities in the trace are probably due to the blocking action 
of atropine at cholinergic neuromuscular junctions, including those of 
the opercular muscles. 
VAP rose by 48.6% and DAP by 49.1%, reaching peak values within 90 
s of injection. As the absolute rise in VAP was greater than that 
found in the DAP, ~Pg was increased by 0.933 kPa. Cardiac output fell 
FIGURE III. 5 Branchial resistance versus time for fish recovering from 
swimming at both speeds. All fish showed falls in 
branchial resistance within the first five minutes. This 
fall is most pronounced in fish swum to apparent exhaustion 
(dotted lines) (see appendix A.44 and table 111.3). 
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FIGURE III. 6 Record of response to administration of 1.8 ~9 adrenaline 
plus 1. 8 ].1g atropine into fish nwnber 24 two hours after 
its last swimming trial via the caudal vein. Cardiac 
output fell slightly while ventral and dorsal aortic 
pressures increased by about 50%. Both branchial 
resistance and tail pressure differential increased (see 
section 111.3.5) • 
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-1 from 9.9 to 8.4 ml min • Thus Kb rose from 0.202 to 0.323 kPa ml min-I. 
~Pt increased from 2.86 to 4.21 kPa, due to the increase in DAP. 
rate rose from 46 to 55 beats per minute. 
Heart 
Eel 26 was injected with 3.6 ~g of isoprenaline in 0.2 ml of eel 
saline solution, a dose calculated to give a half maximal dilatory 
response in the eel caudal circulation (see table II.3). Cardiac output 
rose to a maximal 25% increase at 2 min. ~Pg did not change, though VAP 
and DAP both fell slightly. Thus Kb fell from 0.236 to 0.189 kPa ml- 1 
min. 
At 5 min cardiac output had dropped to 13% below the initial 
value. At this time VAP and DAP reached their minimal values, with a 
relatively greater fall in VAP. Thus ~Pg was reduced and Kb was 
calculated to be 0.224 kPa ml-1min, which is below the initial level 
despite the drop in cardiac output which would tend to cause a rise in 
Kb. Caudal venous pressure decreased by 19.3% in response to iso-
prenaline, with a 25.7% decrease in ~Pt. 
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111.4 Discussion 
Fish in these experiments underwent major surgery and anaesthesia. 
The physiological effects of handling and anaesthesia may still be 
apparent up to 48 hrs after surgery. In all but two cases results were 
obtained at least 18 hr after surgery, a post-operative period similar 
to that adopted by Kiceniuk and Jones (1977). From early trials it was 
apparent that fish could not swim within 10 hr after the end of 
anaesthesia. Two of our experimental fishes exhibited periodic 
ventilation (figure 111.7; see van Dam, 1938; Shelton and Randall, 
1962) . This phenomenon is characteristic of intact resting short-
finned eels, in which the periods without opercular movements increase in 
frequency and length under hyperoxic conditions. Thus fish exhibited 
a normal pattern of ventilation and it is unlikely that they were 
subjected to chronic hypoxaemia. 
The 1.5 m lengths of cannula used in our experiments allowed the 
fish freedom of movement throughout the length of our experimental 
chamber, but will have increased the drag experienced when swimming. 
The highest sustainable swimming speed of 35 cm s-1 compares with a 
maximum reported swimming speed of 45 em s-1 in the american eel 
(Anguilla rostrata), (Lagler, Bardach, Miller and Passino, 1977), and 
-1 
a speed of 51 em s for migrating silver european eels (Tesch, 1978). 
We have calculated Kb from the ~Pg measured between the VA and DA 
and have assumed that blood passing through the gill emerges from the DA. 
As there is an alternative venous pathway for blood returning to the 
heart it is possible that changes in resistance of this second parallel 
circuit will influence the first (see Vogel; Vogel and Kramers, 1973). 
We have assumed that changes in resistance of the cephalic venous system 
will not significantly alter Kb. 
The flow probe replaced part of the ventral aorta. The 
elasticity of the prebranchial circulation in fish plays an important 
part in smoothing blood flow through the gills (Satchell, 1971). 
However, it is the distensibility of the bulbus arteriosus which makes 
the major contribution to the compliance properties of this part of the 
blood system (see Licht and Harris, 1973; Priede, 1976). The presence 
of the flow probe may also contribute to our measurements of resistance 
to blood flow. The resistance of the flow probe was measured and found 
-1 . to be small in relation to Kb (mean Kb = 0.372 kPa ml mln. K flow 
-1 probe = 0.059 kPa ml min). Half of the probe resistance might be 
subtracted from the value of Kb reported, assuming the length of ventral 
aorta replaced has negligible resistance. 
FIGURE III. 7 Record of apnoea from fish 24 before swimming trial. 
There was a gradual fall in cardiac output associated 
with apnoea. Toward the end of the record presented 
here, the fish was subjected to increased water current 
which initiated swimming. The effects of muscular 
contractions on pressures is particularly evident in the 
record of caudal venous pressure. 
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It is possible that movements associated with swimming may have 
changed the pattern of flow inthe ventral aorta and within the implanted 
flow probe. One advantage of the probe that we used is that the 
rigid walls of the probe should maintain constant cross-sectional area 
at the position of the heat sensitive resistors. In this respect it 
is important to note that when the transient bradycardia found at the 
beginning of exercise is disregarded, the change in cardiac output 
recorded in swimming fish was gradual and not abrupt as might be 
expected were mechanical artefacts to intervene. Additionally any 
restriction to flow caused by ventilatory movements would have been 
suddenly released at the start of apnoeic periods. As can be seen in 
figure 111.7, there was a gradual fall in Q during the apnoeic period, 
associated with bradycardia. 
Values of cardiovascular parameters from resting fish reported 
here (table 111.1) are comparable with results from previous workers. 
From data on trans-branchial pressure differentials (He1gason and 
Nilsson, 1973) and cardiac output (Johansen, 1962), Kb of the cod was 
calculated to be around 0.207 kPa ml-1min. Branchial resistance of the 
lingcod was reported to be 0.458 kPa m1- 1min (Stevens et a1., 1972). 
Rainbow trout Kb calculated from the data of Stevens and Randall (1967a, 
b) was 0.151-0.226 kPa m1-1min. All of these estimates are in agreement 
with the range of Kb observed in the short-finned eel. Kiceniuk and 
Jones (1977) however reported rainbow trout Kb at rest to be 0.059-
-1 0.062 kPa ml min, which is considerably lower than estimates in this 
and other species. 
The ventral and dorsal aortic pressures of fresh water eels given 
by Chester-Jones, Chan and Rankin (1969) and Chan and Chow (1976) are 
similar to those reported here. Chan and Chow (1976) gave a post-
cardinal venous pressure 0.12 kPa compared to the mean CVP of 0.844 kPa 
reported here, the difference probably reflecting the pressure drop 
across renal and hepatic portal vascular beds. Thus the estimates of 
Kb, Q and pressures measured in the short-finned eel are comparable to 
reported values from other teleost species and are thought to be 
realistic. 
The most striking response to swimming in these fish was the 
rise in ventral aortic pressure which, when combined with decreased 
cardiac output and the relatively stable dorsal aortic pressure, 
caused the observed increase in Kb. 
Laurent and Dune1 (1976) have described the morphology of the blood 
vessels of the gill filament of the European eel. The central venous 
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sinus differs from that of trout and perch in that it has extensions 
surrounding the primary afferent artery. Engorgement and increased 
pressure in the central venous sinus could in turn increase pressure 
in the afferent filamental arteries. In the secondary lamellae, the 
blood water resp:iratory distance is about 6 11m (Steen and Berg, 1966) and 
a rise in VAP during exercise may threaten their competence. At very 
high Kb swimming ceased. This response may have a protective function 
for the gills. Blood pressures in the ventral aortas of teleosts are 
high in relation to pulmonary artery pressures of tetrapods (Johansen, 
1972), and yet the blood to water distance at the gill lamellae can 
approach the values for mammalian alveoli (Steen and Berg, 1966; Hughes 
and Morgan, 1973). 
Caudal venous pressure showed large fluctuations associated with 
swimming movements (see figure III.7). Low pressures make the venous 
system more susceptible to changes in transmural pressures from 
swimming muscles and could augment blood return to the heart (Satchell, 
1965) • 
Kiceniuk and Jones (1977) have published cardiovascular changes 
associated with swimming in rainbow trout which are in marked contrast 
to the results presented here. These authors reported a threefold 
increase in Q and a fall in Kb. That they recorded very low Kb values 
compared to other data from this and other species has already been 
noted. However they had a more rigorous pre-surgery training schedule. 
In view of the differences in body form and behaviour between the trout 
and the eel, and the clearly different patterns of cardiovascular 
responses to exercise, an in depth comparison is unwarranted. A 
better comparison might be made between cod or lingcod and eels. 
Stevens et ala (1972) reported pressures and flows in the lingcod that 
agree well with Our results. The trace of the responses to spontaneous 
swimming in the lingcod (figure 7 of Stevens et al., 1972) is very 
similar to these results (see figure III.7), including the bradycardia 
at the start of swimming. Likewise the report by Johansen et ala (1960) 
shows that the responses of the heart of some elasmobranchs to swimming 
are very similar to eel heart responses, particularly the rise in 
ventral aortic blood flow after exercise ceased. The,overall pattern 
of cardiovascular responses to swimming in trout differs from that 
described here in eels and previously reported accounts in lingcod and 
elasmobranchs. These differences and the absence of any well defined 
beta dilatory adrenergic response in the trout trunk vasculature indicate 
that the teleost cardiovascular system is not typified by that of the 
rainbow trout. 
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Experiments on two eels after the end of swimming trials showed 
that systemic blood vessels still possessed the ability to respond to 
exogenous catecholamines (section 111.3.5). When combined with the 
responses of the eel to swimming, it is evident that plasma catechol-
amine concentrations did not rise under the conditions of these 
experiments. Plasma catecholamines may have a physiological role in 
the stress response but not in exercise. 
The reasons for the observed changes in the cardiovascular system 
and behaviour during swimming seems to arise from the need to protect 
the gills from very high pressures. Cessation of swimming in response 
to branchial oedema has been suggested by Satchell (1978) from studies 
on the dogfish (Squalus aaanthias) . Since higher vascular pressures 
would result in extravasation of vascular fluid (Landis and Pappenheimer, 
1963) protection of the gills seems a logical explanation for these 
results. The reduced cardiac output observed on swimming is surely 
incompatible with the greater metabolic requirements of exercise. 
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III .5 Summary 
1. Cardiac output, ventral aortic pressures, dorsal aortic pressures 
and caudal venous pressures were recorded from unrestrained short-finned 
eels at rest, swimming at 15 cm.s- 1 and 22-25 cffi.s- 1 and after exercise. 
2. Pressures and flows and calculated values for branchial resistance 
at rest are in good agreement with previously reported values (section 
III. 3.1) • 
3. swimming at 15 cm.s-1 resulted in insignificant changes in branchial 
resistance. After five minutes of swimming at this speed there was a 
fall in branchial resistance caused mainly by a rise in cardiac output. 
Thereafter little change in branchial resistance was recorded (section 
III. 3 .2) • 
4. swimming at 22-25 cm.s- 1 significantly increased branchial resistance 
principally as a result of elevated ventral aortic pressures. Changes 
in heart rate, dorsal aortic pressures and caudal venous pressures were 
small. Cardiac output fell slightly (section III.3.3) . 
5. Changes in cardiac output were achieved largely through changes in 
stroke volume rather than heart rate. 
6. After swimming ceased, branchial resistance fell as a result of 
increased cardiac output and decreased ventral aortic pressure (section 
III. 3.4) . 
7. Plasma catecholamine levels appear to be unimportant in the cardio-
vascular responses to swimming in the short-finned eel. 
8. Spontaneous cessation of swimming was associated with very high 
branchial resistances. 
for the gill tissues. 
This response may have a protective function 
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PART IV SUGGESTIONS FOR FURTHER WORK 
During the course of this study, particularly in the latter stages, 
it has become clear that further research into several aspects could 
significantly contribute to our understanding of fish cardiovascular 
physiology. The more interesting, and possibly more fruitful avenues 
as I see them are noted below. 
1. The caudal lymph heart of the eel is controlled by a unique example 
of a vertebrate neural pacemaker. It has relatively few neural elements 
(for a vertebrate), is easily isolated and with the appropriate micro-
electrophysiological techniques would provide a useful comparison for the 
vertebrate cardiac pacemaker and possibly invertebrate neural pacemaker 
systems. Pharmacological analysis of this organ would complement the 
above study. 
2. The basic adrenergic pharmacology of the isolated saline perfused 
eel tail has been described in this report. On this foundation an 
investigation of the cholinergic and perhaps purinergic vascular 
pharmacology could be undertaken to allow comparison with the work on 
the trout trunk. 
3. As demonstration of the beta dilatory response in the trout trunk 
was difficult to demonstrate, one wonders how the responses might be 
enhanced. Clearly one method would be the use of human serum in the 
perfusate. Another might be the isolation of the vessels that contain 
more beta receptors. Muscle vessels seem to be good candidates and 
perhaps better still, the vessels from red muscle since it is these 
muscles that operate aerobically during swimming. Furthermore it might 
be better to choose fish which are mature and ready to migrate for it 
is in this condition that they should be physically ready to swim. The 
use of immature 'feeding' fish in the past may have resulted in the 
selection of fish where systemic vascular dilation was relatively 
undeveloped. 
4. This preparation is well suited to study the effects of urophysial 
secretions on the caudal circulation. Inclusion of the kidney into the 
preparation may make' it even more suitable since no isolated perfused 
fish kidney preparation is available to fish physiologists as far as I 
am aware. 
5. Cardiovascular responses to swimming in fish are far from well 
described, let alone understood. Results presented here show marked 
differences to those from trout and yet agree well with results from 
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various other fishes. More data on basic changes in pressures and 
flows are needed to establish what changes do occur and the cause of 
the observed responses. 
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Appendix A.1 ~ responses (kPa m1- 1min) to AD. Perfusion line. No serum. 
conca 1 x 10-10 1 x 10-9 5 X 10-9 1 X 10- 8 5 X 10-8 1 X 10-7 5 X 10-7 1 X 10- 6 i 5 X 10- 6 1 X 10- 5 1 X 10-1t 1 X 10- 3 
M 
FISH 
NUMBER 
A101 0 0 0.0951 0.0938 0.1251 0.9651 1.629 1.662 1.662 
Al02 0 0 0.1036 0.3564 0.7786 2.074 2.718 2.240 2.240 
Al03 0 0.0876 0.1607 0.2558 0.4825 2.018 2.630 2.637 2.637 
Al04 0 0.0535 0.0713 0.2676 0.3121 2.311 3.772 3.769 3.769 
Al05 0.0623 0.1824 0.2284 0.2826 0.3422 0.4362 1.0621 1.483 2.347 2.381 2.415 2.415 
Al06 0.3181 0.8235 1.849 
mean 0.0124 0.0647 0.1318 0.2517 0.3303 0.4261 0.9048 1.774 2.100 2.629 2.546 2.546 
1 S .E. ±0.0124 ±0.0338 ±0.0281 ±0.0429 ±0.0171 ±0.0959 ±1.1599 ±0.2173 ±0.3526 ±0.3074 ±0.3081 ±O.3081 
I\.) 
o 
I\.) 
Appendix A.2 
conc. 1 x 10-1Q 
M 
FISH 
NUMBER 
AlOl 
Al02 
Al03 
Al04 
Al05 
Al06 
mean 
1 S.E. 
0 
0 
0 
0 
8.10 
1.62 
±1.62 
AK% responses to AD. Perfusion line. 
1 X 10-9 
0 
0 
8.33 
5.0 
22.97 
7.25 
±4.23 
5 X 10-9 
9.86 
11.11 
15.27 
6.66 
29.73 
14.52 
±4.04 
1 X 10-8 
9.49 
38.19 
24.28 
25.00 
36.81 
26.75 
±5.19 
5 X 10-8 
44.59 
83.72 
64.15 
±19.56 
No serum. 
1 X 10-7 
12.96 
83.33 
45.83 
29.16 
56.75 
45.61 
±12.00 
5x 10- 7 
.128.37 
216.28 
172.32 
±43.95 
1 X 10-6 
101.22 
222.22 
193.05 
215.83 
193.34 
185.13 
±21.78 
5 X 10-6 
305.46 
485.93 
395.69 
±90.23 
1 X 10- 5 
168.80 
293.05 
249.99 
315.16 
309.45 
267.09 
±27.17 
1 X 10-1t 
172.61 
240.27 
249.99 
315.16 
316.21 
258.82 
±26.76 
1 X 10- 3 
172.61 
240.27 
249.99 
315.16 
316.21 
258.82 
±26.76 
I\J 
o 
w 
Appendix A.3 -1 ~K responses (kPa m1 min) to AD. Perfusion line. Plus 5% serum. 
conc. 1 x 10-10 1 X 10- 9 5 X 10-9 1 X 10-8 5 X 10- 8 1 X 10-7 5 X 10-7 1 X 10-6 5 X 10-6 1 X 10-5 1 X 10-4 1 X 10- 3 
M 
FISH 
NUMBER 
A201 0.1593 0.5607 0.5088 0.6678 1.0813 1.5901 2.8463 3.4823 3.4823 
A202 0.1684 0.3649 0.3312 0.3874 0.8669 1.2848 2.4537 2.4537 3.6151 
A203 0 -0.1138 0.2134 0.5334 1.3233 2.4622 2.7889 2.8450 2.8450 
A204 0.0307 0.0799 0.8605 0.2335 0.3811 0.5532 1.6105 2.2005 3.0795 3.1226 3.5681 3.3070 
A205 -0.0992 -0.0555 0.0297 0.1092 0.3078 0.5858 1.5488 1.9163 2.3135 2.4724 2.7008 2.6610 
A206 1.1112 3.2401 4.8199 3.5747 3.5747 
A207 0.5148 1.5449 1.6500 24.2813 
ADB201 1.8454 
ADB202 3.3383 
ADB203 1.0851 
ADB204 1.3628 
ADB205 2.2138 
mean 0.05176 0.1552 0.2338 0.3863 0.4012 0.9746 1.8187 2.0583 2.6072 3.0839 3.1041 3.1475 
1 S .E. ±0.0366 ±0.0888 ±0.0863 ±0.1003 ±0.0494 ±0.1260 ±0.3487 ±0.2434 ±0.2065 ±0.3620 ±0.2027 ±0.1489 
I\J 
0 
~ 
Appendix A.4 ilK% responses to AD. Perfusion line. 1;>lus 5% serum. 
cone. 1 x 10-10 1 X 10-9 5 X 10-9 1 X 10-8 5 X 10- 8 1 X 10-7 5 X 10-7 1 X 10-6 5 X 10-6 1 X 10-5 1 X 10-4 1 X 10- 3 M 
FISH 
NUMBER 
A201 6.90 22.22 22.22 29.16 47.22 69.44 124.31 152.08 152.08 
A202 6.77 14.67 13.31 15.15 34.08 54.26 98.64 98.64 121.21 
A203 0 -5.19 9.74 24.35 60.38 112.33 127.27 129.87 129.87 
A204 3.70 10.16 10.93 29.68 48.43 70.31 204.68 279.68 391.40 396.87 453.1 420.30 
A205 -10.64 -5.31 3.56 13.02 37.23 62.76 185.37 205.31 247.86 264.88 289.35 285.10 
A206 45.23 131.88 196.18 145.50 145.50 
A207 52.57 161.34 183.00 253.61 
ADB201 107.27 
ADB202 145.38 
ADE203 94.16 
ADB204 63.21 
ADB205 166.66 
mean 1.34 7.31 ll.95 22.27 46.07 53.33 141.01 140.84 297.62 201.35 211.42 209.01 
1 S.E. ±3.24 ±5.48 ±3.03 ±1.39 ±5.95 ±5.48 ±17.16 ±29.67 ±61.01 ±46.29 ±55.29 ±48.88 
l\.J 
0 
U1 
Appendix A.5 
Dose 10 pmoles 
FISH 
NUMBER 
Al51 
Al52 0 
A153 0 
A154 0 
A155 0 
mean o 
1 S .E. 
~K responses (kPa ml-1min) to AD. Bolus. 
20 pmoles 50 pmoles 
0 0.3810 
0.0297 0.1040 
0.0741 0.0741 
0 0.3970 
0 0.3491 
0.0207 0.2510 
±0.0145 ±0.0665 
100 pmoles 
0.6792 
0.2318 
0.1112 
0.7036 
0.9652 
0.5382 
±0.1591 
200 pmoles 
0.8447 
0.4624 
0.4171 
1.1909 
1.6225 
0.9435 
±0.2274 
No serum. 
300 pmoles 
1. 2590 
0.6129 
0.3526 
1.6780 
1. 7457 
1.1298 
±0.2801 
500 pmoles 
1. 7725 
0.7432 
0.8527 
2.3457 
1.9716 
1.5394 
±0.3161 
1 ornole 10 ornoles 
2.3523 3.5451 
1.1150 2.3861 
1.2421 2.3541 
2.5261 4.2224 
2.9234 3.3476 
1.9317 3.1711 
±0.3096 ±0.3578 
100 ornoles 
4.0753 
3.0476 
3.9487 
5.0885 
5.8093 
4.3938 
±0.4797 
I\J 
a 
0'1 
Appendix A.6 
Dose 10 pmoles 
FISH 
NUMBER 
Al51 
Al52 0 
Al53 0 
Al54 0 
Al55 0 
mean o 
1 S.E. 
~K% response to AD. 
20 pmoles 
0 
3.81 
5.88 
0 
0 
1.94 
±1.23 
50 pmoles 
19.76 
13.36 
4.99 
16.17 
15.67 
13.98 
±2.47 
Bolus. No serum 
lOO pmoles 200 pmoles 
35.23 
26.41 
7.50 
28.67 
43.34 
28.23 
±5.96 
43.83 
52.83 
28.13 
48.53 
72 .86 
49.23 
±7.23 
300 pmoles 
65.32 
69.81 
23.75 
68.38 
78.39 
60.73 
±9.42 
500 pmoles 
91.95 
95.41 
57.50 
95.59 
88.53 
85.79 
±7.19 
1 nmole 
122.03 
143.12 
83.75 
102.94 
108.82 
112.12 
±9.93 
10 nmoles 
183.90 
306.28 
158.75 
172 .07 
150.33 
194.27 
±28.58 
100 nmoles 
211.41 
391.20 
266.25 
207.36 
261.00 
267.44 
±33.25 
~ 
o 
..... 
Appendix A.7 
Dose 10 pmoles 
FISH 
NUMBER 
A251 0.04984 
A252 0 
A253 0.04032 
A254 0.02750 
A255 0.12216 
mean 0.0479 
1 S.E. ±0.0212 
!::J< response (kPa ml-1min) to AD. Bolus. 
20 pmoles 
0.1352 
0.1853 
0.1288 
0.0990 
0.2809 
0.1658 
±Q.0319 
50 pmoles 
0.1423 
0.3280 
0.2185 
0.1650 
0.4642 
0.2636 
±0.0595 
100 pmoles 
0.2847 
0.7060 
0.3640 
0.3411 
0.7086 
0.4822 
±0.0942 
200 pmoles 
0.4556 
0.9983 
0.5656 
0.4841 
0.8552 
0.6678 
±0.0197 
Plus 5% serUIll. 
300 pInoles 
0.5837 
11.1694 
0.6440 
0.6491 
1.1117 
0.8316 
±0.1270 
500 pmoles 
0.9682 
1. 7257 
0.7785 
0.8142 
1.0715 
±0.2216 
1 nmole 10 nmoles 
1.1177 1.8937 
1.9176 2.5101 
1.0249 1.7642 
1.1663 1. 7384 
1.2217 1.5515 
1.2896 1.8916 
±0.6602 ±0.1641 
100 nmoles 
2.5712 
4.4070 
2.2684 
1.9915 
2.0157 
2.6507 
±Q.4516 
I\.) 
o 
00 
Appendix A.8 
Dose 10 pmo1es 
FISH 
NUMBER 
A251 2.81 
A252 0 
A253 2.06 
A254 1.35 
A255 9.85 
mean 3.21 
1 S.E. ±1. 72 
~% responses to AD. Bolus. 
20 pmoles 
7.63 
9.39 
6.58 
4.86 
22.66 
10.22 
±3.19 
50 pmoles 
7.63 
16.63 
11.17 
8.10 
37.43 
16.19 
±5.54 
100 pmoles 
15.27 
36.15 
18.62 
16.75 
57.14 
23.98 
±8.12 
Plus 5% serum. 
200 pmoles 
24.42 
50.61 
28.93 
23.78 
68.96 
39.35 
±8.88 
300 pmo1es 
31.29 
59.29 
32.94 
31.89 
89.65 
49.01 
±11.45 
500 pmoles 
51.90 
87.48 
39.82 
40.00 
54.80 
±11.25 
1 nmole 
59.92 
97.61 
52.43 
57.20 
98.52 
73.14 
±10.25 
10 nmoles 
101.52 
127.25 
90.25 
85.40 
125.12 
105.99 
±8.68 
100 nmo1es 
137.83 
223.42 
116.03 
97.83 
162.56 
147.53 
±21.84 
N 
o 
~ 
Appendix A.9 ~ responses (kPa ml-1min) to NAn. Perfus;ion line. No sertnn. 
conc. 1 x 10-10 1 x 10-9 5 X 10-9 1 X 10-8 5 X 10-8 1 X 10-7 5 X 10-1 1 X 10-6 5 x 10-6 
M 
FISH 
NUMBER 
N109 0 0.3645 0.8815 1.1114 1.4947 2.1271 
NilO 0 0.3253 0.3635 0.5357 0.5931 
Nl12 0.1262 0.1122 0.2526 0.3437 0.5822 0.6874 1.4245 2.0133 2.8761 
N113 0 0.0509 0.0892 0.4014 0.3632 0.5161 0.8220 0.9877 
N114 0.1546 0.2550 0.4317 0.4389 0.5393 0.5058 0.5728 0.8655 1.2835 
NIlS 0 0 0.1009 0.1682 0.2018 0.4878 1.1858 1.9428 3.5492 
mean 0.0468 0.1847 0.3488 0.4561 0.6290 0.5493 1.0611 1.5542 2.1741 
1 S.E. ±0.0298 ±0.0617 ±0.1191 ±0.1451 ±0.1838 ±0.0464 ±0.2538 ±0.2917 ±0.6176 
1 x 10- 5 1 x 10-4 1 x 10- 3 
3.3144 
1.0906 
3.6197 3.0865 2.4973 
2.7974 3.4092 2.8739 
1.3838 1.5929 1.3588 
3.1960 4.1210 2.5231 
2.5670 3.0524 2.4111 
±0.4359 ±0.5326 ±0.3297 
!'V 
.... 
o 
Appendix A.10 
Cone. 1 x 10-10 
M 
FISH 
NUMBER 
N109 0 
N110 0 
Nl12 12.67 
N113 0 
Nl14 ll.45 
Nll5 0 
mean 4.02 
1 S.E. ±2.55 
~K% responses to NAD. 
1 X 10-9 
25.86 
21.07 
10.95 
3.60 
18.88 
0 
13.39 
±4.18 
5 X 10-9 
62.53 
23.35 
24.65 
6.30 
30.03 
8.57 
25.90 
±8.27 
1 x 10-8 
78.84 
34.71 
33.55 
9.90 
32.50 
14.28 
33.96 
±9.97 
Perfusion line. No sennn. 
5 x 10-8 1 X 10-7 5 X 10-7 
106.04 
38.43 
56.84 
20.40 
39.93 
17.14 
46.46 
±13.29 
67.11 
29.03 
37.74 
41.43 
43.83 
±8.18 
139.02 
42.41 
100.71 
94.04 
±28.09 
1 X 10-6 
150.90 
196.56 
46.23 
64.08 
164.99 
124.55 
±29.41 
5 X 10- 6 
280.79 
55.55 
95.05 
301.42 
183.20 
±62.96 
1 x 10-5 
235.19 
70.60 
353.38 
157.34 
102.47 
271.42 
198.40 
±43.94 
1 x 10-4 
301. 34 
191.75 
117.96 
349.99 
240.26 
±52.52 
1 x 10- 3 
243.81 
161.64 
100.61 
214.28 
180.08 
±31.47 -
N 
I-' 
I-' 
Appendix A.11 
Dose 20 pmo1es 
FISH 
NUMBER 
N151 
N152 
N153 
N154 
N155 0 
N156 0 
N157 0 
N158 0 
mean o 
1 S.E. 
-1 ~K responses (kPa m1 min) to NAn. 
50 pmoles 
0 
0 
0 
0 
0 
0.1107 
0 
0.0158 
±0.0158 
100 pmoles 
O· 
0 
0 
0.1752 
0 
0 
0.2214 
0.0758 
0.0590 
±0.0321 
200 pmoles 
0.2894 
0.0481 
0.0991 
0.3358 
0.1746 
0.0555 
0.4164 
0.2226 
0.2052 
±0.0479 
Bolus. No serum. 
300 pmoles 
0.1734 
0.1298 
0.4786 
0.3857 
0.1220 
0.3983 
0.2301 
0.2781 
±0.0530 
500 pmo1es 
0.6188 
0.4239 
0.4660 
0.5984 
0.7208 
0.1824 
0.6699 
0.2734 
0.4942 
±0.0682 
1 nmole 
0.5782 
1.2496 
0.8966 
1.2641 
0.2934 
1.0864 
1.0068 
0.9107 
±0.1356 
10 nmo1es 
1.8505 
4.8197 
2.0869 
2.6806 
0.8356 
2.2092 
1.3519 
2.2621 
±0.4828 
100 nmo1es 
3.0648 
5.7507 
4.2582 
5.0924 
0.7972 
2.5023 
3.5776 
±0.7448 
IV 
I-' 
IV 
Appendix A.12 
Dose 20 pmoles 
FISH 
NUMBER 
NISI 
N152 
N153 
N154 
N155 Q 
N156 Q 
N157 0 
N158 0 
mean o 
1 S.E. 
~K% responses to NAD. 
50 pmoles 
0 
0 
0 
0 
0 
4.74 
0 
0.68 
±0.68 
100 pmoles 
0 
0 
0 
11.51 
0 
0 
9.49. 
3.24 
3.03 
±1.68 
Bolus. No sermn. 
200 pmoles 300 pmoles 
8.11 
2.20 
6.66-
22.06 
15.55 
3.82 
16.67 
9.91 
10.62 
±2.43 
7.95 
10.69 
31.44 
34.34 
8.42 
15.94 
10.24 
17.00 
±4.23 
500 pmoles 
17.31 
19.44 
31.33 
39.31 
64.18 
12.57 
26.82 
12.66 
27.95 
±6.14 
1 nmole 
26.51 
84.00 
58.90 
112.57 
20.23 
43.49 
46.60 
56.04 
12.33 
10 nmoles 
84.85 
324.00 
137.11 
238.30 
57 . .41 
88.43 
62.66 
141. 91 
±38.46 
100 nmoles 
140.54 
386.58 
279.82 
456.36 
56.71 
115.99 
239.33 
±65.51 
t-J 
f-' 
W 
Appendix A.13 ~ responses (kPa m1- 1min) to ISO. 
conc. 1 x 10-l0 1 x 10-9 5 X 10-9 1 X 10-8 5 X 10- 8 
M 
FISH 
NUMBER 
II0l 
II02 -0.0048 
II03 
I104 0 -0.0300 -0.0451 
II05 -0.0230 -0.0806 
I106 0 -0.0198 -0.0397 -0.0694 -0.1190 
II07 -0.0263 -0.0526 -0.0895 
II08 0 -0.0335 -0.0791 -0.0951 -0.1625 
I109 0 -0.0259 -0.0442 -0.1106 -0.1106 
mean 0 -0.0228 -0.0478 -0.0659 -0.1125 
1 S.E. ±0.0050 ±0.0112 ±0.0133 ±0.0143 
Perfusion line. No serum. 
1 X 10- 7 5 X 10-7 1 X 10-6 
-0.0966 -0.1111 
-0.1205 -0.1654 
-0 .195~ 
-0.2034 -0.2430 
-0.1579 -0.1790 -0.1579 
-0.1734 -0.1678 -0.1678 
-0.1327 -0.1548 
-0.1371 -0.1757 -0.1666 
±0.0175 ±0.0123 ±0.0174 
5 x 10-6 1 x 10-5 
-0.1804 
-0.3225 
-0.1934 -0.1339 
-0.1053 0 
-1.6498 0 
-0.2212 -0.2212 
-0.1712 -0.1430 
±0.0247 ±0.0519 
1 X 10-1t 
-0.0461 
+0.3719 
+0.3264 
+0.8168 
+0.5694 
+0.4070 
±0.1286 
1 x 10-3 
+0.5243 
+0.9275 
+0.5896 
+1.4434 
+5.8015 
+0.8130 
±0.1730 
N 
.... 
"" 
Appendix A.14 ~% responses to ISO. Perfusion line. No serum. 
conc. 1 x 10-10 1 X 10-9 5 X 10-9 1 X 10-8 5 X 10-8 1 X 10-7 5 X 10-7 
M 
FISH 
NUMBER 
II02 0 -0.42 -8.36 
II03 
II04 0 -4.32 -6.45 -16.16 
II05 -2.77 -7.86 -19.10 
I106 0 -2.51 -5.03 -8.80 -12.90 -21.02 
II07 -2.92 -5.84 -9.94 -17.54 -19.88 
II08 0 -5.04 -11.76 -14.28 -23.52 -26.05 -25.21 
II09 0 -2.78 -4.73 -11.34 -11.83 -14.20 
mean 0 -3.01 -6.11 -8.33 -13.21 -17.03 -19.88 
1 S .E. ±0.80 ±1.94 ±1.72 ±2.72 ±3.62 ±1.77 
1 X 10- 6 5 X 10- 6 1 X 10- 5 
-9.62 
-22.22 -24.24 
-31.46 
-25.12 -19.99 -13.84 
-17.54 -11.69 0 
-25.21 -15.96 0 
-16.56 -23.67 -23.67 
-19.39 -17.83 -15.53 
±2.46 ±2.58 ±5.42 
1 X 10-4 
-4.49 
+38.46 
+36.25 
+122.68 
+60.94 
50.76 
±19.86 
1 X 10- 3 
+50.56 
+95.89 
+65.49 
+216.80 
+63.32 
98.41 
±30.58 
I\.l 
I-' 
U1 
Appendix A.15 !::,K responses (kPa ml- 1min) to ISO. 
conc. 1 x 10-10 1 X 10-9 5 X 10-9 1 X 10-8 5 X 10-8 
M 
FISH 
NUMBER 
I201 -0.0561 -0.0748 -0.1309 
I202 -0.2612 -0.2612 -0.3294 
I203 -0.0408 -0.0830 -0.1295 
I205 -0.0476 -0.0692 -0.0692 -0.0953 -0.1428 
I206 -0.0599 -0.0798 -0.0998 -0.1597 -0.6190 
I207 0 -0.0079 -0.0479 -0.0799 -0.1439 
II02 0 -0.0869 -0.1638 
II04 0 -0.0225 
I255 
mean -0.0582 -0.0857 -0.0725 -0.1556 -0.3019 
1 S .E. ±0.0304 ±0.0271 ±0.0150 ±0.0312 ±0.1585 
Perfusion line. plus 5% serum. 
1 X 10-7 5 X 10- 7 1 X 10-6 5 X 10-6 
-0.2712 -0.4208 
-0.5565 -0.8292 
-0.3223 -0.5755 
-0.1559 -0.2122 -0.2252 
-0.6390 -0.7189 -0.7588 -0.8187 
-0.1439 -0.1439 -0.0479 +0.0479 
-0.2223 -0.3286 
-0.0602 -0.1128 
-0.3180 
-0.3179 -0.3396 -0.3933 -0.3319 
±0.0799 ±0.1896 ±0.0818 ±0.2558 
1 X 10- 5 1 x 10-r;. 
-0.7091 
-0.2252 -0.0606 
-0.8187 -0.1397 
+0.1919 +0.9119 
-0.1429 
-0.2131 +0.2371 
±0.1667 ±0.3381 
1 x 10-3 
+0.8489 
+1.6575 
+1.6639 
+1.1159 
+1.3216 
±0.2032 
'" f-' 
O'l 
Appendix A .16 6K% responses to ISO. Perfusion line. Plus 5% serum. 
conc. 1 x 10-10 1 X 10-9 5 X 10-9 1 X 10- 8 5 X 10-8 1 X 10-7 5 X 10-7 
M 
FISH 
NUMBER 
I201 -4.76 -6.34 -10.44 -21.64 
I202 -4.14 -9.26 -11.67 -21.27 
1203 -6.94 -5.45 -7.27 -20.33 
1205 -5.85 -7.92 -7.92 -10.89 -16.33 -17.82 
I206 -3.06 -4.08 -5.10 -8.16 -31.63 -32.65 -36.67 
1207 0 -0.64 -3.84 -6.40 -11.53 -11.53 -11.53 
I102 0 -5.67 -10.72 -14.50 
1104 0 -2.57 -6.85 
1255 
mean -3.09 -5.24 -5.62 -9.36 -19.83 -18.39 -22.01 
1 S .E. ±0.99 ±0.98 ±1.21 ±0.77 ±6.06 ±3.17 ±7.55 
1 X 10-6 5 X 10-6 1 X 10- 5 
-33.58 
-33.28 
-35.25 
-23.04 -25.74 -25.74 
-38.77 -41.83 -41.83 
-3.84 +3.84 +15.38 
-21.44 
-12.85 -16.28 
-28.23 
-25.84 -21.36 -17.12 
±3.43 ±13.26 ±12.05 
1 X 10-4 
-6.93 
-7.14 
+17.03 
+19.65 
±26.68 
1 X 10- 3 
+97.02 
+84.69 
+133.33 
+45.77 
+90.20 
±18.05 
N 
i-' 
...,J 
Appendix A.17 
Dose 10 pmo1es 
FISH 
NUMBER 
1151 
1152 
1153 
1154 
1155 
1156 
mean 
1 S.E. 
0 
-0.0845 
0 
-0.0079 
-0.0231 
±0.0205 
~K responses (kPa ml-1min) to ISO. 
20 pmo1es 
-0.0754 
-0.1592 
-0.0457 
50 pmoles 
-0.0793 
-0.0406 
-0.0943 
-0.0159 
-0.0575 
±0.0179 
100 pmo1es 
-0.2101 
-0.1427 
-0.1016 
-0.1793 
-0.0239 
-0.1322 
±0.0324 
Bolus. 
200 pmoles 
-0.1850 
-0.0358 
-0.1104 
No serum. 
500 pmo1es 
-0.2866 
-0.1320 
-0.0597 
-0.1594 
±0.0669 
1 nmo1e 
-0.2866 
-0.0609 
-0.4133 
-0.2264 
-0.0637 
-0.2097 
±0.0675 
10 nmo1es 
-0.3566 
-0.1219 
-0.2642 
-0.1623 
-0.2262 
±0.0527 
100 nmo1es 
-0.2264 
-0.1745 
-0.2005 
1 '\lI1lole 
+0.0094 
+0.1195 
+0.0670 
I\.) 
I-' 
co 
Appendix A.18 
Dose 
FISH 
NUMBER 
1151 
1152 
1153 
1154 
1155 
1156 
mean 
1 S .E. 
10 pmo1es 
0 
-7.96 
0 
-1.29 
-2.29 
±1.84 
liK% responses to ISO. 
20 pmo1es 
-6.86 
-2.58 
-4.72 
50 pmo1es 
-8.06 
-2.17 
-8.58 
-2.58 
-5.35 
±1. 72 
Bolus. 
100 pmo1es 
-20.88 
-14.51 
-5.43 
-16.30 
-3.89 
-12.14 
±3.25 
No sermn. 
200 pmo1es 500 pmo1es 
-30.61 
-18.81 
-7.06 
-5.84 -9.74 
-12.32 -15.65 
±7.44 
1 nmo1e 
-31.25 
-3.39 
-27.41 
-20.60 
-10.39 
-18.60 
±5.19 
10 nmo1es 
-38.88 
-6.77 
-24.03 
-16.88 
-21.64 
±6.74 
100 nmo1es 
-20.60 
-22.07 
-21.33 
1 llmo1e 
+0.85 
+19.48 
+10.16 
N 
I-' 
\0 
Appendix A.19 ll.K responses (kPa ml-1min) to ISO. 
Dose 10 pmoles 20 pmoles 50 pmoles 100 pmo1es 
FISH 
NUMBER 
1251 -0.0768 -0.1344 -0.2876 
I252 0 -0.2593 -0.2593 
I253 -0.2176 -0.2418 -0.3748 
1254 0 -0.0854 -0.1624 
I255 -0.1940 -0.3638 -0.4245 -0.4614 
1256 -0.3489· -0.1744 -0.4710 -0.6448 
I257 
I258 
IB201 -0.2196 -0.1785 -0.3296 -0.3158 
IB202 
mean -0.1509 -0.2389 -0.2780 -0.3580 
1 S .E. ±0.0491 ±0.0625 ±0.0536 ±0.0593 
Bolus. Plus 5% serum. 
200 pmo1es 300 pmo1es 500 pmo1es 
-0.3649 
-0.5321 
-0.7523 
-0.5458 -0.5822 -0.5822 
-0.9945 -1.1166 -1.1690 
-0.2599 -0.3198 
-0.3447 -0.3447 
-0.3159 -0.3914 
-0.1663 -0.3327 
-0.4378 -0.5909 -0.5893 
±0.1225 ±0.1849 ±0.1114 
1 nmo1e 10 nmoles 
-0.2977 -0.4707 
-0.4369 -0.5378 
-0.7074 -1.0280 
-0.8206 -1.0258 
-0.6186 -0.8126 
-1.1346 -1.3347 
-0.3914 
-0.6296 -0.8683 
±0.1093 ±0.1333 
100 nmo1es 
-1.1852 
-1.0600 
-1.0431 
-1.3347 
-1.1557 
±0.0675 
IV 
IV 
o 
Appendix A. 20 aK% responses to ISO. Bolus. 
Dose 10 pmoles 20 pmoles 50 pmoles 100 pmoles 
FISH 
NUMBER 
I251 -4.57 -7.99 -17.14 
I252 0 -14.09 -14.09 
1253 -9.60 -10.66 -16.53 
I254 0 -3.40 -6.46 
I255 -7.96 -14.92 -17.41 -18.90 
1256 -1.25 -6.26 -16.92 -23.19 
I257 
I258 
IB201 -15.99- -12.99 -23.99 -22.99. 
IB202 
mean -5.62 -11.39 -13.49 -17.04 
1 S .E. ±2.25 ±2.63 ±2.57 ±2.17 
Plus 5% serum. 
200 pmoles 300 pmoles 500 pmoles 
-19.83 
-23.46 
-29.93 
-22.38 -23.38 -23.88 
-35.73 -40.12 -42.00 
-18.26 -22.45 
-19.99 -19.99 
-22.99 -28.49 
-11.37 -22.74 
-21. 79 -26.48 -27.19 
±3.06 ±4.60 .79 
1 nmole 10 runoles 
-17.77 -28.00 
-23.75 -29.23 
-31.20 -45.33 
-38.77 -40.81 
-25.37 -33.33 
-40.75 -47.96 
-28.49 
-29.44 -37.44 
±3.10 ±3.45 
100 nmoles 
-52.90 
-42.17 
-42.78 
-47.96 
-46.45 
±2.51 
N 
N 
I-' 
Appendix A.21 Mean peak response times (seconds) ± 1 S.E.M. for AD, NAD, ISO, administered by verfusion line. 
conc. 1 x 10-9 5 X 10-9 1 X 10-8 5 X 10-8 1 X 10- 7 5 X 10-7 1 X 10- 6 5 X 10-6 1 X 10-5 1 X 10-4 1 X 10-3 M 
DRUG Serum! No serum 
AD No serum 349 263 236 215 173 160 145 136 134 98 76 
± 74 ± 57 ± 47 ±34 ± 23 ± 9 ± 10 ± 7 
AD Serum 278 241 214 187 154 145 134 145 127 90 73 
± 52 ± 44 ± 31 ± 35 ± 19 ± 23 ± 29 ± 9 ± 8 ± 6 ± 7 
NAD No serum 473 494 395 298 240 208 123 127 117 94 91 
± 129 ± 94 ± 57 ± 52 ± 31 ± 21 ± 12 ± 16 ± 8 ± 10 ± 7 
ISO No serum 189 191 188 223 295 271 262 231 224 6.90 375 
± 20 ± 19 ± 16 ± 18 ± 14 ± 20 ± 34 ± 28 ± 23 ± 17 ± 16 
ISO Serum 184 186 212 208 237 245 271 237 229 417 356 
± 25 ± 29 ±19 ± 19 ± 13 ± 24 ± 25 ± 41 ± 26 ± 50 ± 46 
Values without standard errors are derived from two experiments only. 
IV 
IV 
IV 
Appendix A.22 Mean peak response times (seconds) ± 1 S.E.M. for AD, MAD, and ISO administered as bo1i. 
conc. 10 pmo1es 20 pmo1es 50 pmo1es 100 pmo1es 200 pmo1es 300 pmo1es 500 pmo1es 1 nmo1e 10 nmo1es M 
DRUG Serum/ No serum 
AD No serum 90 75 69 60 63 60 60 87 
± 15 ± 5 ± 3 ± 2 ±' 1 ± 2 ± 9 
AD Serum 75 90 81 63 62 61 58 57 55 
± 15 ± 15 ± 8 ± 4 ± 2 ± 1 ± 1 ± 2.4 ± 9 
NAD No serum 150 120 123 102 98.4 96.6 92 
± 15 ± 2.4 ± 21 ± 14 ± 11.4 ±ll 
ISO No serum 234 240 183 245 330 224 179 224 
± 33 ± 49 ± ± 46 ± 28 
ISO Serum 240 285 297 324 309 297 193 210 
± 34 ± 26 ± 29 ± 50 ± 45 ± 37 ± 35 ± 26 
Values without standard errors are derived from two experiments only. 
100 nmo1es 
75 
± 8 
61 
± 10 
104 
± 6 
225 
231 
± 22 
tv 
tv 
W 
Appendix A.23 
four preparations. 
Dose Initial 
moles control 
50p D.K +0.0812 
AD D.K% +4.73 
lOOp tJ.K +0.0634 
AD D.K% +8.32 
200p D.K +0.583 
AD D.K% +53.33 
Responses to AD plus Phent given as a single bolus at dose ratios of 1 10 to 1 10QO. 
1 10 1 25 1 30 1 40 1 50 1 100 1 200 1 1000 
+0.0406 -0.0623 -0.0913 -0.152 
+2.31 -3.46 -5.20 -8.67 
+0.0528 +0.0113 +0.0053 0 -0.711 -0.1726 
+7.41 +1.48 +0.74 0 -4.04 -9.82% 
-0.0729 -0.166 
-6.66 -13.37 
From 
Final 
control 
+0.0408 
+2.32 
+0.0451 
+6.87 
+0.255 
+23.33 
'" 
'" oil>
Appendix A.24 Mean responses to Phent control doses and concentrations (n = 3) • 
Cone. 1 X 10-6 M 1 x 10-SM 1 x 10-'+M 
b.K -0.0254 -0.0372 -0.0665 
Response 
b.K% -2.35 -4.08 -9.33 
Dose 10 nmoles 50 nmoles 100 nmoles 
b.K -0.0231 -0.0406 -0.1015 
Response 
b.K% 
-1.21 -2.31 -5.78 
!-.J 
!-.J 
U1 
1 
Appendix A. 25 Responses to AD plus Phent administered via the perfusion line at concentration ratios of 
10, 1 100 and 1 1000. From three preparations. 
Conc. 
1 x 10-sM D.K 
AD D.K% 
1 x 10-7M D.K 
AD D.K% 
Initial 
control 
+0.187 
+20.42 
+0.522 
+20.97 
1 10 
+0.179 
+18.88 
1 
0.0 
0.0 
100 
-0.125 
-5.44 
1 1000 
-0.137 
-9.79 
-0.077 
-5.77 
I\J 
I\J 
0'1 
Appendix A.26 Mean responses to ISO plus Prop administered as a single bolus at dose ratios of 1 1 to 1 20 (n = 2) . 
Dose 
200 pmoles 
ISO 
ratios of l 
Dose 
200 pmoles 
ISO 
Dose Initial l 1 Control 1 5 Control 1 10 Control 1 20 
ratio control 
8K -0.316 -0.123 -0.233 -0.0822 -0.233 -0.0783 -0.315 -0.219 
8K% -22.99 -6.04 -11.41 -3.61 -11.41 -3.37 -22.99 -9.64 
Mean responses to ISO plus Prop administered as separate boli, Prop preceding ISO by 10 minutes at dose 
1 to 1 : 20 ( n = 2). 
Dose Initial 1 1 Control 
ratio control 
8K -0.734 -0.083 -0.734 
8K% -58.88 -5.47 -58.88 
1 2 Control 
-0· .. 762 -0.730 
-4.76 -57.21 
1 5 
-0.125 
-4.79 
Control 
-0.721 
-55.35 
1 20 
+0.021 
+1.67 
l\J 
l\J 
-.J 
Appendix A.27 Responses to ISO plus DCI administered as a single polus, at dose ratios of 1 100 to 1 
From three preparations. 
Dose Dose Initial l lOO Control 1 200 Control 1 1000 
ratio control 
t:.K -0.059 -0.048 -0.059 -0.048 -0.059 -0.048 
500 pmo1es 
t:.K% 
-9.74 -3.53 -9.74 -3.53 -9.74 -3.53 
t:.K 
-0.413 -0.194 
l nmo1e 
t:.K% 
-27.41 -17.77 
1000. 
N 
N 
Cl) 
Appendix A.28 Mean responses to ISO plus DCI administered via the perfusion line at concentration ratios of 1 10 
to 1 : 1000 (n = 3) • 
Dose 
1 x 10-7M 
ISO 
1 x 10-SM 
ISO 
!:,.K 
!:,.K% 
6.K 
!:,.K% 
Control 1 10 
-0.332 -0.022 
-20.33 -1.99 
-0.575 -0.054 
-35.25 -6.89 
Control 
-0.332 
-20.33 
-Q.575 
-35.25 
1 
0.0 
0.0 
100 
+0.399 
+3.5.82 
Control 
-0.597 
-19.26 
-0.619 
-40.10 
1 1000 
+0.664 
+30.05 
+0.309 
+39.42 
N 
N 
1.0 
Prop 
DCI 
Prop 
DCI 
Appendix A.29 Mean responses to Prop and DCI control doses and concentrations. 
Dose 
11K 
I1K% 
11K 
I1K% 
Cone. 
11K 
I1K% 
11K 
I1K% 
1 nmoles 
-0.093 
-4.13 
5 x 10- 7M 
-0.152 
-7.73 
5 nmoles 10 nmoles 20 nmoles 30 nmoles 
-0.141 -0.352 -0.189 -0.227 
-6.06 -15.15 -7.37 -8.81 
-0.015 
-2.59 
1 x 10-sM 2.5 x 10-sM 5 x 10-sM 
-0.145 -0.208 
-5.45 -9.69 
0.0 
0.0 
50 nmoles 
-0.589 
-24.46 
1 x 10-sM 
-0.207 
-9.70 
-0.044 
-3.98 
100 nmoles 
-0.720 
-31. 72 
+0.055 
+9.09 
1 x 10-4M 
+0.034 
+3.02 
n == 3 
n = 2 
n == 4 
n = 2 
N 
W 
o 
Appendix A.30 Responses to ISO plus Phent administered via the perfusion line at concentration ratios of 1 
and 1 1000. From two preparations. 
Cone. Initial 
control 
1 x 10-aM -0.0718 
ISO -6.12 
1 x 10-7M -0.222 
ISO -14.5 
1 :10 Control 
-0.0747 -0.0718 
-7.01 -6.12 
1 1000 
-0.0864 
-7.36 
-0.376 
-26.79 
Final 
control 
-0.194 
-8.40 
10 
tv 
W 
I-' 
Appendix A. 31 Responses to AD plus Prop administered as a single bolus at dose ratios of 1 
From four preparations. 
Control 1 5 Control 1 10 Control 
10 pmoles D.K +0.103 +0.45 +0.266 
AD D.K% +8.47 +5.22 +16.83 
50 pmoles D.K +0.298 +0.193 +0 .367 +0.823 +0.986 
AD D.K% +23.24 +6.96 +22.49 +3.06 +71.68 
100 pmoles D.K +0.734 +0.678 +0.301 +0.0823 +1.313 
AD D.K% +59.88 +18.85 +18.33 +3.06 +94.29 
300 pmoles D.K +1.820 
AD D.K% +148.24 
500 pmoles D.K +0.928 +0.715 +1.537 +0.941 +2.427 
AD D.K% +75.70 +58.15 +93.33 +33.67 +173.14 
1 nmole D.K +3.273 
AD b.K% 206.91 
5 to 1 
1 100 
+0.084 
+3.34 
+0.211 
+8.18 
+0.344 
+13 .56 
+0.452 
+16.09 
+0.522 
+20.18 
+0.625 
+26.143 
100. 
IV 
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Appendix A.32 Mean outflow changes trols} ± 1 S.E. per minute of perfusion with AD. 
conc. of Initial flCQ flCQ flCQ flCQ flOQ 
n AD M OQ 0-1 1-2 2-3 3-4 4-5 
7 1 x 10-8 0.8593 +0.0073 +0.0022 +0.0145 +0.0081 +0.0084 
± 1 S.E. ±0.0667 ±0.0099 ±0.0037 ±0.0087 ±0.0045 ±0.0173 
7 1 x 10-7 0.8530 +0.0076 +0.0178 +0.0050 +0.0255 +0.0141 
± 1 S.E. ±0.0746 ±0.0072 ±0.0051 ±O .0194 ±0.0064 ±0.0103 
6 1 x 10-6 0.8650 +0.0646 +0.0137 -0.0168 -0.0129 -0.0229 
± 1 S.E. ±0.0552 ±0.0063 fO.0148 fO.0335 fO.0173 fO.0347 
7 1 x 10-5 0.8600 -0.0029 -0.0154 -0.0435 -0.0571 -0.0634 
f 1 S.E. ±0.0578 fO.Ol09 ±0.0238 fO.0234 ±0.0164 ±0.0263 
8 1 x 10-4 0.8628 -0.0077 -0.0224 -0.0616 -0.0628 -0.0773 
f 1 S.E. ±0.0573 fO.0112 fO.0170 fO.0202 ±0.0242 fO.0282 
6 1 x 10-3 0.8181 -0.0005 -0.0010 -0.0289 -0.246 
f 1 S.E. fO.0597 fO.0079 fO.0083 fO.0073 ±0.0044 
flCQ 
5-6 
+0.0051 
±0.0056 
+0.0262 
±0.0043 
-0.0076 
±0.0139 
-0.0432 
fO .0100 
-0.0568 
fO.0229 
flCQ 
6-7 
+0.0341 
±0.0072 
+0.0219 
±0.0054 
-0.0189 
fO.0315 
-0.0363 
fO.0031 
flCQ 
7-8 
+0.0143 
fO.OO72 
"-l 
W 
W 
Appendix A.33 Mean ol.lt::flow changes (mls) ± 1 S.E. per minute of perfusion with ISO. 
conc. of Initial t.OQ t.OQ t.OQ t.OQ t.OQ t.OQ 
n ISO M OQ 0-1 1-2 2-3 3-4 4-5 5-6 
5 1 x 10-9 1.1282 -0.0071 -0.0065 -0.0211 +0.0046 -0.0139 -0.0158 
± 1 S.E. ±0.0116 ±0.0118 ±0.0033 ±0.0084 ±0.0091 ±0.0096 ±0.0054 
6 1 x 10-8 1.1128 +0.0000 -0.0110 -0.0107 -0.0296 -0.0068 -0.0093 
± 1 S.E. ±0.0106 ±0.0043 ±0.0056 ±0.0065 ±0.0133 ±0.0069 ±0.0085 
6 1 x 10-7 1.1163 -0.0056 0.00866 -0.0147 -0.0130 -0.0105 -0.0160 
± 1 S.E. ±0.1085 ±0.0095 ±0.00864 ±0.0140 ±0.0083 ±O.0109 ±0.0105 
4 1 x 10-6 1.1290 +0.0673 -0.01824 -0.0090 -0.0269 +0.0038 0 
± 1 S.E. ±0.0954 ±O .0073 ±0.00851 ±0.0065 ±0.0074 ±0.0051 0 
4 1 x 10-5 1.0580 +0.0279 0.0 +0.0186 -0.0093 +0.0206 +0.0186 
± 1 S .E. • ±0.1532 ±0.0067 ±O.O ±0.0251 ±0.0089 ±0.0153 ±0.0094 
4 1 x 10-1j. 1.0141 +0.0149 +0.0052 +0.0021 +0.0035 +0.0100 +0.0053 
± 1 S.E. ±0.1747 ±0.0213 ±0.0137 ±0.0098 ±0.0103 ±0.0097 ±0.0121 
4 1 x 10-3 0.9028 0.0 +0.0179 0.0 +0.0171 -0.0030 
± 1 S .E. ±0.0982 ±O.O ±0.0106 ±O.O ±0.0314 ±0.0078 
t.OQ 
6-7 
-0.0132 
±0.0054 
-0.0886 
±0.0021 
+0.0093 
±0.0031 
+0.0071 
±0.0085 
t.OQ 
7-8 
+0.0168 
±0.0073 
+0.0241 
±0.0201 
t.OQ 
8-9 
+0.0031 
±0.0097 
(I.) 
w 
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Appendix A.34 Mean out:Uow changes Cmls} ± 1 S.E. each minute after injection of AD. 
n 
Dose of 
AD 
17 Blank 
_ l S.J:.. 
6 50 pmoles 
± 1 S.E. 
6 100 pmoles 
± 1 S .E. 
5 200 pmoles 
± 1 S.E. 
5 300 pmoles 
± 1 S.E. 
Initial 
OQ 
t>OQ 
0-1 
t>OQ 
1-2 
t>OQ 
2-3 
t>OQ 
3-4 
0.7352 +0.07614 +0.00293 -0.00789 
-'-v. \.... ~ ,_.:... _!_', J....L 
0.76408 0.0845 0.0~477 0.000245 -0.00144 
±0.1009 ±0.0196 ±0.00953 ±0.01533 ±0.00613 
0.76002 +0.09012 +0.019~ +0.00196 -0.0078 
±0.2038 ±0.0~46 ±0.0122 ±0.0178 ±0.00764 
< 0.78991 +0.0905 +0.01292 -0.001302 -0.01089 
±O.20039 ±0.00706 ±0.01334 ±0.01078 ±0.01485 
0.79146 +0.09099 +0.00753 -0.00271 -0.0182 
±0.2063 ±0.01475 ±0.00725 ±0.1155 ±0.0161 
t>OQ 
4-5 
+0.00148 
±0.0205 
-0.00464 
±0.00877 
-0.0047 
±0.00941 
-0.00822 
±0.01813 
t>OQ 
5-6 
-0.0110 
±0.00524 
+0.0054 
±0.0161 
-0.004?7 
±0.00731 
-0.00766 
±0.00607 
t>OQ 
6-7 
-0.0125 
±0.00648 
-0.0114 
±0.00480 
-0.0079 
±0.00531 
-0.0123 
±0.00608 
t>OQ 
7-8 
-0.0135 
±0.00751 
-0.00223 
±0.0162 
-0.004 
±0.00972 
-0.00490 
±0.0118 
t>OQ 
8-9 
-0.0171 
±0.00973 
-0.0037 
±0.0052 
0.000 
±O.OOO 
-0.0079 
±0.00014 
t>OQ 
9-10 
-0.00336 
±0.0249 
-0.0101 
±0.01l29 
0.000 
±O.OOO 
+0.0078 
±0.00215 
continued 
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Appendix A.34 (continued) 
Dose of Initial flOQ flO);! flO);! 
n AD O);! 0-1 1-2 2-3 
4 500 pmo1es 0.8173 +0.01195 +0.00345 -0.01188 
± 1 S.E. ±0.2187 ±0.00463 ±0.00959 ±O .0ll72 
5 1 nmo1e 0.8255 +0.09166 +0.00189 -0.0162 
± 1 S.E. ±0.2124 ±0.0109 ±0.02313 ±0.01756 
7 10 nmo1es 0.7535 +0 .09489 ... 0.0123 -0.0445 
± 1 S.E. ±0.1791 ±0.0136 ±0.02048 ±0.0389 
8 .l00 runo1es 0.7472 +0.07647 ... 0.04919 -0.08631 
± 1 S.E. ±0.1657 ±0.02628 ±0.03960 ±O .05449 
flO);! flO);! flO);! 
3-4 4-5 5-6 
+0.00718 +0.00060 +0.00421 
±0.0101 ±0.00085 ±0.0067 
-0.01474 -0.01004 -0.00517 
±0.0117 ±O .01019 ±0.00449 
-0.0439 -0.03140 -0.02518 
±0.02930 ±0.02578 ±0.02584 
-0.10468 -0.09755 -0.09660 
±0.05885 ±0.05828 ±0.04615 
floQ flO);! 
6-7 7-8 
+0.0085 +0.0078 
±0.0095 ±0.00667 
-0.00743 -0.00212 
±0.00621 ±0.00538 
-0.01665 -0.0200 
±0.02933 ±0.01860 
-0.09130 -0.08822 
±0.04851 ±0.04662 
flO);! 
8-9 
0.000 
±O.OOO 
-0.02231 
±0.0171 
-0.09302 
±0.04372 
flO);! 
9-10 
-0.02132 
±0.02567 
-0.0953 
±0.05218 
!I..l 
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Appendix A. 35 Mean outflow changes (mls) ± 1 S.E. each minute after, injection of NAD. 
Dose of Initial t.OQ t.OQ t.OQ t.OQ t.OQ t.OQ t.OQ 
n NAD OQ 0-1 J.-2 2-3 3-4 4-5 5-6 6-7 
14 Blank 0.5557 +0.06589 -0.00330 -0.00015 
± 1 S.E. ±0.0227 ±0.006308 ±0.008927 ±0.00431 
7 500 pmoles 0.6079 +0.08487 +0.00686 +0.00460 -0.00503 -0.00230 -0.00955 -0.00501 
± 1 S.E. ±0.0393 ±0.0112 ±0.00451 ±0.0130 ±0.00497 ±O .00472 ±0.00449 ±0.00599 
7 1 nmole 0.6149 +0.09598 ...,0.00236 -0.0135 -0.0135 -0.01692 -0.01539 -0.0147 
± 1 S.E. ±0.00396 ±0.0287 ±0.00515 ±0.O033 ±0.00515 ±0.00380 ±0.00890 ±0.00636 
5 10 nmoles 0.61897 +0.08479 -0.0260 -0.0444 -0.0425 -0.0378 -0.0337 -0.0308 
± 1 S.E. ±O.04160 ±O.00915 ±0.O111 ±0.0183 ±0.0126 ±0.01426 ±0.0145 ±0.0168 
4 100 nmoles .0.6006 +0.09938 -0.0781 -0.2064 -0.23135 -0.22821. -0.21026 -0.19079 
± 1 S.E. ±0.0420 ±0.0140 ±O.0132 ±O.O749 ±O.1064 ±0.1115 ±O.1096 ±0.lO127 
t.OQ t.OQ 
7-8 8-9 
-0.00278 +0.00583 
±0.00460 ±0.00505 
-0.00445 -0.00346 
±0.00392 ±0.00952 
-0.0124 -0.00937 
±0.00663 ±0.00957 
-0.1483 -0.1071 
±O.09500 ±0.O6133 
t.OQ 
9-10 
+0.00070 
±0.0080 
-0.0004 
±0.00864 
-0.01091 
±0.00981 
-0.09452 
±0.04907 
l\J 
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Appendix A.36 Mean outflow changes tmls) ± 1 S.E. each minute after injection of ISO. 
Dose of Initial LlOQ LlOQ LloQ LlOQ LloQ LloQ LlOQ LloQ LloQ LloQ 
n ISO OQ 0-1 1-2 2-3 3-4 4-5 5-6 6-7 7-8 8-9 9-10 
17 Blank 0.9186 +0.07876 +0.00124 -0.0008 
± 1 S.E. ±0.1370 ±0.01215 ±0.0130 ±0.0041 
I 
3 20 pmoles 1.29105 +0.08609 +0 •. 0144 +0.00006 -0.01065 +0.0104 +0.(>144 +0.0152 0.0 +0.0013 +0.0072 
± 1 S.E. ±0.2051 ±0.0139 ±0.0097 ±0.0084 . ±O .00937 ±0.0138 ±0.0138 ±o .0139 0.0 ±0.0159 ±0.0136 
4 500 pmoles 1.0945 +0.06909 +0.0088 -0.00895 -0.01145 -0.0238 -0.0105 +0.0072 -0.0105 
± 1 S.E. ±0.1478 ±0.0167 ±0.00624 ±0.0110 ±0.0099 ±0.ll20 ±0.0159 ±0.0097 ±O .0113 
5 100 pmoles 1.0556 +0.1017 -0.01317 -0.01351 -0.01449 -0.00408 -0.0232 -0.0311 -0.0216 0.0 
± 1 S.E. ±0.1230 ±0.0195 ±0.0103 ±0.0075 ±0.01148 ±0.00912 ±0.0106 ±0.00446 ±0.0075 ±O.O 
3 500 pmoles. 0.9475 +0.0982 -0.00694 -0.00751 -0.1192 -0.0005 -0.00769 +0.0009 -0.0071 -0.0093 
± 1 S.E. ±0.1560 ±0.0165 ±0.00342 ±0.00393 ±0.00179 ±0.0074 ±0.00629 ±0.0073 ±0.0059 ±0.0103 
7 1 nmoles 0.9426 0.07998 -0.00854 -0.1993 -0.0155 -0.0103 -0.02061 -0.00676 -0.0093 +0.0072 -0.0071 
± 1 S.E. ±0.1462 ±O .01413 ±0.0118 ±0.103 ±0.00297 ±O .0077 ±0.01151 ±0.0070 ±0.00186 ±0.00623 ±0.0093 
5 10 nmoles 1.0575 +0.05736 -0.0346 -0.02195 -0.01381 -0.01045 -0.0398 -0.03007 -0.0138 -0.0107 -0.0214 
± 1 S.E. ±0.13l6 ±0.00949 ±0.0107 ±0.00974 ±0.00899 ±O.00456 ±0.00507 ±O .01071 ±0.00581 ±0.009l ±0.01001 
4 100 nmoles 1.0500 +0.09206 +0.0165 +0.01423 -0.01916 +0.0108 +0.0108 +0.0143 -0.0107 0.0 +0.0014 
± 1 S.E. ±0.1601 ±O.0103 ±0.00556 ±0.00367 ±0.0114 ±0.00935 ±0.00935 ±0.0110 ±0.0093 ±O.O ±0.00713 
N 
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Appendix A.37 Lymph heart frequency changes (~LHf) and amplitude (LHamp) dur:j.ng and after perfusion with whole 
eel blood. 
No. 
NIB 
A255 
II06 
II07 
II08 
FREQUENCY 
mean 
1 S.E. 
AMPLITUDE 
mean 
± 1 S.E. 
Initial 
LHf LHamp 
82 4.0 
70 13.0 
82 3.5 
72 7.0 
86 5.0 
78.4 
±3.12 
6.5 
±1. 73 
~LHf LHamp 
-2 
0 
+12 
+4 
0 
0-1 
4.5 
15.0 
5.0 
7.0 
9.0 
+2.8 
±2.49 
8.1 
±1.90 
~LHf LHamp 
+4 
+2 
+10 
+10 
-1 
1-2 
6.0 
14.0 
8.0 
12.0 
10.0 
+5 
±2.19 
10 
±1.41 
~LHf LHamp ~LHf LHamp ~LHf LHamp 
2-3 3-4 4-5 
+4 5.5 +4 5.0 +4 4.5 
+2 13.0 +6 12.0 +5 12.0 
+8 6.5 +7 5.5 +7 5.5 
+9 13.0 +12 13.0 
0 9.5 
WHOLE EEL BLOOD 
+4.6 
±1. 71 
9.5 
±1.57 
+7.25 
±1.70 
8.87 
±2.11 
+5.33 
±0.88 
7.33 
±2.34 
~LHf LHamp 
5-6 
+7 5.5 
~LHf LHamp ~LHf LHamp 
0-1 9-10 
+8 3.5 +6 2.5 
+7· 9.0 +6 7.0 
0 5.5 +4 4.0 
+10 13.0 +2 7.0 
-2 8.0 0 7.0 
RINGER 
+4.6 
±2.35 
7.8 
±1.62 
+3.8 
±1.28 
5.6 
±0.88 
'" W ID 
n 
8 
8 
8 
8 
9 
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Appendix A.38 Mean lymph heart frequency changes (8LHf) and lymph heart amplitude (LHamp) during infusion of AD. 
Cone. of Initial 8LHf IHamp 8LHf LHamp 8LHf IHamp 8LHf LHamp 
AD M LHf, Amp 0-1 1-2 2-3 3-4 
1 x 10-0 62.12 -0.5 -0.25 +0.42 -0.28 
± 1 S.E. ±3.86 ±0.37 ±0.35 ±0.56 ±0.37 
_7 
1 x 10 63.87 -0.87 -0.75 -0.86 -1.28 
± l S.E. ±4.00 ±1.08 ±0.79 ±1.09 ±0.94 
1 x 10-6 67.2 2.3 +0.5 2.3 -1.25 2.56 +0.14 3.41 +0.28 4.75 
± 1 S .E. ±2.17 ±0.54 ±0.71 ±0.54 ±0.39 ±0.88 ±1.03 ±0.51 ±O.81 ±1.09 
1 x 10- 5 66.5 4.6 -0.25 4.7 +1.25 5.0 -0.37 5.45 +1.28 6.12 
± 1 S .E. ±4.07 ±0.42 ±0.87 ±0.05 ±0.39 ±0.62 ±0.77 ±0.65 ±0.69 ±0.48 
1 x 10-4 68.2 3.12 0 3.37 7.55 4.25 3.0 5.07 3.57 4.32 
± 1 S.E. ±3.63 ±0.77 ±0.93 ±0.79 ±0.68 ±0.73 ±1.13 ±0.71 ±1. 71 ±0.89 
1 x 10- 3 65.6 -1.0 +2.8 +9.0 
± 1 S .E. ±7.06 ±1.22 ±0.73 ±1.24 
continued 
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Appendix A.38 (continued) 
flLHf LHamp flLHf LHamp 
n 4-5 5-6 
8 1 x lO-a +0.20 -1.25 
± 1 S.E. ±0.96 ±0.75 
8 1 x lO-7 
-1.0 -1.0 
± 1 S.E. ±1.11 ±1.21 
8 l x 10-6 +2.0 5.12 +2.2 5.12 
± 1 S.E. ±0.86 ±1.06 ±1.02 ±0.95 
8 1 x 1Q-5 1.28 6.87 2.66 7.43 
± 1 S.E. ±1.09 ±0.32 ±0.91 ±0.38 
9 1 x 10-~ +2.5 5.98 +7.5 6.0 
± 1 S .E. ±1.69 ±0.87 ±1.08 ±0.97 
5 1 x lO-3 
± 1 S.E. 
flLHf LHamp flLHf LHamp 
6-7 7-8 
-0.66 0.0 
±1.04, ±O.O 
-0.66 -0.50 
±1.15 ±1.25 
+4.74 4.75 +2.3 5.0 
±1.49 ±0.79 ±1.91 ±0.96 
+2.33 6.62 
±1.13 ±0.55 
flLHf LHamp 
8-9 
0.0 
±O.O 
-1.0 
±1.50 
+12.5 5.0 
±0.78 ±0.96 
flLHf 
9-10 
+1.5 
±1.39 
LHamp 
5.0 
±0.96 
rY 
~ 
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Appendix A.39 Mean lymph heart frequency changes t~LHfl during each minute after injection of AD. 
Dose of Initial lUHf lUHf ~LHf tUHf flLHf flIRf flIRf flIRf 
n AD IRf 0-1 1-2 2-3 3-4 4-5 5-6 6-7 7-8 
4 1 nmole 78.25 ~1.0 -0.25 -0.5 +0.25 +1.0 +1.5 
± 1 S.E. ±1.84 ±1.22 ±0.63 ±0.85 ±0.29 ±0.49 ±0.85 
7 10 nmoles 55.0 -1. 71 +0.14 +5.71 +9.14 +12.5 . +15.0 +21.5 +23.66 
± 1 S.E. ±11.51 ±2.85 ±2.48 ±3.05 ±5.31 ±6.94 ±8.33 ±9.36 ±10.00 
9 100 nmo1es 68.33 -0.44 +3.66 +10.33 +13.88 +14.44 +13.66 +13.77 +14.33 
. 
± 1 S.E. ±6.03 ±0.33 ±1.21 ±2.47 ±3.05 ±3.97 ±4.22 ±4.59 ±5.78 
flIRf 
8-9 
+35.75 
±10.65 
+15.20 
±6.57 
flIRf 
9-10 
+35.75 
±10.39 
+14.16 
±5.98 
I;..) 
0I:>-
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n 
6 
7 
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Appendix A.40 Mean lymph heart frequency changes (IlWfl and lymph heart amplitude each minute after injection of NAD. 
Dose of 
NAD 
500 pmo1es 
± 1 S.E. 
1 runo1e 
± J. S.E. 
10 runo1es 
± J. S.E. 
100 runo1es 
1 S.E. 
Initial 
wf IEamp 
40.83 
±5.25 
35.57 
±5.53 
41.01 2.35 
±3.02 
39.16 2.1 
±7.57 
llIEf IE amp llIEf 
0-1 
0.0 
±O .03 
-0.86 
±0.51 
+1.80 2.35 +3.45 
±1.02 ±2..30 
-0.16 2.35 +0.66 
±1.64 ±1.02 
IE amp 
1-2 
+0.16 
±1.02 
+0.14 
±1.09 
2.37 
3.35 
llLHf LHamp llLHf IE amp llIEf IEamp 
2-3 3-4 4-5 
-1.0 -0.16 +0.08 
±1.58 ±1.43 ±1.25 
-1.57 1.14 2.71 
±1.04 ±2.55 ±2.97 
+5.41 2.5 +5.41 -3.0 +6.0 3.65 
±3.32 .29 .21 
-0.16 3.6 +4.52 3.75 +8.83 3.5 
±1. 71 .23 ±4.11 
continued 
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Appendix A.40 (continued) 
Dose of t::.LHf LHamp t::.LHf lHamp t::.LHf lHamp t::.LHf lHamp t::.LHf LHamp 
n NAn 5-6 6-7 7-8 8-9 9-10 
6 500 pmo1es -0.33 -0.40 +0.33 0.0 -0.5 
± l S.E. ±0.87 ±l.30 ±0.28 ±0.59 ±0.45 
7 l nmo1e -0.l4 0.57 -0.57 -1. 33 -2.0 
± l S.E. ±2.ll ±2.42 ±0.6l ±0.99 ±0.99 
5 lO nmo1es +4.8 3.75 +5.2 3.5 +5.2 4.0 +6.66 3.75 +4.66 4.0 
± 1 S.E. ±4.05 ±3.87 ±3.86 ±4.93 ±4.9 
6 lOO nmo1es +9.83 3.56 +9.83 3.75 +lO.8 4.0 +lO.5 4.0 +11.5 4.0 
± l S .E. ±4.85 ±4.87 ±5.8l ±6.l9 ±6.25 
Note. Standard errors for lymph heart amplitude are not given as only two preparations each at lO and 100 nmo1es gave 
sufficiently large records to accurately measure amplitude. 
N 
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Appendix A.41 Mean values of cardiovascular parameters ± 1 S.E.M. during swimming at 15 cm s-1. n = 8 
Kb Q .0.Pg VAP DAP .0.Pt CVP Heart rate 
kPa m1- 1min ml min- 1 kPa kPa kPa kPa kPa beats min- 1 
rest 0.350 ± 0.071 6.95 ± 1.19 2.01 ± 0.203 5.15 ± 1.32 3.14 ± 0.146 2.14 ± 0.0987 0.989 ± 0.166 53.5 ± 1.07 
5 min 0.299 ± 0.0544 7.38 ± 1.22 1. 79 ± 0.139 4.81 ± 0.115 3.02 ± 0.0776 2.08 ± 0.0823 0.889 ± 0.112 52.9 ± 1.06 
swimming 
15 min 0.365 ± 0.0788 7.025 ± 1.23 2.07 ± 0.264 5.19 ± 2.00 3.14 ± 0.131 2.26 ± 0.186 0.881 ± 0.140 53.9 ± 0.953 
swimming 
30 min 0.248 ± 0.0481 8.81 ± 1.52 1.98 ± 0.0596 5.13 ± 0.202 3.15 ± 0.0619 2.00 ± 0.198 1~14 ± 0.173 53.8 ± 1.56 
swimming 
t..J 
~ 
IJI 
Appendix A.42 Mean values of cardiovascular parameters ± 1 S.E.M. during swimming at 22-25 cm s-l. n = 6. 
Kb Q LlPg VAP DAP LlP t CVP Heart rate 
kPa ml- 1min m1 min- 1 kPa kPa kPa kPa kPa beats min- 1 
rest 0.322 ± 0.0405 6.79 ± 1.20 2.23 ± 0.300 5.26 ± 0.510 3.03 ± 0.223 2.23 ± 0.286 0.715 ± 0.0594 47.8 ± 2.21 
5 min 0.462 ± 0.0474* 6.36 ± 0.856 2.92 ± 0.616 5.99 ± 0.0544 3.07 ± 0.156 1.96 ± 0.257 0.884 ± 0.111 50.0 ± 2.32 
swimming 
15 min 0.534 ± 0.0746* 6.43 ± 1.16 3.33 ± 0.609 6.24 ± 0.486 2.91 ± 0.202 2.079 ± 0.241 0.804 ± 0.614 49.2 ± 3.05 
swimming 
30 min 0,568 ± 0.0717* 6.28 ± 1.03 3.60 ± 0.767 6.64 ± 0.569 3.04 ± 0.236 2.17 ± 0.227 0.912 ± 0.100 49.8 ± 2.18 
swimming 
* indicates significant change from resting value at P < 0.05 level. Paired Student's t-test. 
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Appendix A.43 Mean values of cardiovascular parameters ± 1 S.E.M. during recovery from swimming. n = 12 
Kb Q - b,Pg VAP DAP kPa ml-1min ml min 1 kPa kPa kPa 
End of 
swimming 0.555 ± 0.084 6.25 ± 0.831 2.96 ± 0.390 6.01 ± 0.335 3.06 ± 0.126 
trial 
5 min 0.394 ± 0.071** 7.09 ± 0.987* 2.30 ± 0.333* 5.37 ± 0.278* 3.06 ± 0.125 
rest 
15 min 0.382 ± 0.0696** 7.18 ± 1.06* 2.25 ± 0.335* 5.33 ± 0.255* 3.08 ± 0.127 
rest 
30 min 0.35J. ± 0.0706* 7.525 ± 1.075* 2.25 ± 0.423* 5.34 ± 0.313* 3.08 ± 0.127 
rest 
* indicates significant change from value at end of swimming trial at P < 0.05 level. 
** indicates significant change from value at end of swimming trial at P < 0.01 level. 
Paired Student's t-test. 
b, Pt CVP 
kPa kPa 
2.09 ± 0.100 0.950 ± 0.0985 
2.14 ± 0.130 0.921 ± 0.107 
2.14 ± 0.130 0.887 ± 0.120 
2.33 ± 0.183 O. 751 ± O. 164 
Heart rate 
beats min- 1 
48.2 ± 2.23 
50.5 ± 1.45 
50.9 ± 1.49 
50.0 ± 1.62 
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Endpiece 
(Reproduced with the kind permission of Mr Murray Ball.) 
